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ABSTRACT  
Vascularization is recognized to be the biggest challenge for the fabrication of 
tissues and finally, organs in vitro. So far, several fabrication techniques have been 
proposed to create a perfusable vasculature within hydrogels, however, the vascularization 
and perfusion of hydrogels with mechanical properties in the range of soft tissues has not 
been fully achieved. 
My project focused on the fabrication and the active perfusion of hydrogel 
constructs with multi-dimensional vasculature and controlled mechanical properties 
targeting soft tissues. Specifically, the initial part of the research has focused on: (1) the 
fabrication and characterization of gelatin constructs with 2D and 3D perfusable vasculature 
and (2) the development of a fluidic platform to allow the direct perfusion of the fabricated 
constructs. Throughout the developed technology, it was possible to fabricate and perfuse 
densely populated constructs integrating a 3D vasculature. Also, it was possible to fabricate 
and test a hydrogel-based fluidic system integrating sensors capable of simulating a barrier 
environment.  
 
The research presented in this thesis is part of the EU-funded FP7 project 
NanoBio4Trans (“A new nanotechnology-based paradigm for engineering vascularised liver 
tissue for transplantation”) and the Danish National Research Foundation and Villum 
Foundation’s Center for Intelligent Drug delivery and sensing Using microcontainers and 
Nanomechanics (Danish National Research Foundation (DNRF122). 
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CHAPTER 1 
INTRODUCTION 
Tissue engineering (TE) has emerged to address the major issues concerning organs 
transplantation, such as the absence of available organs for the patients in the waiting list 
and the problems related to the immune response of the patient organism after the donated 
organ [1–4]. In this context, it was necessary to design and fabricate functional and living 
tissues using living cells, which are usually associated with a support matrix to guide tissue 
development [5]. Although in the last 30 years there have been extensive progress in the TE 
field, the fabrication of engineered thick tissues and organs such as the heart, kidney, and 
liver remains a challenge [3,6]. One of the major problem concerning the fabrication of thick 
engineered tissues, and finally organs, rely on the absence of a perfusable vasculature [6–
18]. The absence of a perfusable vasculature means that the three-dimensional (3D) 
engineered tissue construct will not have sufficient oxygen, nutrients, waste removal and 
gas exchange needed for its maturation in time [7,11]. In the normal TE approach 
bioreactors are responsible to induce the transport of oxygen and nutrients by means of the 
fluid flow [19–32] whereas scaffolds, which are responsible to give a temporal extracellular 
matrix (ECM) for the cells, are most of the times porous structures that can be perfused 
[1,24,33–40]. This combination could partially overcome the limitations of the absence of a 
perfusable vasculature when fabricating large and tick tissue constructs [12,24,25,35,36,41–
44]. However, a 3D porous scaffold is not able to produce the characteristic 3D cell-cell 
cell-ECM interaction presented in vivo [27,45–50]. By contrast, if the scaffold is just a 
combination of cells encapsulated in a hydrogel material (e.g., cell-laden hydrogel) capable 
to present a more in vivo like environment, the bioreactor is not sufficient anymore to 
guarantee the appropriate level of nutrients and oxygen while extracting metabolic waste 
from the cells in the inner core of the a thick construct [27,29,51–54]. Cell-laden hydrogels 
without a network of channels are unable to provide physiological cues such as oxygen 
nutrient and growth factors (essentially all para and autocrine factors) required to the cells 
for growing, and fusing together to form large functional tissues and ultimately organs 
[18,55]. By contrast, at the organ level, the cells are 3D distributed around a vascular branch 
responsible to guarantee the physiological factors required for the cells to maintain their 
homeostasis [4,12]. 
Despite the advances in the biofabrication technology, it is still challenging to 
fabricate thick, functional and densely populated engineer constructs with an integrated 
vascular network [7,55]. In addition, the available fabrication techniques don’t allow the 
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fabrication of tissue engineer constructs with multi-scale vascular network, able to resemble 
the human vascular anatomy [55]. Moreover, while fabricating the construct, it is still difficult 
to control at the same time the mechanical properties of the ECM used to simulate the bulk 
where the cells are encapsulated and to control the complexity of the vasculature within the 
ECMs [7,55]. Finally, the success of the tissue constructs relies on the time needed for its 
maturation [25]. This means that the construct should stay in a controlled environment (e.g., 
temperature, pH, O2, CO2) to give time for the cells to grow to remodel the ECM with which 
continuously interacts, to form tissues and finally organs. Therefore, not only is crucial the 
ability to fabricate constructs with perfusable vasculature but it is also crucial to induce 
these constructs to be actively perfused to ensure the cells encapsulated within the 
construct to be metabolically functional and to mature in a more complex and functional 
construct [51,56].  
1.1 Background 
Many TE approaches involve the use of cells cultured in vitro on a biomaterial 
scaffold to generate functional tissue constructs [20,25,57]. However, it is not sufficient to 
generate functional constructs, since the in vivo biophysical environment is dynamically 
more complex than a static culture of cells on a scaffold [8,58–60]. It is also well understood 
that traditional two-dimensional (2D) culture techniques cannot recapitulate the 
microenvironment experienced by the cells and tissues [47,61] In a 2D environment the cells 
are not able to experience the typical cell-cell, cell-ECM interaction and temporal chemical 
gradients in a 3D configuration as it happens in a tissue. Therefore, the control of the in vitro 
environment represents one of the key challenges to produce 3D constructs able to 
resemble the in vivo milieu [27,62,63] (Figure 1.1).  
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Figure 1.1. The behavior of individual cells and the dynamic behavior of multicellular tissues 
is regulated by complex bidirectional molecular interactions between cells and 
the 3D ECM. This ECM is a hydrated protein and proteoglycan-based gel 
network that comprise soluble and physically bound signals and signals 
originating from cell-cell interactions. The specific binding of these signaling 
cues with the cell-surface receptors induces complex intracellular signaling 
cascades that converge to regulate gene expression, establish cell phenotype 
and direct tissue formation, homeostasis and regeneration. The image is 
reprinted from [64].  
In particular, the working hypothesis is that the precise control of the in vitro culture 
conditions would have a significant influence in the control of the structure, composition, 
biochemical and biological function and mechanical properties of the engineered tissues 
[19,20,25]. The main constituents that are responsible for defining the in vitro culture 
conditions or model are: 3D tissue-engineering scaffold systems, bioreactors, growth 
factors, and mechanical conditioning regimens that control cell behavior and functional 
tissue assembly [19,20,25,65]. Therefore, the general strategy used to engineer functional 
tissues in vitro rely on four main building blocks: cells, scaffolds, bioreactors and growth 
factors Figure 1.1).  
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Figure 1.2. Cells, scaffolds, bioreactors and growth factors are the four building blocks 
required for the fabrication of functional tissues in vitro. The image is reprinted 
from [25].  
There have been several reports in the last decade where describing how to 
manipulate the cell environment using scaffolds, bioreactors, and signals together for 
guiding the cell behavior to create functional tissue engineered constructs able to resemble 
the in vivo complexity. As an example, there have been an extensive research on the 
creation of tissue engineered constructs for the cartilage [66–68], bladder [69–72], bone [73–
77], and human skin [78–81]. In addition, there have been attempts to engineer more 
complex organs such as the heart [65,82–85], the kidney [86–88] and the liver [30,89–92]. 
Despite that great success for simple organs (i.e., cartilage, the bladder, and the skin) both 
from a research point of view and from translational point of view with the artificial skin (e.g., 
Derma graft®, Alloderm®) and blood vessel substitutes (e.g., Goretex®, Dacron®), the 
same didn’t occurred for the more complex ones [3,60]. The simple organs were easier to 
engineer because they are characterized by simple and small geometries, small demand for 
blood vessels, and small cell consumption rate. By contrast, it was extremely complex to 
engineer thick and functional tissues or organs, mainly because of the absence of an 
efficient media exchanger to guarantee an adequate level of oxygen and nutrients while 
removing the waste [12,93]. The absence of an efficient media exchanger caused a 
nonhomogeneous cell distribution and limited cell activity.  
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1.2 Fabrication of tissue engineered constructs 
The basics behind the tissue engineering process involves: a cellular or several 
cellular candidates depending on the final application, cellular incubation and proliferation 
(when is possible), design and fabrication of a 3D biomaterial scaffold, scaffold seeding with 
the incubated cells, construct cultivation by means of a bioreactor, tissue generation and 
implantation (Figure 1.2) [20,25]. The bioreactor, and the scaffold plays the decisive role in 
manipulating the cell environment and guiding the cell behavior [51,77,94] 
1.2.1 Cells 
When fabricating functional tissue engineer constructs with relevant dimensions, one 
of the critical aspects resides in the type of the utilized cells, the available amount and 
available source of them. In general, cells can be extracted from various sites and sources 
(e.g., solid tissues, or fluidic ones such as bone marrow or blood) [95]. Once the cells are 
divided by source categories, generally they are grouped into: autologous cells, allogenic 
cells, xenogeneic cells. Every group comprises primary cells, cell lines and stem cells. 
Recently many researchers have started to favour the use of autologous cells in 3D cultures 
applications. This is because autologous cells are seen as a more relevant tool for studying 
human biology and also in review of a possible clinical application. As an example, a 
previous study showed chondrocyte cells isolated from a small and healthy biopsy of the 
cartilage. The isolated chondrocyte were seed onto a poly(lactic acid) (PLA) scaffold 
creating 3D constructs that were implanted in 12 different patients. The implanted 
constructs were able to form new cartilage tissue showing the success of the application 
[96]. However, autologous cells are difficult to be isolated from the tissue source, and most 
of the time they are not available. In addition, once the primary cells are cultivated in vitro 
they lose the ability to proliferate limiting therefore the available number of cells at 
disposable for the fabrication of densely populate constructs. On the contrary, allogenic 
cells can be used in clinical application but it must be considered complications regarding 
the immune incompatibility. Xenogeneic cells were used for clinical purposes where was 
necessary to supply or to remove chemicals within a tissue or organ. As an example, 
xenogeneic cells where used to fabricated a bioartificial liver (BAL). Here, the developed 
BAL consisted on a bioreactor with porcine hepatocytes that populates non-woven 
polyester matrix. Patient plasma flows through the bioreactor into direct contact with the 
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porcine hepatocytes without provoking any downsides moving the BAL to phase one trial 
[97].  
Stem cells are also used as an alternative of primary cells since they represent a new 
source of cells. In addition, stem cells are capable of proliferate and they have the capacity 
to be self-renewal [98,99]. This means that once proliferated, the resulting daughter cells 
continues to be unspecialized, like the parent stem-cells. Remarkable advances have been 
made in isolation, expansion, characterization [4,100–104]. In fact, the number of sites 
available for stem cells isolation comprises: embryonic stem cells (ES) from discarded 
human embryos [105], induced pluripotent stem (IPs) cells by genetic reprogramming of 
somatic cells [106], and adult stem cells (so named regardless of sourcing, from fetal, 
neonatal, pediatric or adult) either autologous or allogeneic (Figure 1.3) [107]. Stem cells are 
called multipotent (ES, IPs) or, if constrained to a single fate, unipotent (adult stem cells) 
[108,109]. 
 
Figure 1.3. Stem cells source used in TE application. Adult stem cells can be isolated from a 
patient biopsy (autologous) or can be isolated from tissue donors. By contrast, 
pluripotent stem cells can be used to achieve potentially any desired cell line by 
reprogramming to pluripotency cells from the available cells obtained from 
biopsy. Allogeneic cells can be sourced form tissue donors. The image is 
reprinted from [4].  
Despite the theoretical possibility to drive stem cell differentiation towards any 
cellular lineage, there is a still a challenge in direct the differentiation with accuracy towards 
an intended phenotype. (46,47). As an example, Engler et al., demonstrated that when 
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mesenchymal stem cells (MSCs) are cultured in a hydrogel with control mechanical 
properties with the presence of soluble induction factors, the MSCs differentiate towards 
the lineage specified by the matrix elasticity (Figure 1.4).  
 
Figure 1.4. (A) Solid tissues exhibit different mechanical properties, as measure by the 
elastic modulus (i.e., E) and (B) The mechanical properties of the hydrogel are 
controlled trough crosslinking and the control of cell adhesion is mediated by 
using collagen-I. The mechanical properties of the gel system were capable to 
guide the MSCs differentiation towards the brain (0.1-1 kPa), muscle (8-17 kPa) 
and the bone (25-40 kPa), after 96 hours of culture. The image is reprinted from 
[110].  
1.2.2 Bioreactors 
The bioreactor is responsible to initiate, maintain and direct cell growth and tissue 
development in a well-defined, closed and controlled culture conditions (e.g., pH, 
temperature, pressure, nutrient supply and waste removal) [21]. Bioreactors have been 
successfully used to overcome the limitations associated with oxygen and nutrient transport 
that are often observed in tissues cultured in static environments. , and to enhance matrix 
synthesis and mechanical properties by biophysical stimulation of the fabricated constructs 
[19,111,112]. In fact, static cell culture techniques are unable to support 3D cultures or 
tissues because they depend on diffusional transport mechanisms that are efficient only 
through a thin superficial layer in contact with the medium culture (in most cases only within 
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~100-200 µm) [113]. In addition, as the cell density increase, so does the nutrient requested 
by the cells. As consequence, nutrients are depleted over short distances leading the cells 
positioned further from the source of nutrients and oxygen to die [113–116]. Different 
bioreactors have been designed and developed to increase the mass transport between the 
cells within the scaffolds and the culture medium (Figure 1.4) [21,26,117]. Spinner flask 
bioreactors create an undulating motion of the culture medium to limit the size of the 
stagnant cell layer present at the surfaces of tissue constructs. Spinner flask have been 
used to culture 3D constructs [118]. The medium stirring generate by the bioreactor 
enhances external mass-transfer but also generates turbulent at the edges that could be 
damaging for the development of the tissue (Figure 1.5(A)). Rotating-wall bioreactors 
provide a dynamic culture environment to the constructs, with low shear stresses and high 
mass-transfer rates. The bioreactor rotates at a rate that induces the drag force (Fd), 
centrifugal force (Fc) and net gravitational force (Fg) on the construct to be balanced to 
guarantee that the construct remains in a free-fall state within the culture medium. (Figure 
1.5(B)) [26,114]. A possible drawback of associated with the spinner flask and the rotating 
bioreactors resides on the generation of shear stresses that could cause cell differentiation 
[119]. Also, the size and viability of the tissue constructs is strictly depended on the internal 
diffusion of nutrients, since there is no perfusion throughout the construct. Another 
configuration of bioreactor used is the hollow-fiber (Figure 1.5(C)). It is used to enhance the 
mass transport of highly metabolic and sensitive type of cells, like the hepatocyte. In fact it 
is the preferred configuration used in the design of BAL [120]. Finally, the perfusion 
bioreactor represents the best configuration in terms of mass transport since the medium is 
pumped through the 3D constructs (Figure 1.5(D)). In fact, the easiest way to increase the 
transport of mass in a scaffold is to increase the diffusion using the convection [116]. The 
medium pumped through the scaffold is capable to provide nutrients and oxygen, removing 
waste, in the inner areas of the porous construct that wouldn’t be reached by means of 
simple diffusion. Perfusion bioreactor were successfully used for the culture of 3D 
constructs [121,122]. As an example, Figallo et al. developed a perfusion micro-bioreactor 
able to perfuse porous 3D scaffolds and thin layers of hyaluronic acid hydrogel (HA) using 
different flow configurations [121].  
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Figure 1.5. Bioreactors used in TE applications to enhance the mass transport: (A) spinner 
flask bioreactor., (B) rotating-wall bioreactor, (C) hollow fiber bioreactors and (d) 
direct perfusion bioreactors. The image is reprinted from [114].  
1.2.3 Scaffolds 
The scaffold is not only a temporary “support” for the cultured cells to growth and 
proliferate, but it is a complex 3D matrix with suitable physical (e.g., stiffness and mass 
transfer) and chemical (e.g., employed material type and degradation rate) properties 
[35,51,123–126]. It has been demonstrated that cells are capable to sense and to interpret 
the information coming from the ECM [127–132]. The topography, mechanical properties 
(e.g., stiffness, viscosity and elasticity), molecules presented by the ECM, and the 
concentration gradients of soluble growth factors represents some of the characteristics 
presented by the scaffold [34,40,57,123,133]. Therefore, the cells receive and process a 
multiple combination of physicochemical and biological cues always within a 
spatiotemporal context by reorganizing themselves via cell–cell contacts [134] and cell–
ECM interactions [135]. As an example, it has been show that using gel matrices with well-
controlled elasticity, and non-limiting ligand density, all cells were found to adhere, to 
spread and to anchor more strongly to stiff substrates compared to soft ones (Figure 1.6(A-
B)) [136]. Dolega et al. demonstrated that spheroids grown under isotropic compression 
presented reduced proliferation capacities within the center in comparison to the ones 
grown in normal conditions (Figure 1.6(C)) [137]. Finally, it has been shown that the cell-
ECM interaction can be a more potent cue of differentiation for MSCs than standard 
induction methods. In particular, human MSCs encapsulated in poly(ethylene glycol) (PEG) 
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functionalized with various small molecules were induced to proliferate towards osteogenic 
and adipogenic pathways. Benoit et al. demonstrated that by controlling the 3D 
environment using tethered small-molecule chemical functional group dispersed within the 
hydrogel material it was possible to control the induction of multiple MSCs lineage [138]. 
 
Figure 1.6. Soft tissue elasticity scale ranging from soft brain, fat, striated muscle to stiff 
cartilage and precalcified bone. (B) In vitro substrates mimicking soft and stiff 
tissue microenvironments: cells anchor more strongly to stiff substrates, 
whereas for softer substrates the force of adhesion is weaker. The images are 
reprinted from [127]. (C) Cellular proliferation along the radius of a spheroid 
grown under a mechano-osmotic stress of 1 and 5 kPa in respect to the control 
(0 kPa). The images is reprinted from [137] . 
All these considerations are crucial when choosing the biomaterial and the 
fabrication technique employed to fabricate the scaffold [139,140]. From an engineering 
stand-point, it is important that the scaffold integrates all the regulatory functions and 
properties within the scaffold design in a reproducible and controlled way. This is crucial 
because the design of the scaffold would be primarily responsible to induce and control the 
tissue formation in a stepwise manner [64,141] (Figure 1.7). 
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Figure 1.7. Breakdown of the processes necessary to understand the design principles and 
the enabling technologies to design and fabricate a scaffold. Adapted from [142] 
. 
1.2.3.1 Biomaterials 
The two main classes of biomaterials used to fabricate TE scaffolds are biologically 
derived and synthetic polymers [143]. Biologically derived polymers are materials created by 
living organisms whereas synthetic polymers are man-made.  
1.2.3.1.1 Biologically derived polymers: collagen and gelatin 
One important class of biologically derived materials are the proteins [50,143,144]. 
Proteins are polymers derived from naturally occurring a-L-amino acids, where the 
connection of the amino acids are obtained through hydrolytically stable amide bonds. This 
means that these materials are degraded through enzymatic mechanisms. The main 
limitations connected to protein polymers are represented by their inherent immunogenicity, 
their lack of ’processibility’ and their mechanical properties for their use as medical implants 
[143]. The immunogenicity is because proteins carries the risk of being recognized as 
foreign by the patient’s immune system since they are created by living organisms. The lack 
of ’processibility’ is the major shortcoming of proteins as starting materials of the fabrication 
of medical implants. The ’processibility’ means the ability of creating a shaped device by 
any of the conventional processing technologies used in the plastic industry: compression 
molding, extrusion, injection molding and fiber spinning. Finally, their weak mechanical 
properties make the proteins the worse candidate to fabricate medical devices. By contrary, 
the outstanding biological properties presented by the proteins makes them the perfect 
candidate for designing polymers with controlled biological activities. Two of the main used 
proteins in TE applications are collagen and gelatin [145]. 
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Collagen represents the richest protein in the human body (~ 30%) as well as the 
main component of the ECM of many tissues. Fibroblasts and osteoblast cells are the ones 
that mostly synthetizes collagen [146]. So far, fourteen types of collagen have been 
identified [147]. Among all, collagen I is the most abundant since is extracted from several 
tissues (e.g., skin, ligaments, bones) by acid and enzymatic treatments [148]. In addition, 
thanks to its unique physical and biological properties, collagen I has been extensively used 
in the formulation of biomedical materials [146]. The structure of type I collagen has been 
extensively investigated, and it consist of a triple helical structure extending over a large 
portion of the molecule [149]. The helices are organized in complex supramolecular 
structures and every third amino acid of the helix chain is a glycine [150]. The remaining (~ 
one third) amino acids presented in the helix chain are proline and hydrosyproline with their 
side chains pointing towards the outer region of the helix [150]. Because of the well-
conserved primary sequence and its helical structure collagen I is only partially 
immunoreactive [151]. Collagen can be fast biodegraded in via collagenases and 
metalloproteinases enzyme to yield the corresponding amino acids. The free amines on 
lysine residues on collagen can be used for crosslinking to increase the mechanical 
properties of type I collagen and to modulate the rate of degradation [152]. It has been 
recognized that substrate attachment sites are crucial for growth, differentiation, replication, 
and metabolic activity of most cell types in culture [153]. Collagen represents a perfect 
candidate since it presents integrin-binding domains (e.g., arginine glycine-aspartic acid 
(RGD) sequences). As an example, fibroblast grown on a 2D collagen matrices differentiate 
in ways that resembles the in vivo cellular activity exhibiting almost identical morphology 
and metabolism [150]. In addition, when cultured in collagen matrices, chondrocytes are 
capable of maintain their phenotype and cellular activity [154]. These results show that type 
I collagen represents a good candidate for the fabrication of tissue engineer scaffolds for 
almost any number of cell constructs. Moreover, collagen has been used in several TE 
applications [155], such as cartilage repair [156], bone regeneration [76] and the most 
common clinically used biomaterial for skin repair [78].  
Gelatin is the product of the rupture of the collagen triple helix into single-strain 
molecules [157]. Two different types of gelatin can be obtained by two different collagen 
treatments. The first type of gelatin can be obtained by the hydrolysis of the amide groups 
of asparagine and glutamine carboxyl groups whereas the second type of gelatin is 
obtained from an acid treatment. This means that the variations in the collagen treatment 
allows the gelatin to bind with either positively or negatively charged molecules [158]. In 
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contrast to collagen, gelatin exhibits limited antigenicity due to heat denaturation [145]. In 
addition, the important bioactive sequences presented by the collagen (e.g., RGD peptides) 
for cell attachment and matrix metalloproteinase (MMP)- sensitive degradation sites are 
retained in the gelatin backbone [159]. This is extremely important because critical cellular 
functions like migration, proliferation, and differentiation, can be modulated via integrin 
mediated cell adhesion and cell-mediated enzymatic degradation [144,160,161]. Gelatin is 
thermo-responsive hydrogel: this means that gelatin undergoes into a reversible sol-gel 
transition by decreasing the temperature below 37 °C, while liquefies by heating at 
physiological temperatures. To stabilize gelatin at physiological temperatures, gelatin can 
be chemically or enzymatically cross linked with different crosslinking agents (e.g., 
glutaraldehyde [162], formaldehyde [163], genipin [164], microbial transglutaminase (TG) 
[126,165]) [166,167]. As an example, TG was used to fabricate gelatin scaffolds with tunable 
degradation rates. Yung et al. showed that HEK 293 cells encapsulated in TG crosslinked 
gelatin were capable of proliferate forming spheroids that increased in size in time. They 
also showed that the construct was stable a physiological temperature and showed that 
proteolytic degradation was controlled by surface erosion [126]. Gelatin has been 
chemically modified, where methacrylate groups were added to the its lateral chains 
creating a photo-crosslinkable gelatin-methacryloyl (gelMA) [144]. GelMA has been 
extensively used as a bioink for fabricating bioprinted constructs [144]. 
1.2.3.1.2 Synthetic polymers: poly(lactic acid) (PLA) and poly(vinyl alcohol) (PVA) 
PLA is an aliphatic polyester widely used in the fabrication of porous scaffolds for TE 
applications [168]. PLA is biocompatible, biodegradable, highly hydrophobic with limited 
water uptake and soluble in organic solvents (e.g., choloroform) [169]. PLA with different 
molecular weight has been produced by a multistep process where, firstly the cyclic dimer 
of the lactic acid is produced and isolated and secondly the isolated product is used as 
monomers ring-opening polymerization [170]. Considering that PLA is made by a lactic acid, 
which is a chiral molecule, it exists in two stereoisomeric forms that give rise to four 
morphologically distinct polymers. The first two are D-PLA and L-PLA, which are the 
stereoregular polymers; the second two are D,L- PLA, which is the racemic polymer 
obtained from a mixture of D- and L-lactic acid, and meso-PLA can be obtained from D,L-
lactide [143]. The differences in the crystallinity of D,L- PLA and L-PLA have important 
practical considerations. On one hand, D,L- PLA is usually considered for application such 
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drug delivery since is an amorphous polymer [169]. On the other hand, the semi-crystalline 
L-PLA is employed in application where high mechanical strength is required (e.g., sutures 
and orthopaedic devices) [171,172]. In fact, L-PLA (PLLA) is a rigid material that has a glass 
transition temperature (Tg) of approximately 60 °C, and a melting point temperature (Tm) of 
180 °C. The PLLA Young’s modulus is close to 3.5 GPa while its stress at break is 65 MPa 
and a maximum break elongation smaller than 6 % [173,174]. PLLA polymers degrade by 
hydrolysis: the degradation starts with upper uptake followed by random cleavage of the 
ester bonds in the polymer chain. The degradation is throughout the bulk of the material 
[175]. During the degradation of semi-crystalline PLLA, the crystallinity of the residual 
material increases because the degradation takes place initially in the amorphous domains 
[176]. By contrary. the final degradation and resorption of the PLLA implants involves 
inflammatory responses. Although this late-stage inflammatory response can have a 
deleterious effect on some healing events, PLLA has been successfully employed as 
matrices for cell transplantation and tissue regeneration [177,178]. 
PVA is a synthetic polymer produced via partial or full hydrolysis of the poly(vinyl 
acetate) [179]. The physical, chemical and mechanical properties of the PVA it is dependent 
from the degree of hydrolysis [180]. The resulting PVA polymer is highly soluble in water but 
resistant to most organic solvents [179]. PVA is a vinyl polymer in which the main chains are 
joined by only carbon-carbon links [181]. The resistance of the PVA against organic solvents 
as well as the aqueous solubility made PVA a suitable material for several applications. In 
fact, PVA is commonly used for food packaging, textile industries, and paper products 
manufacturing [182,183]. PVA is also used as a biomaterial since is biocompatible, nontoxic, 
noncarcinogenic. In addition, the PVA swelling properties, bioadhesive characteristics, and 
biodegradability made PVA a perfect candidate material for the fabrication of medical 
devices as well as for TE applications [178,184,185]. PVA is a biodegradable polymer, and 
its degradability is enhanced through hydrolysis because of the presence of hydroxyl 
groups on the carbon atoms. PVA is manly used to create hydrogels [183]. PVA hydrogels 
and membranes have been developed for biomedical applications such as contact lenses 
[186], artificial pancreases [187,188], hemodialysis [189], and synthetic vitreous humor [190], 
as well as for implantable medical materials to replace cartilage [191–193] and meniscus 
tissues [194,195].It is an attractive material for these applications because of its 
biocompatibility and low protein adsorption properties resulting in low cell adhesion 
compared with other hydrogels [179,185]. PVA hydrogels have been also investigated as 
artificial cartilage replacements due to their rubber elastic physical properties, and because 
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the hydrogels can be manufactured to have tensile strength in the cartilage range of 1–17 
MPa [179]. Moreover, PVA implants have been used in meniscus replacements. Kobayashi 
studied PVA hydrogel for the replacement of meniscus using a rabbit model. The PVA 
hydrogel implants were placed in the lateral compartment of one knee of female rabbits. 
Five rabbits were examined after 2 year and the postoperative follow-up showed that the 
PVA hydrogel implants were intact, with no wear or dislocation seen [194,195].  
1.2.3.2 Fabrication methods 
To date, several technologies have been employed to fabricate scaffolds for TE 
applications. Porous random scaffolds with a limited control of scale have been fabricated 
using freeze-drying [196–198], electrospinning [75,199,200], solvent casting/particulate 
leaching [201–203], whereas scaffolds with controlled 3D architectures were fabricated 
using additive manufacturing technologies (AM) [204–207]. In particular, fused deposition 
modelling (FDM) has been used to fabricate, via layer-by-layer, porous and complex 3D 
scaffolds with resolution of 100-200 µm [34]. However due to the rigidity of the biopolymers 
used (e.g., PLA, poly(caprolactone) (PCL)) in FDM the fabricated scaffolds were mainly used 
to engineer the bone [39,74,205]. FDM has been also used to 3D print poly(vinyl alcohol) 
(PVA)sacrificial structures [202,208] (Figure 1.8(A-C)). The fabricated 3D printed structures 
were used as sacrificial templates to create thick and 3D elastomeric scaffolds with 
controlled 3D architecture (Figure 1.8(D-R)). The 3D scaffolds were seeded with HepG2 and 
were kept in culture for 12 days. Mohanty et al. demonstrated that the 3D architecture of the 
scaffold was sufficient to ensure an adequate transport of oxygen and nutrients to maintain 
a good cell activity and viability (Figure 1.8(S)). Although the constructs could maintain good 
cell viability, the elastomeric material employed does not represent a suitable material 
choice for the fabrication of scaffolds for TE applications since it is not degradable. In 
addition, the initial seeding was not homogenous throughout the scaffold showing the 
difficulties of the tissue scaffolding approach.  
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Figure 1.8. (A-F) Schematic illustration of the steps required to fabricate structured porous 
elastomeric scaffolds. (G-R) Photographs of the molds and the fabricated 
scaffolds with (G, N) hexagonal and (H, O) lattice-like structures; SEM images of 
the sacrificial templates and the fabricated scaffolds having (I,P) hexagonal and 
(L,P) lattice-like; (I-J) Photographs of the sacrificial templates 3D printed with 50 
(1 cc cube) and 150 (75 cc cube) layers and (J) the fabricated elastomeric 
scaffold using the sacrificial templates in I. (Scale bars: 1cm.) (S) Live/dead 
staining of HepG2 cells grown on the top and bottom surface of elastomeric 
PDMS scaffold at day 4, 8 and 12 (Scale bars: 1 mm). The image is reprinted 
from [208]. 
Another AM technology used to fabricate porous scaffolds is the sterelitography. 
Stereolitography is a solid freeform fabrication technique where a photocurable resin placed 
in a reservoir is crosslinked by a laser controlled in X-Y. A vertically controlled stage is 
immersed at the surface of the resin reservoir and the laser starts the polymerization at the 
resin surface. Every layer the stage move up and the polymerization proceeds thus creating 
a 3D structures. The resolution of the stereolitographyc process can me tuned by focusing 
the laser as well as increasing the laser power. In addition, the stereolitography fabrication 
technique can achieved extremely high resolutions. Traditionally, stereolitography has been 
used to fabricate 3D cell-free scaffolds, but with the development of more biocompatible 
resins, the potential for the stereolitography to be used for TE increased [209–211]. As an 
example, Hang Lin et al. fabricate 3D hydrogel scaffolds with specific shapes and internal 
architectures by using stereolitography. They showed that human adipose-derived stem 
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cells (hADSCs) encapsulated in a hydrogel composed by PEGDA and lithium phenyl-2,4,6- 
trimethylbenzoylphosphinate (LAP) as photo-initiator were capable of stay alive for 7 days 
thanks to the 3D architecture of the fabricated scaffolds [212]. Although the fabrication of 
porous scaffold was beneficial to enhance the mass transport properties, there is still a lack 
of understanding of tissue and organ formation leading to the limitation in fabricating 
constructs through tissue scaffolding [25]. In tissue scaffolding is still difficult to include and 
to homogeneously seed high densities of cells within a porous scaffold, particularly when 
the goal is the scaling up of the final construct [25]. In addition, higher cell densities might 
require an optimized media exchanger to guarantee the necessary supply of oxygen and 
nutrients required to the cells to maintain their metabolic activity [52].  
Another possible approach used to generate engineered construct is to use natural 
or synthetic hydrogels as scaffold candidate material [213]. Cells within a tissue interact with 
neighboring cells and with the ECM throughout 3D interactions establishing a 3D 
communication network that maintains the specificity and homeostasis of the tissue 
[58,62,135]. Hydrogels are able to resemble the nature of most tissues due to their high 
water content and the presence of pores that facilitate the free diffusion of oxygen, nutrients 
and growth factors, morphogens, etc. [135] [18,23]. In addition, hydrogels have been 
employed to encapsulate cells to create 3D cell cultures: such cultures are able to re-
establish such physiological cell–cell and cell–ECM interactions that can mimic the 
specificity of real tissues better than conventional two-dimensional (2D) cultures [213,214]. 
3D cultures platforms are currently used in several biological applications, including tumor 
biology [46,215,216], cell migration and cell adhesion [217–219]. As an example, a recent 
study showed that collagen crosslinking-induced ECM stiffening supports the invasive 
phenotype by enhancing integrin signaling [220]. By using glutaraldehyde as a crosslinker to 
increase the stiffness of collagen gels independently from pore size or collagen 
concentration, Lang et al. showed that 3D invasion is dependent on pore size; while 
increased matrix stiffness promotes 3D invasion in gels with large pores (small steric 
hindrance), increased matrix stiffness hinders cell invasion in gels with small pores (large 
steric hindrance) [221]. Although encapsulated cells within hydrogels could potentially mimic 
artificial ‘‘mini’’ organs [32,222] or be used to create more complex tumors models [46], the 
absence of adequate perfusion limits the final scalability of the construct.  
Finally, a third possible approach used in TE to fabricate 3D constructs does not 
require a solid scaffold structure. It consists in the belief that the tissue is a cell-generated 
material and therefore the direct manipulation and the control of cells is more important that 
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the provision of the structural, mechanical and chemical cues via the intermediary of a 
scaffold [223]. In such approach, cells are encapsulated in hydrogels forming clusters or 
aggregates that are manipulated or positioned into 3D cellular constructs in a bottom-up 
approach using bioprinting technology [7,224–226]. These aggregates are used as single 
bricks that are deposited in controlled positions in the 3D space generating constructs with 
more in vivo like cellular conditions [223] (Figure 1.9).  
 
Figure 1.9. From 2D cell culture to bioprinting of tissues. The image is reprinted from [144]. 
Recentely, Kesti et al. designed two different inks for the fabrication of cartilaginous 
graft structures. The first ink, a combination of gellan gum, alginate, HA (hyaluronic acid) 
particles and cells, was responsible for defining the tissue graft. The second ink, Pluronic 
F127, was used as support material for the dual printing of complex structures. They were 
capable of bioprinting different cartilaginous grafts with different complexities such as the 
ear, meniscus, intervertebral disk, and a nose [226]. Although the bottom-up approach has 
a number of hidden advantages over the scaffold fabrication approach, the mechanical 
strength of the final construct is not sufficient to guarantee the long-term stability of the 
constructs during maturation, and the assembly of large structures is still limited by the 
transport of oxygen and nutrients until a vascular system is developed [7,60]. 
All the proposed approaches have been currently used to fabricate TE constructs 
with different degree of complexities trying to recapitulate the whole complexity of the 
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native tissue. However, many authors agree on the fact that high levels of complexity are 
not necessary for many applications, since many tissues and organs are capable of 
remodeling and regeneration, and a correctly designed engineered construct could take 
advantage of this capacity [51,227]. In fact, cells enclosed within 3D matrices rapidly 
remodel their microenvironment depositing their ECM molecules [51,61]. For this reason, it 
is possible to atone the absence of such complexity with artificial systems capable of 
inducing desired effects in a more efficient and rational way to the hosted cells [227]. In 
addition, when designing and fabricating tissue constructs with relevant dimensions the 
absence of a network of perfusable channels and finally the lack of an existing vasculature 
is still the limiting factor to the fabrication of thick and dense tissues and finally organs. 
1.3 Strategies for the vascularization of tissue constructs 
The ability to fabricate tissues constructs with a network of perfusable channels 
represents one of the main challenges that TE is facing today. In fact, the lack of an efficient 
way to exchange media rate ensuring oxygen and nutrients and at the same removing 
waste is the limiting factor for the fabrication of complex and dense tissues. 
Nonhomogeneous cell distribution and limited metabolic activities are often observed, since 
seeded cells cannot get enough oxygen, growth factors, and nutrients for metabolic 
activities that are needed for maturation during perfusion [6,18,228]. Moreover, the 
biomaterial employed plays an important role since it is responsible to transport and release 
bioactive molecules, while meeting regulatory biocompatibility and biodegradability 
standards together with a network of molecules important for the cellular adhesion [6]. The 
currently strategies employed to fabricate vascularized tissue constructs are: microfluidic 
system integration, 3D sacrificial molding, direct bioprinting and the combination between 
bioprinting and sacrificial moulding using fugitive inks. 
1.3.1 Microfluidic system integration 
Several methods to fabricate microfluidic systems have been employed to fabricate 
vascularized constructs. These methods comprises soft lithography [54,228–231], and 
laser-based technologies [232–238]. However, each of the above-mentioned fabrication 
techniques had its own advantages and disadvantages. Soft lithography represents a 
popular method in vasculature network fabrication due to its accuracy, reproducibility, and 
low cost. Using soft lithography technology, Zheng et al. fabricated a microfluidic network in 
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a collagen matrix, that was populated by human umbilical vein endothelial (Huvec) cells 
[229]. The micro vasculature was actively perfused and the huvec cells formed a confluent 
monolayer within the collagen channels showing the differences in the channel permeability 
in response to the presence of the cells (Figure 1.10 (A-B)).  
 
Figure 1.10. Endothelialized micro- fluidic vessels: (A-B) huvec cells are culture within a 
vascular network creting vascular channels with changed permeability. Red, 
CD31; blue, nuclei (Scale bar: 100 μm.) The image is reprinted from [229].  
Cuchiara et al. developed a soft lithography process to fabricate a microfluidic 
network by using poly(ethylene glycol) diacrylate hydrogel. They demonstrated that by 
having an active perfusion, encapsulated mammalian cells where able to maintain a high 
viability within the hydrogel [230]. However, soft lithograph does not represent the best 
approach for fabricating complex 3D constructs due to cumbersome procedures. Despite 
their superior accuracy and repeatability, laser-based methods may not be suitable for 
fabricating thick tissue constructs because of their limited light-penetrating depths in 
precursor solution and because of the chemical residuals released during the reaction that 
might affected the cell culture. Ovsianikov et al. proposed a two photon polymerization to 
fabricate poly(ethylene glycol) (PEG) microstructures (300 µm height) with arbitrary shapes 
[238]. 
1.3.2 3D molding technique 
The 3D molding technique consist of (i) the fabrication of a rigid 3D template, used 
as a negative mold to define the network of the microfluidic architecture, (ii) the casting of 
the 3D template into a suitable material and (iii) the sacrifice the template revealing a 
microfluidic architecture in the bulk material. Therriault et al. was able to use the 3D molding 
technique to fabricate microvascular networks. A fugitive ink was direct printed to fabricate 
the 3D lattice network. The 3D lattice network was casted into an epoxy resin, and the 
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epoxy resin was cured and finally, the 3D network was extracted from inside the cured resin 
revealing the complex microfluidic architecture. The fabricated scaffolds had 3D 
microvascular networks with geometric complexity and where able to generate complicated 
flow patterns. However, the 3D sacrificial molding required the use of processing 
conditions, for either removing the sacrificial filaments or casting the surrounding material, 
that could not be accomplished with aqueous-based ECMs or in the presence of living cells 
[239]. By the contrary, Miller et al. was the first one that coupled the 3D sacrificial molding 
with ECMs and living cells (Figure 1.11(A)). They used FDM to fabricate 3D sacrificial lattice-
like templates using a glass carbohydrate material (Figure 1.11(B)). The peculiarity of their 
3D printed templates was that the glass carbohydrate material used to fabricate the 3D 
templates were water soluble. Then different ECMs (e.g., agarose, alginate, PEG, fibrin and 
matrigel) with encapsulated cells were casted around the 3D printed structures starting the 
dissolution and subsequently the removal of the sacrificial templates. They demonstrated 
that the presence of a perfusable network of channels was essential to deliver sufficient 
nutrients to the encapsulated cells, and higher cell viability resulted in regions closer to the 
vasculature network [240] (Figure 1.11(C-D)).  
 
Figure 1.11. (A) An open interconnected, self-supporting sacrificial template is printed for the 
casting of 3D vascular network. The sacrificial template is encapsulated in ECM 
with cells, and then the sacrificial structure is dissolved in minutes in media. The 
process allows the creation of a tissue construct with a vascular network that 
matches the original lattice. (B) Printed multilayered carbohydrate-glass lattice 
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(scale bar, 1mm.) (C-D) Live/Dead images of primary rat hepatocytes and 
stabilizing stromal fibroblast encapsulated in agarose gels (slab versus 
channeled) after eight days in culture (scale bar, 1mm.) The image is reprinted 
from [240]. 
Sacrificial templates have been fabricated also by using alginate bioprinted 
structures. Bertassoni et al. showed that by bioprinting agarose, it was possible to create 
complex microchannels within methacrylated gelatin (GelMA), star poly(ethylene glycol-co-
lactide) acrylate (SPELA), poly(ethylene glycol) dimethacrylate (PEGDMA) and poly(ethylene 
glycol) diacrylate (PEGDA) hydrogels (Figure 1.12(A-B)). In addition, GelMa was used to 
demonstrate the importance of a single channel in maintaining good cell viability in the 
encapsulated cells as wells to deliver signals to guide cell activities [241] (Figure 1.12(C-F)). 
 
Figure 1.12. (A) Bioprinted agarose template fibers and respective microchannels. (scale bar 
1 mm.) (B) Cross-section (indicated by red dotted-line) of a fluorescent 
microbead GelMA hydrogel indicating the rounded shape of the lumen (scale bar 
250 μm.) Viability of MC3T3 cells encapsulated in 10% GelMA hydrogels 
comparing constructs with (E-F) fabricated microchannel versus a slab-hydrogel 
(C-D) at day one and day 7. (scale bar 700 μm.) The image is reprinted from 
[241]. 
By contrary, Nam Chan et al. used stereolitography to fabricate complex 3D molds. 
A photocrosslinked resin was used to 3D print the negative mold for the subsequent 
fabrication of the sacrificial templates. Then, the sacrificial templates were embedded in 
10% agarose hydrogel encapsulated with HepG2 to form the vascular channels. Although 
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their constructs had a complex vasculature network, the encapsulated cells didn’t present 
signs of proliferation after 3 days in perfusion. In addition, the overall fabrication consisted 
in several steps, requiring the use of toxic solvents for the dissolution of the 3D printed resin 
mold. 
Several fabrication techniques such as molding [242,243], FDM [240,244,245], 
bioprinting [241], and stereolitography [246,247] have been used to fabricate sacrificial 
molds with a plethora of different sacrificial materials (e.g., carbohydrate glass, sodium 
alginate, PVA) as well as complexities. However, in some cases the sacrificial templates 
employed to fabricate the constructs with encapsulated cells were rather simple, based on 
single or parallel planar microchannels [240–243,245]. In others, the complex sacrificial 
templates were achieved by several fabrication steps [244,246,247] and the final constructs 
didn’t have a clear strategy of active perfusion [240–242,245]. 
1.3.3 Direct bioprinting 
The direct bioprinting fabrication technique was employed to fabricate vascular 
tissue constructs by a layer by layer deposition of hydrogels and cells at the same time 
[7,28,55,84,225,226,248,249]. Gao et al. presented a bioprinting technique with a coaxial 
nozzle where they fabricated vascular conducts made by alginate filament (Figure 1.13(A)). 
They demonstrated that the bioprinted conducts could fuse together creating a construct of 
fused conducts with different geometries where the cells encapsulated nearby the channel 
could survive during 7 days (Figure 1.13(B-D)) [250].  
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Figure 1.13. (A) Schematic showing the coaxial nozzle-assisted 3D bioprinting system along 
with details about the modified coaxial nozzle. (B) Photographs of the fused 
adjacent alginate hollow filaments in a printed cuboid structure consisting of 6 
layers of hollow filaments. (C) Macroscopic view of the cross section of the 
printed cuboid structure. (D) SEM image of fused filaments in the printed cuboid 
structure. The image is reprinted from [250]. 
By contrary, Colosi et al. showed the fabrication of a bioprinted 3D lattice-like 
structures using an engineered blend ink based on a mixture of gelatin methacroyl (GelMA), 
alginate, photoinitiator and cells (Figure 1.14(A-B)). The ink was bioprinted using a coaxial 
needle to generate 3D vascularized constructs with huvecs lining in the inner regions of the 
lattice-like structure (Figure 1.14(C-F)). They also showed that the spatial deposition control 
of the ink was obtained using the bioprinting fabrication techniques and they were capable 
of cast cardiomyocytes encapsulated on a hydrogel to create a co-culture of a vascularized 
cardiac tissue (Figure 1.14(G-J)) [251].  
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Figure 1.14. (A) Photograph of the 3D printed construct (30 layers). (B) 3D µCT 
reconstructions of the top and view of the lateral and 3D µCT final bioprinted 
structure. (C) Schematic of the migration to outer regions of the encapsulated 
HUVECs in the bioprinted fibers after 10 days of culture. (D-F) Confocal 
microscopy images showing the (D) top view, (E) cross section and (F) fiber 
junctions showing interconnected structures. (G-J) Confocal microscopy images 
of a 1 mm thick lattice-like structure showing (G) the transversal cross-section, 
(H) the longitudinal cross-section, (I) outer surface of the construct. (J) Top view 
of a single fiber immunostained for CD31 (red) and DAPI (blue). The image is 
reprinted from [251].  
Also, Another study has been shown a bioprinted 3D construct using an engineered blend 
ink based three different hydrogels: gelatin methacryloyl (GelMA), sodium alginate, and 4-
arm poly(ethylene glycol)-tetra-acrylate (PEGTA). The ink was bioprinted using a tri-layered 
coaxial nozzle to generate perfusable structures with cells encapsulated on it. Jia et al. 
showed that the spatial deposition control of the ink was obtained using the bioprinting 
fabrication techniques by creating 2D structures with different shapes, and by creating also 
3D lattice-like structures with encapsulated cells on it [252]. Finally, Zhu et al. presented a 
pre-vascularized construct fabricated with a microscale continuous optical bioprinting 
(µCOB). In one case, A mixture of GelMA and LAP were used to encapsulate HepG2. In the 
other, Huvecs cell and supportive 10T1/2 cells were encapsulated in the same hydrogel 
composition to form pre-vascularized constructs. They have showed that their fabrication 
technique was fast (~1min) and was able to have good cell viability (~80%). In addition, the 
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pre-vascularized constructs were implanted in vivo for 2 weeks showing a formation of an 
endothelial network [253]. Although bioprinting could represent the future for the fabrication 
of thick tissue constructs, there are some technological challenges, such as material 
printability, special nozzle requirement, printing time and complexity of the forms that can 
be printed without the presence of a support structure underneath [254].  
1.3.4 Direct bioprinting and sacrificial molding  
Direct bioprinting and 3D molding were coupled to fabricate several complex TE 
construct. It consists on printing different inks at the same time, where one of the inks 
represents a “fugitive ink”. The fugitive ink is characterized from a viscosity that changes in 
function of the temperature. For certain ranges of temperature, the viscosity of the fugitive 
ink is enough to be printed whereas for other ranges of temperature the viscosity of the 
fugitive is small enough to be removed from inside the ECM without causing damages to 
the printed construct. Several studies have been used fugitive inks in combination with the 
bioprinting technology to fabricate vascularized tissue constructs [87,255–259]. As an 
example, a recent study used gelatin hydrogel as a fugitive ink to fabricate vascularized 
constructs. The tissue construct was fabricated by a multi-step approach: first collagen was 
bioprinted for defining the construct bottom. Then gelatin was bioprinted to define the 
internal channels followed by the deposition of a mixture of fibrinogen, thrombin, huvecs 
and normal human lung fibroblast (NHLS) cells. Then, another layer of collagen was 
bioprinted on top of the structure finalizing the construct. Finally, the gelatin was removed 
from within the construct leaving behind the open channels and Huvecs were seeded within 
the channels to form the vasculature (Figure 1.15(A)). Lee et al. demonstrate that the 
perfusion of the channels and the composition of the ECMs as well as the presence of the 
cells where able to induce the formation of micro-capillaries (Figure 1.15(B-F)) able to 
increase the diffusion of fluorescence molecules within a hydrogel construct [259] (Figure 
1.15(H)).  
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Figure 1.15. (A) Fabrication steps of the 3D printed construct using 3D bio-printer. (B-F) 
Capillary network formation of GFP-huvecs within thirteen days and (G) CD31 
staining on Day 14. (H) Time-lapse fluorescence images of 10 kDa dextran 
diffusion in structure with capillary network (top panel) and structure without 
capillary network (bottom panel). The image is reprinted from [259]. 
In another study, Pluronic F127 has been used as fugitive ink to fabricate micro-
channels. Kang et al. developed a fabrication technique called integrated tissue–organ 
printer (ITOP) (Figure 1.16(A)). It basically consists on printing several materials at the same 
time with different purposes: bioinks made by ECMs with cells encapsulated are used to 
define the location of the cells whereas pluronic F127 is used to create a network of micro-
channels with the purpose to enhance the transport of oxygen and nutrients. To increase 
the mechanical properties of the final fabricated tissue construct, PCL was also printed 
together with the other inks. They showed that they could fabricated large constructs with 
different sizes and morphologies. Moreover, they demonstrated that the different fabricated 
engineer constructs (Figure 1.16(C-F)) where able to be implanted in vivo regenerating the 
damaged tissue without any host immune response [257].  
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Figure 1.16. (A) The ITOP system. (B) Illustration of basic patterning of 3D architectures with 
several hydrogels, PCL and pluronic F127. (C) Steps necessary to fabricate TE 
constructs: from the conversion of medical data to the conversion in the STL 
format, the generation of the machine instructions and the fabrication of the 3D 
vascular constructs. The image is reprinted from [257]. 
By contrast, Kolesky et al. has been shown the fabrication of vascularized tissue constructs 
using a combination of bioprinting with the moulding approach together with the 3D 
moulding approach. They bioprinted a lattice-like structure with two different inks at the 
same time: the first ink used was pluronic F127, which was the sacrificial material 
responsible for defining the vascular channels. The second ink was a mixture of cells and 
suitable ECM that was made by a blend of gelatin and fibrinogen, which was direct printed 
in the positions along the vascular channels. The fabricated structure was used as mold and 
another mixture of gelatin and fibrinogen cross-linked by a dual-enzymatic strategy by using 
thrombin and transglutaminase (TG) was casted around the direct printed structure to give 
mechanical stability on the final printed construct. Then, the pluronic was removed from 
inside the fabricated construct leaving behind the open vasculature network (Figure 1.17(A)). 
Finally, the construct was connected to a pump and was perfused for up to 6 weeks (Figure 
1.17(B-D)). They demonstrated that their fabricated constructs where able to be actively 
perfused with growth factors to differentiate human mesenchymal stem cells (hMSCs) 
toward an osteogenic lineage in situ [256] (Figure 1.17(E-F)). 
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Figure 1.17. (A) Schematic illustration of the tissue Manufacturing process. (B-D) 
Photographs of a printed construct within a perfusion chamber. (Scale bars: 5 
mm.) E) Confocal microscopy trough a cross section of 1cm thick construct after 
30 days of perfusion showing the osteogenic differentiation. (Scale bar: 1.5 mm.) 
(F) Osteocalcin intensity within the fabricated construct inside the dotted red 
lines in C.  
Despite all the presented works were a huge step forward in the field, especially in 
fabricating thick tissue constructs, there are still some aspects that needs to be addressed. 
From a mechanical point of view, the fabricated constructs are mechanically weak, and in 
some cases they required the use of biopolymers to stabilize the structure [227]. In other 
cases, the bioprinted structure needed a cast of a hydrogel mixture to mechanically stabilize 
the construct [256]. Nevertheless, it still an open question if pluronic F127 can be used in TE 
applications due to its poor cell compatibility [260].  
1.4 Research strategy 
1.4.1 Problem definition 
Despite several technologies have been used to engineer vascular constructs, the 
biofabrication of a perfusable branch network in thick engineer constructs remains a 
challenge. The majority of the proposed constructs only presented a single or a built-in 
planar vasculature and the constructs that showed a more complex one are based on 2D 
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lattice-like structures [28,87,240–243,251,252,255,256]. A natural blood vessel network, on 
the other hand, is a complex hierarchical organization, where tubular vessels branch into 
smaller-scale vessels up to capillary scale. In addition, in some cases, the majority of ECMs 
employed in the bioprinting technique are based on synthetic hydrogels that require 
initiators to be photocrosslinked, and the byproducts released during the fabrication 
process are usually toxic or acidic, which further devastates the cell culture environment. In 
other cases, the ECMs are based on natural hydrogels that have exceptional 
biocompatibility and biodegradability providing an ideal substrate for cell encapsulation. 
However, the inks based on natural hydrogels are intrinsically weak, and therefore the final 
mechanical properties of the fabricated construct are rather limited. Finally, to engineer 
constructs with some functionality, it is necessary to have different cells populations 
encapsulated within the same ECM to guide the tissue towards the proper maturation, and 
a continuous perfusion to ensure the adequate level of oxygen and nutrients to the 
fabricated tissue construct. 
1.4.2 Research objectives 
The objective of this thesis is to contribute to the knowledge of how to fabricate TE 
tissue constructs having: (1) relevant sizes, (2) targeted mechanical properties, (3) relevant 
number of cells, and (4) perfusable 3D vasculature.  
More precisely, it investigates how to use FDM and 3D molding technique to 
fabricate thick constructs with a built-in network of channels and controlled mechanical 
properties that can be actively perfused. The presented method has greater flexibilities 
compared to existing strategies in the literature. The offered advantages are: (1) it uses 
natural hydrogels (e.g., gelatin) and (2) it allows the fabrication of complex 3D shapes (e.g., 
2D, and full 3D structures) using a cheap and commercial layer-by-layer printed process. 
The proposed method allows the fabrication of thick (e.g., 1 cm) tissue constructs 
with an integrated vasculature that supports the perfusion media, including nutrients, water, 
and oxygen, and the removal of waste.  
1.4.3 Thesis outline 
This thesis comprises two theoretical and four experimental chapters. Chapter 2 
includes a discussion regarding stem cells differentiation, together with a description of an 
in vitro system used to differentiate hiPSC-derived DE cells towards mature hepatocytes by 
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the effect of the fluid flow. A tissue engineering bioreactor platform was used to perfuse a 
3D tissue scaffold, having different 3D architecture, at two different flow rates for long term 
periods (> 21 days). Hepatic differentiation and functionality of hiPSC-derived hepatocytes 
are assessed using freshly obtained human liver as an ex vivo liver representative model. 
Chapter 3 introduce the methods used to fabricate TE constructs with a built-in 
network of microchannels. The constructs are made by gelatin hydrogel with tunable 
mechanical properties (e.g., 2-8 kPa), and are fabricated by a 3D molding approach. It is 
illustrated how 2D and 3D sacrificial templates are manufactured using the FDM technology. 
Besides, it is also showed how the sacrificial structures are cast in the hydrogel material to 
fabricate constructs with embedded vasculature and with encapsulated cells. Chapter 4 
illustrates the effect of the active perfusion in thick and densely populated construct with a 
3D complex vasculature. The presented construct had controlled mechanical properties 
(e.g., liver), and HepG2 cells encapsulated on it. It is, therefore, demonstrated that the 
control of the ECM environment and the active perfusion could sustain a high concentration 
encapsulated cells, inducing them to proliferate and to aggregate forming spheroids with 
compact morphology. 
In Chapter 5 is introduced a hydrogel-based fluidic system fabricated to simulate 
physiological barriers. Two parallel channels (1.2 cm long) are separated by 370 µm of 
gelatin that acts as a relevant tissue barrier. The fluidic system integrates electrodes for 
measuring the trans-epithelial electrical resistance (TEER), a common-used parameter to 
assess biological membranes integrity.an electrical setup to perform impedance 
measurements in real-time. The system was electrically characterized showing the potential 
of the fabricated device.  
Finally, the conclusions of this thesis and the considerations regarding the future 
perspectives of the presented research concerning the challenges in the field are described 
in Chapter 6.  
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Abstract 
Hepatic differentiation of hiPSCs under flow conditions in a 3D scaffold is expected to be a 
major step forward for construction of bioartificial livers. The aims of this study were to in-
duce hepatic differentiation of hiPSCs under perfusion conditions and to perform functional 
comparisons with fresh human precision cut liver slices (hPCLS), an excellent benchmark for 
the human liver in vivo. The majority of the mRNA expression of CYP isoenzymes and trans-
porters and the tested CYP activities, phase II metabolism, and albumin, urea and bile acid 
synthesis in the hiPSC derived cells reached values that overlap those of hPCLS, which indi-
cates a higher degree of hepatic differentiation than observed until now. Flow based compared 
to static differentiation had a strong positive effect on phase II metabolism, suppressed AFP 
expression but resulted in slightly lower activity of some of the phase I metabolism enzymes. 
Gene expression data indicates that hiPSCs differentiated into both hepatic and biliary direc-
tions. In conclusion, the hiPSC differentiated under flow conditions towards hepatocytes ex-
press a wide spectrum of liver functions at levels comparable to hPCLS indicating excellent 
future perspectives for the development of a bioartificial liver system for toxicity testing or as 
liver support device for patients. 
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Introduction 
Even though fully matured primary human hepatocytes (PHH) exhibit all the specific liver 
functions, their limited availability and loss of liver specific functions during culturing in vitro 
are still the major limitations for their application in a bioartificial liver (BAL) 1,	2. Therefore, 
porcine primary hepatocytes and carcinoma cell lines (HepG2, HepG2/C3A and HepaRG) 
have been widely employed in liver engineering 3-5. The drawbacks of these cells are however 
the risk of zoonotic diseases, immunological responses, tumor formation or poor liver specific 
functions compared to PHH  3,	4. 
Stem cells, especially human induced pluripotent stem cells (hiPSCs), have therefore received 
great attention during the past years for liver tissue engineering 1,	3. hiPSCs represent a poten-
tially unlimited cell source for a large-scale production of hepatocytes required for BAL de-
velopment. Furthermore, the use of the patients’ own hiPSCs may allow for personalized 
treatment and thereby avoiding immunological reactions. Although hiPSC-derived hepato-
cyte-like cells have been shown to have certain liver-specific phenotypic characteristics and 
exhibit many of the liver specific functions 6-9, most of these functions are expressed at levels 
several magnitudes lower than in fresh liver tissue or freshly isolated human hepatocytes 10 
suggesting that improvements in the differentiation protocols are still warranted.  
In most of these studies the induced pluripotent stem cell derived hepatocyte-like cells were 
obtained by maturation in 2D cultures, and the cells are loaded in a bioreactor only after mat-
uration. Hepatic differentiation and maturation directly in the 3D bioreactor may offer great 
advantages such as overcoming the need to harvest the total amount of cells needed for the 
BAL from the 2D culture and loading in a 3D bioreactor. However, relatively few studies 
have investigated the hepatic differentiation of stem cells directly in a 3D perfusion bioreactor 
or BAL using embryonic stem cells 11-16, and only two of them used hiPSCs 17,	18. Flow of the 
medium was shown to have beneficial effects on hepatic differentiation of ESC and fetal liver 
cells and to improve liver functions of ESC-derived hepatocytes 13,	15,	19,	20.  Even simple recir-
culation of medium in a rotating bioreactor improved the function of the differentiated 
hepatocyte-like cells 14,	 16. The flow may not only physically influence the cells by creating 
flow forces, but it also may improve mass as well as gas transfer between the cells and the 
medium, and promote the removal of waste products 15,	 20. However, in another study perfu-
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sion inhibited adipogenic differentiation of adipose derived stem cells possibly by washing 
away auto- or paracrine factors 21.   
A limitation of many studies is the absence of a proper benchmark to evaluate whether the 
cells are fully differentiated with respect to the expression levels of liver specific markers and 
liver functions of the generated hepatocytes. For example, many studies have not used a 
benchmark at all while others have used PHH cultured in vitro for 2 days or more 6,	 22,	 23. 
However, it is known that PHH cultured beyond 24-48 hours rapidly lose their phenotype and 
liver-specific functions, and using these cells as a benchmark results therefore in an overesti-
mation of the maturation level of the stem cell derived hepatocytes 10. By contrast, fresh hu-
man precision-cut liver slices (hPCLS) contain hepatocytes in their natural 3D tissue-matrix 
configuration, in contact to the other liver cell types, and retain expression as well as activity 
of phase I and phase II metabolic enzymes at levels comparable to the in vivo situation 24,	 25. 
Therefore, hPCLS can be considered the gold standard for assessing the maturation of stem-
cell derived hepatocytes into fully differentiated hepatocytes.  
Here, we differentiate hiPSC-derived definitive endoderm (DE) cells into hepatocytes in situ 
in a perfusion bioreactor system. Hepatic differentiation and functionality of hiPSC-derived 
hepatocytes were assessed using fresh hPCLS as benchmark for ex vivo liver, and 2D static 
cultures were used to compare differentiation efficacy in 2D static and 3D flow systems.  
Results 
Differentiation of definitive endoderm cells into hepatocyte-like cells under 3D flow con-
dition. 
Differentiation of hiPSC-derived DE cells into hepatocytes was performed in perfused 3D 
bioreactors with highly porous 3D PDMS scaffolds and for comparison in conventional 2D 
cultures in polystyrene (PS) wells or PDMS coated wells. Frozen DE cells were seeded at a 
density of 2.5 x 106 cells per scaffold and differentiated into hepatocytes as illustrated in Fig-
ure 1A. Differentiation under flow on 2D surface showed very good morphology of differen-
tiated cells (Figure 1B), provided that the amount of differentiation factors was reduced by 
50%, since 100% differentiation factor concentration results in poor cell adhesion during flow 
(Supplementary Figure S2 left panels).  Cells differentiated on PS and PDMS respectively 
under static conditions showed similar morphology (Figure 1C, Supplementary Figure S3).  It 
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was not possible to obtain bright field images of the cells in the 3D scaffold due to the poor 
optical characteristics of the scaffold.  
The cells adhered typically in clusters in the scaffolds (Figure 1F) at a relatively low overall 
final cell density (200.000-300.000 cells/scaffold) as determined by visual inspection (Sup-
plementary Figure S4) and measurement of protein content (Supplementary Figure S5) in the 
scaffold. As DE cells and differentiated hepatocytes adhere well to PDMS (Supplementary 
Figure S4), the relatively low number of adhering cells to the scaffold is likely due to difficul-
ties to seed the cells in the scaffolds although seeding was performed by rotating the scaffolds 
in six different directions with 30 min incubation in each direction. Calculations indicate that 
a scaffold has a surface area of approximately 10 cm2 (Supplementary Figure S6) and thus the 
cells in the 3D scaffold had an effective cell density of 20.000-30.000 cells/cm2, which is 
lower than the corresponding 2D static cultures (usually 80.000-100.000 stem cell derived 
hepatocytes/cm2, data not shown). However, as determined by visual inspection, the cells ad-
hered typically in clusters, and therefore, the local cell densities were probably higher. 
Differentiation of hiPSC-derived DE cells loaded in the scaffolds was performed at a flow 
rate of 1 µl/min (exchange rate every 50 minutes) and 5 µL/min (exchange rate every 10 
minutes). It was calculated that in both flow regimens, shear forces were very low (1.1e-4 
dyn/cm2, or less, Supplementary Figure S7 and S8). Furthermore, the exchange rate of once 
per 10 minutes was shown to be compatible with differentiation into hepatocytes in 2D flow 
cultures (Supplementary Figure S2) and has previously shown to support differentiation of 
adipose derived stem cells into adipocytes using conditioned medium 21. 
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Figure 1.  A: Schematic overview of the experimental process of differentiation of DE cells to mature hepato-
cytes. B: Differentiation of iPSC under flow regime (500 nL/min) on flat surface for 25 day using normal con-
centration of differentiation factors or ½ concentration of differentiation factors. C: Differentiation of iPSC for 
19 days on polystyrene and on PDMS. D: hPCLS at 0h and 24h of incubation (Haematoxylin & eosin staining). 
E: Scaffolds and house (left panel) used for perfusion. F: Confocal microscopy images of iPSCS derived hepato-
cyte like cells.  Blue is nucleus (DAPI) and red is actin staining. 
 Comparison of gene expression of hepatocyte markers of human iPSC-derived hepato-
cytes and hPCLS 
We investigated the hepatic differentiation of hiPSC-derived DE cells in the 3D scaffold at 
two different flow rates, 1 µL/min and 5 µL/min, and in two different scaffold designs (Figure 
1E), and compared the results with cells differentiated under static 2D conditions in standard 
polystyrene (PS) well plates or in well plates coated with a PDMS layer. hPCLS were used as 
a benchmark for cells differentiated in the scaffold under perfusion.  hPCLS were prepared 
from 10 individual livers of human donors, aged 20-73 year (60% female) as described 26. 
Due to the limited amount of liver material, not every test was performed on all donor livers. 
The morphological appearance and ATP content of the hPCLS after a preincubation of 1 hour 
to restore ATP levels (0h) and after 24h of incubation, indicated that the slices were viable. 
ATP levels were 9.7±1.3 pmol/µg protein and 8.24±0.76 pmol/µg protein at 0h and 24h re-
spectively (mean±SEM). Morphology showed intact liver tissue at 0h and after 24 h of incu-
bation (Figure 1D). 
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The gene expression of the liver-specific genes of the cells differentiated under the conditions 
outlined above and the hPCLS is depicted in Figure 2. A summary based on classification of 
gene expression into broader groups is presented in Figure 3. When comparing the differenti-
ated cells in static cultures on PS with hPCLS, most of the CYP genes, the expression of the 
epithelial biliary cell markers (CK7, BGP) and the drug transporter ABCB1 (multidrug re-
sistance protein, P-gp) in the cells was in the range of that seen in hPCLS. Large differences 
in gene expression were observed for the genes CAR, ALB and BSEP, which were clearly 
under expressed in differentiated cells compared to hPCLS. These three genes were, however, 
higher expressed in differentiated cells than in the DE cells (Figure 2 and 3). Furthermore, the 
differentiated cells showed higher expression of AFP and HNF4a than the hPCLS. The differ-
entiated cells on PS therefore had a mixed phenotype, where some genes suggest a partly to 
fully maturated phenotype (HNF4a, CYP3A4, 3A5, 3A7 and 2B6 and P-gp), while others 
suggest a less mature phenotype (ALB, AFP, CAR, BSEP). In addition, maturation of a part 
of the cells into biliary epithelial cells is suggested by expression of CK7 and BGP. 
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Figure 2. Expression of different hepatic genes by DE cells cultured and differentiated under different condi-
tions. Data are given for each individual sample to appreciate the variation within each condition and the overlap 
between the different conditions. Data are presented as Ct values of the respective genes normalized to Ct values 
of the housekeeping gene CREBBP. Results are from four independent differentiation experiments and seven 
donors. Due to poor RNA yield, some genes where only analyzed in two (P-gp) or three (CK7, BSEP, BGP) of 
the cultures.  
	
	
 
 
60 
 
Differentiation on the scaffold material PDMS in static cultures had only a minor impact on 
the gene expression compared to cells on PS; all genes showed overlapping expression in 
cells on PDMS and PS respectively (Figure 2 and 3).  
Flow modulated the gene expression of differentiated cells only to a small extent, with 5 
µl/min performing slightly better than 1 µl/min for CYP 3A4 and 2B6. Flow also modulated 
the ALB and AFP expression; the ALB expression was suppressed by flow compared to the 
corresponding static cultures. The AFP expression was lowest in cells exposed to the 5 µl/min 
perfusion compared to static and perfusion with 1 µl/min, but did not result in the very low 
levels observed in hPCLS (Figure 2 and 3).  
 
 
Figure 3. Summary of the comparison of the gene expression levels between the differentiated cells and the 
hPSLC as benchmark from Fig 3. The different grades of color in the chart represent the gene expression levels 
in the hiPSC-derived hepatocytes relative to the gene expression levels in hPCLS as follows: Black: all individu-
al data of the cells are higher than those in hPCLS. Dark grey: the individual data of the cells are higher than or 
in the higher range of those of hPCLS. Middle grey: all data of the cells are in the same range as those of 
hPCLS. Light grey: the individual data of the cells are lower than or in the lower range of those of hPCLS. 
White: all individual data of the cells are lower than those of the hPCLS. 
 
 
 
 
	
	
 
 
61 
 
Liver functions 
Phase I and Phase II metabolic activity, albumin, urea and total bile acid (TBA) production 
was analyzed in hPCLS and the hiPSC-derived hepatocytes for each of the different condi-
tions described above.  
Phase I metabolism 
Differentiated hiPSC-derived DE cells as well as hPCLS were exposed to the substrates under 
both static and flow conditions to account for possible effects of flow on metabolism. The 
metabolic activities in the hPCLS showed large inter-donor variations as expected, as inter- 
individual differences in drug metabolism are well described. 
Overall the hPCLS showed similar metabolic activity when cultured under flow or in static 
conditions, although a lower metabolic activity was found for CYP3A and CYP2B6 activity 
under flow (Figure 4). These differences may be explained by binding of the lipophilic sub-
strates midazolam and bupropion to the PDMS of the biochip 27, although it cannot be exclud-
ed that the perfusion conditions may have influenced the metabolic activity.  
The hiPSC-derived hepatocytes differentiated under flow conditions as well as under static 
conditions showed overlapping activities of CYP3A, CYP1A, CYP2C9, CYP2D6 and 
CYP2C19 with the hPCLS (Figure 4). However, at a flow of 1 µl/min somewhat lower activi-
ties of CYP2C9 and CYP2C19 were found compared to a flow of 5 µl/min. CYP2B6 showed 
very low activities in cells compared to hPCLS irrespective of perfusion or static culture con-
ditions. The overlap in activities of most of the CYP isoforms, with exception of CYP2B6, in 
the differentiated cells with those of hPCLS under flow, indicate a high degree of hepatocyte 
drug metabolic function in the differentiated cells.  
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Figure 4. Phase I metabolite production of midazolam, phenacetin, diclofenac, bufuralol, bupropion and me-
phenytoin by hiPSC-derived hepatocytes and hPCLS cultured in static or under flow conditions. The individual 
values are expressed as pmol/min/mg protein. Results are from three independent differentiation experiments 
and seven donors. 
 
Phase II metabolism. 
Differentiated cells exhibited high uridine UDP-glucuronyltransferase (UGT) and sulfotrans-
ferase (SULT) activities when exposed to 7-hydroxycoumarin (7-HC) (Figure 5). Both phase 
II activities were higher in hiPSC-derived hepatocytes at a flow of 5 µl/min than at 1 µl/min. 
While the activities in cells cultured under static conditions were similar to those in hPCLS 
static cultures, the 7-HC-glucuronide (HC-G) production by cells cultured at 5µl/min flow in 
both hexagonal and random scaffolds was on average two-fold higher than in liver slices at 
flow conditions. In addition, the sulfation rate of 7-HC resulting in 7-hydroxycoumarin sulfate 
(HC-S) was 30-40 fold higher in cells differentiated under flow condition compared to differ-
entiation under static condition and the  hPCLS.  
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Figure 5. Production of 7-hydroxycoumarin glucuronide (HC-G) (left panel) and 7-hydrocycoumarine sulfate 
(HC-S) (right panel) from 7-hydroxycoumarin by hiPSC-derived hepatocytes and hPCLS cultured in static or 
under flow conditions. The individual values are expressed as pmol/h/mg protein. Results are from three inde-
pendent differentiation experiments and seven donors).  
 
Albumin production  
Albumin production by the hiPSC-derived hepatocytes was in the lower range of that of 
hPCLS (Figure 6). No difference was observed between the two types of scaffolds at both 
flow rates or between static and perfusion cultures. 
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Figure 6. Albumin production by hiPSC-derived hepatocytes and hPCLS cultured in static or under flow condi-
tions. The individual data values are expressed as ng/h/mg protein. Results are from three independent of differ-
entiation experiments and seven donors. 
Bile acid secretion and urea synthesis. 
Bile acid secretion by the hiPSC-derived hepatocytes was at the same level of 25-30 
pmol/h/mg protein in cells differentiated under static conditions for 22 days or 24 days as in 
hPCLS (Supplementary Figure S9). We could not detect bile acids in the samples of the out-
flow medium obtained of the scaffolds, due to the high dilution of the excreted compounds, 
which is a consequence of the perfusion flow rate. The observed total bile acid secretion of 
25-30 pmol/h/mg protein by differentiated cells or hPCLS would result in a concentration of 
about 20-100 pmol/ml at a flow rate of 1 and 5µl/min respectively, which is below the detec-
tion limit.  
On average, the urea production by hiPSC-derived hepatocytes was below or in the lower 
range of that of hPCLS (0.06-7.6 µg/h/mg protein for hiPSC-derived hepatocytes and 1.6-11.9 
µg/h/mg protein for hPCLS) (Supplementary Figure S10). Cells differentiated at 5µl/min flow 
and under static conditions tended to show higher urea synthesis (0.3-7.6 µg/h/mg protein) 
than those differentiated under 1µl/min flow (0.06-0.55 µg/h/mg protein).  
Discussion 
We have obtained highly differentiated hepatocytes from hiPSCs. To assess their differentia-
tion status, we compared the expression and function of the cells in this BAL model with 
fresh human liver slices  that have in vivo like activities 25-27 and found as yet unprecedented 
liver functions in the differentiated cells. Moreover, we found that DE cells can be successful-
ly differentiated into hepatocyte-like cells in a 3D scaffold in a bioreactor under flow condi-
tions, to a similar or only slightly better differentiation grade than under static 2D conditions, 
especially with respect to phase II sulfation activity and a lower AFP expression, which can 
make the production of a BAL easier and more effective in the future. 
hiPSC derived cells differentiated under flow in a 3D bioreactor resulted in a BAL model 
with overlapping phase I metabolism (except for CYP2B6) and similar or higher phase II me-
tabolism, compared to fresh human liver slices. Urea production was present in the hiPSC but 
was below or in the lower range of the hPCLS. However, the capacity of urea production in 
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the BAL from ammonia from extrahepatic sources was not assessed since no ammonia was 
added to the medium and, further studies with exposure to extracellular ammonia are needed 
to show the ability of the cells to detoxify ammonia, which is important for patients with liver 
diseases where high concentrations of neurotoxic ammonia are detected. Bile acid production 
by hiPSC-derived hepatocytes was on the same level as in fresh tissue slices. The gene ex-
pression of P-gp in hiPSC-derived hepatocytes was shown to be higher than in hPCLS, which 
is remarkable as a 10-20 fold lower expression in differentiated hiPSC compared to human 
hepatocytes was found by Lu et al. 19. However, the gene expression of BSEP in the differen-
tiated cells was lower than in the hPCLS. Similar to hPCLS, the hiPSC derived cells ex-
pressed both CK-7 and BGP indicating that the hiPSC derived cells are a mixture of both 
hepatocytes and biliary epithelial cells (BEC). This bipotent differentiation potential of iPSC-
derived hepatic progenitor cells was also found previously 28. The albumin secretion of stem 
cell-derived hepatocytes achieved here is similar to hiPSC-derived hepatocytes 8 or 10-100  
fold higher than in human ESC-derived hepatocytes 12 and 3-40 fold higher than mouse iPSC-
derived hepatocytes 22,  but lower than in fresh tissue slices. Although the mRNA expression 
was high for HNF4a indicating hepatic differentiation and low for CYP3A7, which is a fetal 
enzyme with low expression in the adult liver, the relatively high expression of the fetal pro-
tein AFP indicates that maturation of the cells is not fully complete. This has also been ob-
served by others 7,	8,	22,	29, and it needs to be addressed how relevant this is for the functioning 
of the BAL in patients who need liver support or for toxicity testing. Taken together, these 
results show overall that hiPSC differentiated under static conditions as well as under flow in 
a scaffold have liver functions close to those in fresh human liver tissue. The significant im-
provements with respect to liver functions of the differentiated cells presented here compared 
to other studies could be due to better differentiation protocols, resulting in a favorable bal-
ance of paracrine or autocrine factors affecting differentiation, whereas the difference be-
tween the cells differentiated under 2D static and 3D perfusion conditions could be ascribed 
to better nutrient delivery and waste removal.  
Most studies have used PHH cultured in vitro for 1-3 days as benchmark for hepatic activity 8,	
10,	 19,	 23. Because PHH functions decrease rapidly and drastically (10-1000 fold after 48h cul-
ture) during in vitro culture 10, using these PHH as standard tends to overestimate the metabol-
ic function of hiPSC-derived hepatocytes. Therefore, the comparison of those data with our 
study is difficult. Moreover, comparison of the metabolic activity data between different stud-
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ies is further hampered by the fact that the substrate concentrations and experimental condi-
tions used are largely different. Fresh human PCLS, on the other hand, show similar metabol-
ic activity as the fresh PHH and give a good representation of liver functions in vivo 44. Even 
though nowadays it is possible to culture PHH for several days with preservation of their met-
abolic capacities in certain culture conditions, none of the above mentioned studies have de-
scribed or showed that the appropriate measures have been taken to maintain PHH functions. 
The only published study which used fresh hepatocytes as a control is the study of Ulvestad et 
al. 10. Comparison of the results of that study with our data shows that the CYP3A, CYP2C9 
and CYP1A activities of hiPSC-derived hepatocytes in our study were ten to several hundred 
folds higher than those of the iPSC-derived hepatocytes in the study of Ulvestad et al. We 
were the first to measure phase II metabolism in hiPSC and found that glucuronidation was 
comparable to PCLS but sulfation was remarkably higher after differentiation under flow, 
which requires further studies.  
The gene expression of CYP-enzymes and their activity varied notably between donor livers, 
which is very well known in the human population, which is among others a result of poly-
morphisms and induction by environmental and physiological factors. For example, CYP1A2, 
CYP2D6, CYP2C9, CYP2C19, CYP2B6 and CYP3A4 are known to be important polymor-
phic and highly inducible enzymes in human 30. With this in mind it is noteworthy that the 
gene expression and enzyme activities in hiPSC derived cells overlapped in most cases with a 
few discrepancies noted below.  For example, the CYP3A5 gene was higher expressed in 
hiPSC-derived hepatocytes compared to hPCLS, whereas CYP3A4 gene expression only 
reached up to the lower range of human livers (Figure 2). However, as CYP3A4 and 3A5 
have strongly overlapping specificities 31, it may explain why the total CYP3A metabolism of 
midazolam was similar in hiPSC-derived hepatocytes and hPCLS (Figure 4). Although, the 
gene expression of CYP2B6 in the differentiated cells was in the lower range of hPCLS pos-
sibly due to low CAR expression, the activity of this enzyme was at least 10 times lower in 
hiPSC-derived hepatocytes than in hPCLS indicating a post transcriptional regulation. Future 
research will be focused to improve also the as yet under expressed CAR mediated pathway. 
We found a limited influence of the flow rate on the hepatic differentiation of hiPSC in the 
BAL, as 5µL/min flow resulted in a somewhat better hepatocyte differentiation and matura-
tion than the 1µL/min flow. This might be explained by the better nutrient and oxygen supply 
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and removal of waste metabolites at the higher flow rate. Also the type of scaffold had no 
obvious impact on the differentiation.  
In conclusion, most of the drug metabolism enzyme activities of the developed hiPSC-based 
BAL were in the same order of magnitude as in the fresh human tissue, which is an important 
achievement in liver tissue engineering and for future applications in drug metabolism and 
toxicity testing. A limitation of the present study is that besides hepatocytes and biliary epi-
thelial cells, which were present in the developed BAL according to gene expression profil-
ing, no non-parenchymal cells are present yet. Although no toxicity studies have been done 
yet, for future toxicity tests it is necessary to also add these other liver cell types to better rep-
resent the liver functions by the BAL. Moreover, future experiments with more donor indi-
viduals for both iPSC and PCLS will help to better estimate the variation in the population as 
well as the robustness of the differentiation protocol. Finally, future studies should show the 
BAL’s detoxification capacities for human serum. 
 
Materials and Methods 
Differentiation of hiPSC-DE cells into hepatocytes under static conditions and flow con-
ditions. 
Human iPS-derived definitive endoderm (DE) cells (Cellartis Definitive Endoderm 
ChiPSC18, Cat. No. Y10040, derived from human dermal fibroblasts, authenticated using 
STR and mycoplasma free according to qPCR (see further information about this cell line on 
http://www.clontech.com) were cultured and differentiated into hepatocytes for 25 days ac-
cording to the suppliers’ recommendations in the Cellartis Hepatocyte Differentiation Kit 
(Cat. No. Y30050), see Figure 1A. Briefly, the cell culture surface (cell culture plates or scaf-
fold) was coated with Hepatocyte Coating (from Cellartis Hepatocyte Differentiation Kit, Cat. 
No. Y30050) at 37°C for 1-2 days and subsequently washed with Phosphate buffered saline 
solution (PBS, 10 mM Na phosphate in 0.9% NaCl, pH 7.4). DE cells were thawed and seed-
ed in Hepatocyte Thawing and Seeding Medium at an initial density of 2.5 x 106 cells/scaffold 
and for the static references 1.5 x 105 cells/cm2 in 24 well plate format (using polystyrene 
well plates or corresponding PDMS coated well plates, see below) in 1 ml of medium. The 
DE cells were differentiated in Hepatocyte Thawing and Seeding Medium for 2 days at 37°C, 
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before changing to Hepatocyte Progenitor Medium for another 5 days of differentiation to 
hepatoblasts. The cells were then differentiated further in Hepatocyte Maturation Medium for 
4 days to immature hepatocytes and finally matured in Hepatocyte Maintenance Medium for 
another 14 days of culture to mature hepatocytes. In the static cultures, the medium was ex-
changed every 2-3 days. The derivation of DE cells from iPSC cells as well as the robustness 
of the hepatic differentiation protocol has already been shown before in 2D conditions on 
hiPSC cell lines from different donors 44. 
Scaffolds fabrication and perfusion cell differentiation culture 
Polydimethylsiloxane (PDMS) was chosen instead of hydrogels as scaffold material to due to 
its biocompatibility and structural stability enabling production of liter-sized scaffolds 32,	 33. 
Random porous scaffolds (Figure 1E) were fabricated from PDMS by using salt leaching 
techniques similar to that described previously 34. Hexagonal combined structured/porous 
scaffolds (Figure 1E) were made using a sacrificial mold with hexagonal pattern fabricated by 
3D printing using commercially available water dissolvable polyvinyl alcohol (PVA) (Mak-
erBot, USA) and packed with salt crystals as described in 32. The scaffolds were treated with 
oxygen plasma (125 W, 13.5 MHz, 50 sccm, and 40 millitorr) to render their surfaces hydro-
philic and sterilized by autoclaving. They were coated with Hepatocyte coating (from Cel-
lartis Hepatocyte Differentiation Kit, Cat. No. Y30050) by centrifugation at 300 x g for 5 
minutes and then left overnight at 37 °C. The scaffolds were subsequently washed with PBS 
centrifugation at 300 x g for 5 minutes and then left in a media at 37 °C for 2h prior to being 
used to experiments. 
A self-sustained perfusion system with 16 parallel reactors was constructed (Supplementary 
Figure S1) holding PDMS scaffolds. The scaffold bioreactor array, glass vials, caps and PTFE 
tubing were sterilized by autoclaving before assembling in a laminar flow bench. 0.5 M 
NaOH was flushed throughout the system to ensure a sterile fluidic path. The system was sub-
sequently flushed with sterile water and then with culture medium. Coated scaffolds were 
placed in cylindrical holes in a custom built tray. 2.5 x 106 freshly thawed DE cells in 30 µL 
of Hepatocyte Thawing and Seeding Medium was pipetted into each scaffold and cells were 
allowed to adhere for 3h at 37 °C under 95% air/5% CO2. The seeding tray was inverted as 
well as placed vertically in four different positions to allow the cells to distribute throughout 
the scaffolds during the 3h. The scaffolds were then placed in the 4×4 bioreactor array of the 
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fluidic platform, and media was perfused through the scaffolds at flow rates of either 1 µL/ 
min or 5 µL/ min. The entire system was incubated at 37 °C under 95%air/5% CO2. Cells 
were cultured and differentiated for 25 days.  
Human liver tissue  
Human liver material was obtained from liver tissue of 10 individual patients, remaining as 
surgical waste after reduced liver transplantation patients, from liver tissue donated after car-
diac death but not suitable for transplantation due to the age or from patients undergoing 
hepatectomy for the removal of carcinoma. This study was approved by the Medical Ethical 
Committee of the University Medical Centre Groningen, according to Dutch legislation and 
the Code of Conduct for dealing responsibly with human tissue in the context of health re-
search (http://www.federa.org), refraining the need of written consent for ‘‘further use’’ of 
coded-anonymous human tissue. The procedures were carried out in accordance with the ex-
perimental protocols approved by the Medical Ethical Committee of the University Medical 
Centre Groningen. 
hPCLS were prepared as described previously by de Graaf et al. 26. The hPCLS were made 
about 200µm thick and had 5 mg wet weight. In order to remove cell debris and to restore 
function, hPCLS were pre-incubated in the incubator (Panasonic, USA) for 1 hour at 37ºC in 
a 12-well plate filled with 1.3 ml of Williams’ Medium E (Gibco, USA) saturated with 
80%O2/5%CO2 while gently shaking 90 cycles per minute.   
Static hPCLS culture. After pre-incubation, slices were transferred individually to a 12-well 
plate filled with 1.3 ml of Hepatocyte Maintenance Medium (from Cellartis Hepatocyte Diff 
Kit (Cat. No. Y30050) saturated with 80%O2/5CO2 and supplemented with 50 µg/ml gen-
tamycin (Invitrogen). Plates were gently shaking 90 cycles per minute in the incubator at 
37ºC.  
hPCLS culture under flow condition. After pre-incubation, slices were transferred individually 
into small micro-chambers of PDMS biochips. The fabrication process of the biochip, as well 
as a schematic view of the biochip set-up was extensively described before 35. Slices were 
embedded in MatrigelTM (BD Biosciences, Bedford, MA, USA) as described previously and 
the biochips were perfused with 2 times diluted Hepatocyte Maintenance Medium from Cel-
lartis Hepatocyte Diff Kit supplemented with 50 mg/ml gentamycin at 10µl/min flow in a 
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humidified incubation chamber saturated with a mixture of 95%O2/5%CO2 as described in 
detail before 36. Viability of hPCLS was assessed by analysis of ATP content and morpholog-
ical examination after 0h and 24 h. More details are provided in Supplementary materials. 
Imaging and confocal microscopy 
Phase contrast images of 2D flow cultures and fluorescence based imaging of the scaffolds 
were acquired by a Zeiss Axio Observer as described in details in Supplementary materials. 
Confocal acquisitions of the scaffolds were performed using a Zeiss LSM 700 module in the 
Axio Imager M2 upright microscope using a 40x/1.20 W Korr C-Apo objective. More details 
are provided in Supplementary materials. 
Functional characterization of hiPSC-derived hepatocytes and hPCLS 
Phase I metabolism. To test the activities of several different CYP isoenzymes, hPCLS and 
cells in perfused and static systems were exposed for 1-3 hours to a drug cocktail containing 
10µM phenacetin (CYP1A), 10µM bupropion (CYP2B6), 50µM mephenytoin (CYP2C19), 
10µM diclofenac (CYP2C9), 10µM bufuralol (CYP2D6) and 5µM midazolam (CYP3A) in 
Hepatocyte Maintenance Medium without phenol red and supplemented with 2mM L-
glutamine and antibiotics (50 mg/ml gentamycin for hPCLS and 0.1% penicillin and streptav-
idin for cells. Medium was collected and  stored at -80°C until further analysis. Metabolite 
concentrations were measured at Pharmacelsus (Germany) by LC/MS according to in house 
protocols. The metabolite production was normalized per milligram protein and per hour.  
Phase II metabolism. For Phase II metabolism studies, hPCLS and cells in perfused systems 
or in static condition were exposed to 100µM of 7-hydroxycoumarin (7-HC) (Sigma-Aldrich, 
St.Louis, MO, USA) for 1-3 hours. Medium was collected at outlet tubes or from the incuba-
tion medium and stored at -20°C until further analysis, using 7-HC, 7-HC-G and 7-HC-S as 
standards. The metabolite production was normalized per milligram protein and per hour. 
Gene expression 
Total cellular RNA from cells or PCLS was purified by using the RNeasy Micro kit (Qiagen, 
74004) or using Maxwell 16 LEV simplyRNA Tissue Kit (Promega, USA) respectively. The 
RNA was converted to cDNA using the High Capacity cDNA Reverse Transcription Kit (Ap-
plied Biosystems, 4374966) and quantitative real time PCR was conducted using the TaqMan 
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Gene Expression Assays (Applied Biosystems 4331182). More details are provided in Sup-
plementary Materials. 
Statistical analysis 
Four independent experiments were performed with 4 batches of DE cells from one donor, 
and hPCLS from 7 different human donors. Since the number of donor livers for slices and 
number of donors for stem cells are limited, and inter-individual variations are large in the 
human population, we conclude on the differentiation of the cells by comparing the range of 
expression or activity rather than the mean or median values.  
Additional Methods can be found in Supplementary materials. 
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Supplementary Information 
Description of perfusion system 
A schematic view of the perfusion culture system and fluidic/air circuit is illustrated in Sup-
plementary Figure S1. The main components of the system include an array of 4×4 bioreac-
tors for culture of cells, vials and vial trays for storage of culture media and waste and peri-
staltic pumps and motors for perfusion of media. All parts are secured onto a single platform. 
Four 8-channel micropumps (previously described 37, 38) that generate pulsatile flow are in-
cluded in the system, controlled by motors and controllers from the Lego Mindstorm (Lego, 
Billund, Denmark) kit. This allows culturing of cells at four different flow rates in a single 
experiment. The pumps allow flow rates of sub-µl/min to approximately 90 µl/min 38. The 
fluidic circuit is formed by the pumps, bioreactor array and media storage vials that are con-
nected using polytetrafluoroethylene (PTFE) tubing (inner diameter of 0.8 mm) (BOLA 1818-
10, Bohlender GmbH, Germany). Inlet and outlet vials are coupled with PTFE tubing and 
supplied with air supplemented with 5% CO2 through a sterile filter. To avoid the formation 
of gas bubbles in the microfluidic network, an overpressure of 30 kPa is put on the flow sys-
tem during its operation. All components are mounted onto a base platform for portability and 
user-friendly handling. The entire system can be placed in an incubator for cell culture exper-
iments.  
Design of the bioreactor array 
The bioreactor array (Supplementary Figure S1) allows culture of 16 cylindrical 3D con-
structs having thicknesses of 5 mm and diameters of 6 mm (Figure 1E). The bioreactors are 
designed with conical inlets and outlets for uniform delivery of media through the pores of a 
scaffold in the cylindrical cavity 39, 40. Additionally, the conical inlet geometry gives rise to 
lower shear stress in the areas of the scaffold close to the inlet as assessed from a finite ele-
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ment study of the flow profile within two bioreactor designs as discussed in following sec-
tions. Silicone tubes (having inner diameter of 1.8 mm and 1 cm in height) are press fit to the 
ports of the bioreactor (inner diameter of 1 mm and outer diameter of 2 mm) and serve as 
connectors between the bioreactor and the rest of the perfusion network.  
The 4×4 bioreactor array was implemented in an easily exchangeable single device, as shown 
in Figure S1. The upper plate of the device (having dimensions of 100 x 100 x 5 mm3) incor-
porates the outlet ports for waste removal from each bioreactor. The lower plate (with dimen-
sions of 100 x 100 x 10 mm3) incorporates 4×4 cylindrical chambers (each with a diameter of 
6 mm and height of 5 mm) for housing scaffolds and inlet ports for perfusion of media into 
the chambers. The two parts of the array are secured together using screws with a custom de-
signed polydimethylsiloxane (PDMS) gasket (having a thickness of 1 mm) placed between 
them in order to ensure a tight seal and form a leak proof system. The gasket was designed 
such that it incorporated a raised lip (0.5 mm high) around each bioreactor array.  
Fabrication 
The two parts of the bioreactor array were fabricated by micromilling the required features 
into polycarbonate substrates. The gasket was fabricated by moulding of PDMS in a custom 
milled polycarbonate mould. Vial trays capable of housing 32 vials (16 for holding cell cul-
ture media and 16 for storage of the waste media), were fabricated in 5 mm sheets of 
polymethylmethacrylate (PMMA) using a CO2 laser cutter (Epilog Mini 18 Laser, CO 80403, 
USA).  
Viability determination of hPCLS 
ATP content of hPCLS was assessed according to the manufacturer’s protocol of the ATP 
Bioluminescence Assay Kit CLS II (Roche, Mannheim, Germany) in a black 96-well plate in 
the Lucyl luminometer (Anthos, Durham, NC) using a standard ATP calibration curve. The 
ATP content was normalized for protein content of the hPCLS as described below. Morphol-
ogy was assessed on 4 µm sections of formaldehyde fixated, paraffin-embedded slices, 
stained with hematoxylin and eosin according to the described protocol 26.  
Protein Content of hPCLS and IPSC-derived hepatocytes in the scaffold 
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The pellet left from homogenized ATP samples was used to determine the protein content of 
hPCLS according to Lowry by using the Bio-Rad DC Protein Assay (Bio-Rad, Munich, Ger-
many) as described before using bovine serum albumin for the standard curve 41. Protein con-
tent of cells in the scaffold was measured according to the manufacturer instructions of Pierce 
BCA Protein Assay Kit (cat. no. 23227) after protein extraction by an over-night incubation 
of the scaffold in 0.2 M NaOH. More information is found in Supplementary Figure S5.  
Gene expression analysis 
Total cellular RNA was purified by using the RNeasy Micro kit (Qiagen, 74004). Differenti-
ated cells were lysed directly in the scaffold in the bioreactor using the lysis buffer provided 
in the Qiagen RNeasy Micro kit. The lysate was collected in microtubes and purified accord-
ing to manufacturer’s instructions (Qiagen, 12/2007). Total RNA from the hPCLS was isolat-
ed using Maxwell 16 LEV simplyRNA Tissue Kit (Promega, USA). The RNA was converted 
to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
4374966) according to the manufacturer’s instructions (06/2010). Quantitative real time PCR 
was conducted using the TaqMan Gene Expression Assays (Applied Biosystems 4331182), 
ALB (albumin) ID: Hs00910225_m1, AFP (alpha-fetoprotein) ID: Hs00173490_m1, 
CYP2B6 ID: Hs04183483_g1, CYP3A4 ID: Hs00604506_m1, CYP3A5 ID: 
Hs00241417_m1, CYP3A7 ID: Hs00426361_m1, HNF4A (hepatocyte nuclear factor-4-
alpha) ID: Hs00230853_m1, NR1I3 (CAR, constitutive androstane receptor) ID: 
Hs00231959_m1, ABCB11 (BSEP, Bile Salt Export Pump) ID: Hs00184824_m1, ABCB1 
(P-gp, permeability glycoprotein) ID: Hs00184500_m1, and KRT7 (cytokeratin-7) ID: 
Hs00559840_m1), TaqMan Gene Expression Master mix (Applied Biosystems, 4370048) and 
RNase-free water according to the manufacturer’s instructions (Applied Biosystems 11/2010). 
The respective Ct values obtained after analysis in a Chroma4 real time PCR machine (MJ 
Research, the program run at 50 ºC for 2 minutes, 95 ºC for 10 minutes and 40 cycles of 15 
sec at 95 ºC and 1 minute at 60 ºC) were normalized to the Ct value of CREBBP (CREB-
binding protein) ID: Hs00231733_m1. CREBBP has been shown to be a good candidate to 
use for normalization since the gene expression does not change significantly during differen-
tiation 42. The gene expression is presented as individual data points using the formula: 2-∆Ct.  
Imaging 
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Phase contrast images of 2D flow cultures were acquired by a Zeiss Axio Observer.Z1 micro-
scope equipped with a 10x/0.3 Plan-Neofluar objective, and a Zeiss Axiocam MRm B/W 
camera. A scan of each cell culture chamber was recorded with an exposure time of 5 msec. 
All images were acquired with a z-stack of 5 image planes (6 µm between each image plane). 
The images were processed by applying the AxioVision Extended Focus module on the z-
stacks to obtain the best focused image, stitching the individual images together and finally 
converting the stitched images to one image.  
Fluorescence based imaging of a cross section of the scaffold was carried out at day 22 of the 
cell culture differentiation. Scaffolds were sectioned longitudinally (along the axis of flow). 
Each scaffold was stained with either Höechst for showing cell distribution or Calcein AM for 
live cell imaging. Non-fluorescent Calcein AM is converted to highly fluorescent Calcein by 
intracellular esterase activity and stains viable cells green. Cells were imaged using an invert-
ed microscope (Zeiss Axio Observer) using the appropriate excitation lights and filters.  
Confocal Microscopy 
Scaffolds were sectioned longitudinally (along the axis of flow) on day 22 of the cell culture 
differentiation. Each sample was fixed in 3% paraformaldehyde (in PBS) for 10 minutes and 
permeabilized with Triton X-100 for 5 minutes. Subsequently, they were stained for 30 
minutes with either Höechst 33342 (Invitrogen) for labeling the cell nuclei as well as Phal-
loidin (F432, Invitrogen) for labeling the F-actin. Confocal acquisitions were performed using 
a Zeiss LSM 700 module in the Axio Imager M2 upright microscope using a 40x/1.20 W 
Korr C-Apo objective. The confocal settings were as follows, section thickness 0.8 µm, pixel 
dwell 0.79 µs, pixel size 145 nm, optimal Z section number determined by the confocal soft-
ware. To eliminate any possible cross-talk between channels, images were collected with a 
sequential scan, using the following laser lines and mirror settings: 488(30%) 495-560nm; 
555(30%) 605-700nm.  
Albumin synthesis 
Albumin production was measured using the Human Albumin ELISA kit (Bethyl Laborato-
ries, Mongomery, USA) according to the supplier’s recommendations. In brief, medium was 
collected from the well plate (static conditions) after 24 hours of incubation or at the outlet 
tubes (perfused systems) for 24 hours from both differentiated cell and hPCLS cultures and 
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stored at -20°C until analysis. Samples were diluted if necessary and human albumin was 
used to prepare a calibration curve. The amount of albumin was calculated based on a stand-
ard curve generated as a parameter curve fit. Values are expressed as ng albumin produced 
per hour, per milligram total protein.  
 
Supplementary Figure S1. System Description Figure 1.  A: Parts of the 3D perfusion system. B: Render of 
assembled 3D perfusion system. C: Picture of a perfusion system with tubes and vials.  
 
 
Supplementary Figure S2. Effect of concentration of signalling factors on cell morphology at flow condi-
tions. Left panels: low magnifications, right panels high magnifications. DE cells were cultured and differentiat-
ed at 2D flow conditions in a chamber having dimensions of 1.5 mm (w) x 6 mm (l) x 0.5 mm (h). The concen-
tration of signalling factors was either the normal used and optimized for static culture conditions or 1⁄2 the 
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normal concentration but otherwise a full base medium. The cells were perfused at two different flow rates, 250 
nL/min or 500 nL/min, corresponding to an exchange of the medium in the entire chamber every 20 and 10 
minutes. Phase contrast images acquired at day 25. The shown images are a representative area of one chamber 
out of 4 chambers for each condition. A better cell attachment and less dead/floating cells were observed at per-
fusion with medium supplemented with half of the normal concentration of signalling factors compared to perfu-
sion with medium supplemented with the normal concentration of signalling factors.  
 
Supplementary Figure S3. Cell morphology of differentiating cells at static conditions. Phase contrast im-
ages were acquired at day 9, 15, and 19. The cell morphology was very similar between the PDMS scaffold 
material and the PS conventional surface substrate, although some larger cells were observed on PDMS)  
 
 
Supplementary Figure S4. Microscopy imaging of hiPSC-derived DE cells cultured and hepatic differentiated 
inside a porous scaffold at perfusion conditions: Image at day 22 after cell seeding of the middle of a cross-
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sectioned scaffold. A) Scan of entire cross-sectioned scaffold showing cell distribution. Höechst stained cell 
nuclei in blue color. B) Close-up view of cell distribution with Höechst stained cell nuclei. The homogeneus blue 
fields in the image is likely not cells but reflections within the scaffold.  The fluorescence image is merged with 
a phase contrast image of the scaffold. C) Calcein-AM live-stained cells in green. 
 
Supplementary Figure S5. Determination of protein content in the BAL. DE cells were loaded into the BAL 
as described in material and methods. Three replicates of the four investigated BALs (two different scaffold 
designs and two different flow conditions), where prepared and cultured for one week. Scaffolds with cells were 
perfused with Dulbecco’s Phosphate Buffered Saline with MgCl2 and CaCl2 (Sigma D8662) for 30 min to re-
move protein containing medium and then transferred to a 1.5 mL Eppendorf tube with 0.5 mL 0.2M NaOH. To 
enhance distribution of NaOH within the scaffold, the tubes were vortexed for 30 seconds three times with 10 
minutes incubation between each vortex. The tubes were incubated over night at 4°C. To enhance the release of 
cell material from the scaffold into the NaOH, the tube was again vortexed for 3 X 30 seconds with 10 minutes 
incubation between each vortex, and then centrifuged at 500 x g for 5 minutes. The supernatant was diluted 1:1 
with milliQ water to 0.1M NaOH. The protein content was measured using the Pierce® BCA Protein Assay Kit 
(cat. no. 23227) according to the supplier’s microplate procedure. The absorbance was read at 570 nm and pro-
tein calculated based on a standard curve for bovine serum albumin. The results showed that the variance be-
tween the same type of scaffold was limited. If it is assumed that 0.1 mg protein corresponds to 100.000 cells 
(Anders Aspegren, personal observations), each BAL contains about 200.000-270.000 cells. This corresponds 
well with theoretical calculations that there can be a maximum of about 600,000-1,000,000 cells per BAL (see 
supplementary figure 6). 
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Supplementary Figure S6. Theoretical calculations of the surface area of a scaffold. Two estimates were made: 
Estimate 1 was based on an idealized network of cubes that are connected and then surrounded by PDMS. The 
calculation involved trying to find out how many salt cubes that can fit into the volume of the scaffold and then 
calculate the surface area by taking the number of salt particles multiplied by the total surface of one salt parti-
cle. The side of a salt cube is approximately 0.35 mm as determined by scanning electron microscopy investiga-
tions 43. The distance to the next salt particle is estimated to be 0.1 mm (can also be larger) meaning that a salt 
crystal takes up about 0.45*0.45*0.45= 0.091125 mm3 including the surrounding PDMS. The cylinder volume 
(Figure 1C) is r2*pi*h=3*3*pi*5=141mm3. 141/0.091125= 1556 particles. The surface area of a salt particle is 
0.35*0.35*6=0.735 mm2. 1556*0.735= 11.39 cm2. However, because the salt crystals need to touch each other 
in order to form a network, some of the area is lost. In the idealized situation, each cube loses about 1.5 sides in 
surface area as it shares that area with other salt crystals. Therefore, the area is estimated to be 11.39*9/12=8.5 
cm2 In Estimate 2 we used the measured porosity (determined to be 65%) 43 of a random scaffold as input pa-
rameter and calculated the number of salt molecules that could fit into pores with a total volume of 0.65 multi-
plied by the scaffold volume: r2*pi*h*0.65=3*3*pi*5*0.65=92 mm3. Volume of salt particle is 
0.35*0.35*0.35mm3=0.042875mm3. Number of salt particles in scaffold are 92/0.042875 = 2145 particles. 
Number of particles multiplied by the surface of each salt cube (6*0.35*0.35mm2=0.735mm2) = total surface 
volume: 1577 mm2=15.8 cm2. However, just as in the case above, some of the sides of the cubes are shared be-
tween each sugar cube. Using the estimate above, it is suggested that the surface area is 15.8 cm2*9/12= 11.85 
cm2. In this case, the surface area is estimated to be about 12 cm2, which is close to Estimate 1 of 11.39 cm2. For 
simplicity, we estimate the surface of a scaffold to 10 cm2 (1000 mm2).  
The number of cells fitting the scaffold is proportional to the surface of one side of the cuboidal cell. A 20 µm x 
20 µm cell surface will result in a theoretical cell limit of 1000/(0.02*0.02)=2.5 million cells per scaffold. This is 
given that the cell surface area is the same in the 3D scaffold as on the 2D batch culture. Typically, 80,000-
100,000 iPSC-differentiated hepatocytes can be harvested per cm2 cell culture dish indicating that the maximal 
total cell number in the scaffold is between 800,000- 1,000,000 cells.  
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Supplementary Figure S7. Evaluation of shear stress acting on the 3D scaffold at the microscale 
Velocity profile (a) and pressure gradient (b) within the bioreactor as well as in the 3D scaffold. Different 
COMSOL simulations were performed to calculate the shear stress that cells sense within the 3D scaffold. The 
first analysis was made at the macro scale, evaluating the velocity field and pressure gradient in the reactor as 
well as in the 3D porous scaffold. 
The domain region outside the scaffold was modeled by using the incompressible Navier-Stokes equation, which 
describes how the velocity, pressure, temperature and density of a moving fluid are related and include the ef-
fects of viscosity on the flow. ! "#"$	 − '∇)* + 	! * ∙ ∇ *	 + 	∇p = 	F    (1) ∇ ∙ * = 0      (2) 
where, ρ is fluid density (kg∙m-3), u is the fluid velocity (m∙s-1), η is viscosity (Pa∙s), p is the pressure (Pa), F the 
volume force (N), and  the standard del (nabla) operator. 
The region containing the porous scaffold was modeled by using the Darcy-Brinkman equation, assuming that 
the scaffold has uniform microarchitecture and cylindrical pores. 1∇)*2 − 	34 *2 = ∇     (3) ∇*2 = 0      (4) 
where µ is the effective viscosity of the porous medium (Pa∙s), us is the fluid velocity (m∙s-1), p is the fluid pres-
sure (Pa) and κ is the permeability of the porous scaffold (m2).  
A flow rate of 3.3 µl/min was applied to the inlet, the boundary condition at the outlet was set at zero pressure, 
and the no slip boundary conditions were used along the walls of the model.  
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         (a) 
 
          (b) 
Supplementary Figure S8.  
Velocity profile (a) and shear stress (b) profile inside of a single channel having a pore diameter of 200µm with-
in the 3D porous scaffold. The model shows that with a pore diameter of 200µm the shear stress acting on the 
wall is 1.2·10-5N·m-2, which is beyond the shear stress limit that leads hepatocytes to death. To evaluate the mag-
nitude of the shear stress acting on the walls of the porous channels within the 3D scaffold, an analysis at the 
micro-scale was assessed.  
If we considered the scaffold as a cylindrical structure with interconnected channels with different pores diame-
ters, the flow rate for a single channel is described by the Fanning equation:  
56 = 789:∆<=)>3?       (5) 
where µ is the medium viscosity and L and Di are the channel length (that is the scaffold height), and the channel 
diameter respectively and ∆P is the total pressure drop. The total pressure drop was evaluated in the analysis at 
the macro-scale, and the mean pore diameter was evaluated experimentally and it was found to be 200µm 33. The 
single channel was modeled with the equation (1) and (2), by using as input the flow rate calculated with the 
equation (5). For a channel having the diameter of 200µm, the shear stress acting on the walls, which correspond 
to the domain where the cells formed focal adhesions, is approximately 1.2·10-5N·m-2.  
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Supplementary Figure S9. Bile acid production by hiPSC-derived hepatocytes and human PCLS. 
Graph represents mean values ± SEM. Total bile acid (TBA) content was measured using the Total Bile 
Acid kit (Diazyme Laboratories, Poway, CA, USA) in medium after 24 h incubation (static cultures) or 24 h 
perfusion (perfused cells and slices). 1ml of medium was concentrated 10 times using the CentriVap Bench-
top Vacuum Concentrator at 35°C (Labconco, Kansas City, MO, USA). TBA content was determined ac-
cording to the manufacturer’s protocol of the TBA kit with a few modifications. Conjugated cholic acid 
(50µM) was used as a calibrator. Measurement was performed at 37°C in a 96-well plate in the Synergy HT 
plate reader (BioTek, Winooski, VT, USA). The absorbance was read at 405nm at 5 and 30 min. The TBA 
production is expressed as median with interquartile range.  
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Supplementary Figure S10. Urea production. Urea concentrations in the medium were measured using the 
Urea Assay Kit (Abnova, Taiwan). Medium samples from differentiated cells and PCLS flow and static cultures 
were concentrated 10 times before measurement using the CentriVap Benchtop Vacuum Concentrator at 35°C. 
Urea content was determined according to the manufacturer’s protocol of the Urea Assay kit with a few modifi-
cations. Accordingly, 25µL of samples were added to each well and incubated for 30 min at room temperature 
with a reagent mix. The absorbance was read at 430nm and urea levels calculated based on standard curve of 
urea standard provided with the kit and expressed as µg urea produced per h, per mg total protein. Data are ex-
pressed as individual values  
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CHAPTER 3 
 
FABRICATION OF CELL LADEN SOFT HYDROGELS PERFORATED WITH A 3D 
CHANNELS NETWORK INTERFACED TO A PERFUSION SYSTEM 
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Abstract 
Vascularization is recognized to be the biggest challenge to the fabrication of tissues and fi-
nally, organs in vitro. Vascularization within hydrogels with mechanical properties in the 
range of soft tissues has not been achieved. Therefore, we developed a three-dimensional 
(3D) molding technique using 3D printed poly(vinyl alcohol) (PVA) to fabricate microchan-
nel networks with two-dimensional (2D) and 3D architecture within large gelatin hydrogel 
constructs targeting the stiffness range of 1 - 10 kPa. A two-step gelation process was devel-
oped leading to well defined channels by sacrificial molding of PVA in gelatin. Perfusion of 
such soft construct is not trivial as the mechanical strength of these gels are very poor. A 
plasma treated PDMS case, “fluidic mold”, was developed in which gelatin was cased around 
PVA sacrificial structures. The direct casting of gelatin in the fluidic mold ensured leakage 
free perfusion immediately after gelation. This was utilized to rapidly extract out the PVA 
sacrificial mold by perfusion. Stem cell derived hepatospheres were encapsulated into soft 
gelatin (3kPa) structures and perfused for seven days without any apparent signs of cell death 
indicating excellent biocompatibility and robustness of the complete system. The proposed 
method represents a powerful and simple way to engineer thick constructs with controlled 
mechanical properties and controlled vasculature that could pave the way towards a new 
range of relevant applications for tissue engineering. 
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Introduction 
Vascularization is currently regarded as one of the main challenges that need to be solved to 
translate tissue engineering to clinical applications at a large scale [1–4]. When designing 
tissue engineer-constructs with relevant dimensions that are much larger than the diffusional 
limit for nutrients and oxygen, the absence of existing vasculature is still the missing key. 
Ideally, a cell must be located at a maximum distance of 200 µm from any vascular network 
to be metabolically active [5,6]. However, the presence of channel networks might be not 
sufficient to guarantee the necessary exchange of oxygen and nutrients that are needed in 
thick engineered constructs containing biologically relevant cell densities [7,8]. Therefore, it 
is important to create a strategy to induce perfusion through the channel network to guarantee 
the final success of the engineered construct [2]. 
Current vascularization methods relies either on cellular strategies or in the fabrication of a 
network of microchannels [8,9]. Cellular strategies involve the use of endothelial cells, often 
in combination of other cell types such as pericytes and stem cells, to induce the formation of 
stable capillaries embedded within constructs [10–15]. Cellular strategies, however, require 
time as being heavily dependent on complex biological mechanisms, and mostly remains re-
stricted to relatively thin constructs [14,16]. By contrast, there has been an extensive use of 
different fabrication techniques to create organized vascular networks [17,18]. In particular, 
direct printing technology [19–25], 3D sacrificial molding technique [26–28] or a combina-
tion by both techniques [29–44] have gained a dominant role for the fabrication of vascular-
ized constructs. So far, many reports have described vascularized constructs fabricated via 
several layer-by-layer techniques such as bioprinting [21,29], stereo lithography [41,44], and 
fused deposition modeling (FDM) [31]. Recently, direct printing of three different inks has 
been used with FDM to fabricate constructs with controlled architecture in a process denoted 
integrated tissue-organ printer [21]. The first two inks were composed by different cell-
hydrogel mixture and were used for the patterning of cells. The third ink, Pluronic F127, was 
used as a sacrificial material for the 3D printing of a lattice of microchannels. To ensure me-
chanical stability to the final construct a thermoplastic biopolymer (poly(ε-caprolactone)) was 
printed at the same time with the other three inks. By contrast, stereolitography has been em-
ployed in combination with a sequential 3D molding approach to create sacrificial templates 
[44]. A photocrosslinked resin was used to 3D print the negative mold for the subsequent fab-
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rication of the sacrificial templates. Then, the sacrificial templates were embedded in an aga-
rose hydrogel for the formation of the vascular channels. Finally, FDM in combination with 
the 3D molding technique has been used to 3D print carbohydrate glass structures serving as 
the sacrificial template [31]. Then, a poly(ethylene glycol) based hydrogel with cells encapsu-
lated was cast around the sacrificial template. The sacrificial template was dissolved and re-
moved leaving behind an open microchannel network within the PEG hydrogel. Although all 
these approaches are innovative and promising, most of them rely on complicated and expen-
sive modified machines [21] and require several fabrication steps [44]. The majority of the 
proposed engineered constructs relies on vascular structures composed by single microchan-
nels or by square lattices [23,33–35], and this is due to the inability of the 3D printing tech-
nology to achieve a real 3D freedom that the technology has to offer without the presence of a 
support material [45]. By contrast, when a complex vascular network was achieved, the final 
construct did not have the expected cellular viability since the focus was not the ECMs em-
ployed. Furthermore, the freedom of tuning the construct stiffness has not been explored in 
detail [2–4,6,7,46–49]. From a mechanical point of view, the demonstrated methods resulted 
in constructs that where either very stiff or soft [2–4,6,7,46–49]. For the tissue constructs fab-
ricated with direct bioprinting process, the hydrogels employed needed to work in a narrow 
viscosity window to provide suitable viscoelastic properties to be used as ink 
[21,24,25,29,30]. By contrast, in the 3D molding technique, the majority of employed hydro-
gels are photo-cross-linked, making it difficult to decrease the mechanical properties below 
10 kPa [23,26,31]. Finally, it is still unclear how these constructs can be effectively perfused 
to guarantee the cells to stay metabolically active in thick and densely populated constructs. 
In this paper, we describe a method for the creation of 3D constructs with engineered vascular 
networks and with stiffness in the range of soft tissues. Planar and non-planar PVA sacrificial 
structures with a well-defined and controlled architecture were 3D printed. Such structures 
were used to create embedded channel networks within a gelatin hydrogel crosslinked with 
microbial transglutaminase (TG) having stiffness in the range of 1-10 kPa. To demonstrate the 
flexibility of our fabricated constructs, a fluidic mold and a fluidic platform were developed 
to allows the fabricated engineer constructs to be actively perfused for long term periods. The 
fluidic platform was entirely 3D printed and integrated all components required for the direct 
perfusion of the constructs (e.g. peristaltic pumps along with electronics, reservoirs, etc.). 
Finally, hepatospheres were encapsulated within gelatin/TG hydrogel and kept alive by perfu-
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sion for seven days proving that our platform could be beneficial for the design of more com-
plex and more bio-inspired constructs for tissue engineering and regenerative medicine. 
Materials and Methods 
Characterization of the PVA dissolution in water  
Water dissolvable poly(vinyl alcohol) (PVA, Makerbot Industries, Brooklyn, NY, USA) fila-
ment was cut in cylindrical shapes (figure S1A). Each cylindrical PVA filament part was 
weighted and its radius and thickness were measured (figure S1A). The cylindrical PVA part 
was submerged (time = 0) in 1L of distilled water in a beaker. The liquid was stirred at a max-
imum and constant speed to ensure the Nernst model validity, and therefore a sink condition. 
At defined time intervals, the cylindrical PVA was taken out of the solution, dried, weighted, 
and its radius and thickness were measured. The temperature of the solution was kept constant 
at 25 °C for the entire duration of the experiment.  
Hydrogel preparation 
Gelatin cross-linked with TG was used in this study. A total of 7.5% (w/v) gelatin (48723 
Fluka) was mixed with serum-free cell culture medium (Cellartis Medium) and stirred at 60 
°C until fully dissolved. The degree of cross-linking of the resultant gelatin/TG hydrogel was 
controlled by varying the amount of TG in respect to the mass of the gelatin. The TG (Activa-
TI, Ajinomoto, Inc., activity of approximately 100 U·g-1 of TG according to the manufactur-
er) was dissolved in 15 mL of PBS (Sigma Aldrich) using the appropriate mass of TG to give 
concentrations of 2.5, 5, 10, and 20 Units of TG per g of gelatin. The final concentrations of 
the gelatin/TG hydrogel used were 5% (w/v) gelatin, with 2.5, 5, 10, and 20 Units of TG per g 
of gelatin.  
Mechanical properties 
A total of 1mL of the 5% (w/v) gelatin/TG pre-polymer solutions with varying concentrations 
of TG (2.5, 5, 10 and 20 Units of TG per g of gelatin) were poured in a cylindrical mold of 10 
mm in diameter (n = 6). The cylindrical samples were incubated at 37°C for 24 hours and 
then, they were compressed to 10% of the initial length using 0.1% strain rate using a Solid 
Analyzer instrument (RSA II, Rheometrics, Inc.). The compressive elastic modulus of each 
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sample was evaluated within the first linear zone from the strain stress curve (i.e. within 2% 
strain).  
Design and 3D Printing  
All the sacrificial structures and molds used in this study were designed and converted into 
STL files using CAD software (computer aided design, Dassault Systemes SolidWorks Cor-
poration, US). All STL files were processed by KISSlicer (www.kisslicer.com/) software and 
sliced into 100-µm-thick layers to generate G-code instructions for the 3D printer. G-code 
instruction sets were sent to the printer using Repetier-host (https://www.repetier.com), an 
open-source 3D printer host program. Then commercially available PVA and poly(lactice 
acid) (PLA) filaments (Makerbot Industries, Brooklyn, NY, USA) were printed using the Fe-
lix 3 (Felix Printers, IJsselstein, Netherlands) printer with a nozzle diameter of 250 µm.  
3D Printing of planar and 3D sacrificial templates 
All 2D sacrificial templates were printed using PVA as material. The printing settings were as 
follows: nozzle temperature 200 °C for the PVA, bed temperature 55 °C. The 3D sacrificial 
templates were printed using a dual material strategy where PVA and PLA were used as main 
and support material respectively. The 3D printing settings were as follows: nozzle tempera-
ture 190 °C for PLA and 200 °C for the PVA, bed temperature 55 °C. 
Dissolution of support material in the 3D sacrificial structures 
Chloroform was used as solvent to remove the PLA support from the PVA sacrificial template 
for the non-planar structures. The 3D printed structures were immersed in 200 mL of chloro-
form under continues stirring until all the solid PLA support was dissolved. After the total 
dissolution of the PLA, the 3D sacrificial structures were immersed in 20 mL of clean chloro-
form for a day to get rid of the residual PLA.  
Fluidic mold fabrication 
The fluidic mold was fabricated from a flexible clear polydimethylsiloxane (PDMS, Sylgard 
184, Dow Corning Corporation) polymer by using a molding technique. The designed mold 
consisted on three main parts responsible to define the external surface of the fluidic mold, 
one part responsible to define the internal chamber (14 mm (L) x 11.5 mm (W) x 10 mm (H)), 
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and two hub-free stainless steel blunt needles (18G; Kimble Chase, Vineland, NJ) used to 
define the fluidic connections. The mold was fabricated by 3D printing the internal chamber 
in PVA and all the remaining parts in PLA. The 3D printing settings were as follows: nozzle 
temperature 190 °C for PLA and 195 °C for the PVA, bed temperature 55 °C. The mold 3D 
printed parts were assembled and secured together using screws. PDMS pre-polymer (10:1 
w/w ratio of PDMS to curing agent) was casted in the assembled 3D printed mold. The mold 
was degassed in a vacuum chamber to ensure the removal of the entrapped bubbles. The mold 
with the polymer was placed in an oven overnight at 60˚C to ensure the polymer to be com-
pletely cured. After curing, the mold was disassembled and the resultant PDMS fluidic mold 
was immersed into water to dissolve the PVA printed part responsible to define the internal 
chamber of the fluidic mold. The fluidic molds were treated with oxygen plasma (125 W, 13.5 
MHz, 50 sccm, and 40 millitorr) to render their surface hydrophilic and sterilised by autoclav-
ing. 
Fluidic Platform: hardware 
Figure 1(A) shows the schematic of the designed fluidic platform. The fluidic platform was 
fabricated from PLA polymer by using a 3D printer. The designed fluidic platform consisted 
on one modular platform that integrates an array for 3 fluidic molds, vial trays for storage of 
culture medium, a one 4-channel micro peristaltic pump (previously described in [50,51]), a 
stepper motor, and the electronics controlling the pumps. The whole platform, except for the 
array and the lid for the electronics, was 3D printed in a single part, and the 3D printing set-
tings were as follows: nozzle temperature 190 °C for PLA, bed temperature 55 °C. The device 
is simple, compact, light and can be easily positioned in a sterile hood as well as inside the 
sterile incubator for long-term experiments. Two electronics boards are integrated in the fluid-
ic platform. An arduino micro (Arduino, Italy) and an easydriver stepper motor driver (Brian 
Schmalz, Creative Commons Attribution 3.0 United States License) were used to control and 
to power supply the stepper motor respectively. Using the dedicated software (see below), the 
flow rate, and the direction of the flow rate can be set and controlled in the range of 1-120 
µL·min-1. The 3D CAD assembly designed using SolidWorks, as well as Gcodes generated 
for every part can be downloaded at https://3dprint.nih.gov.  
Fluidic Platform: software 
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Figure 1(B) shows the dedicated software designed to control the peristaltic pumps integrated 
in the fluidic platform utilized in the present study. The fluidic platform control software 
(PumP Interface) was developed in Microsoft Visual Studio 2014. The libraries to control the 
hardware components were compiled with C# .NET, while the graphical user interface (GUI) 
was designed using windows forms application. In the case of the stepper motor low-level 
control, the microcontroller was programmed in the Arduino IDE environment. To enable 
easy installation, a single executable file was compiled including all the .NET libraries, and 
can be used standalone on any windows computer. The GUI helps the user to control the vol-
umetric flow rate by: (i) enabling the stepper motor, (ii) setting the system in stand-by mode, 
(iii) setting the direction of pumping, and (iv) setting the desired volumetric flow rate. 
 
Figure 1. (A) Designed fluidic platform. (B) GUI used to control the peristaltic pumps. (C) Photograph of 
the assembled fluidic platform with the three fabricated tissue constructs. (Scale bars: 6 mm) printing 
branch. Lines of green indicate the dispensing paths of PLA whereas lines of blue indicate the dispensing 
paths of PVA. (Scale bars: 6 mm) 
Encapsulation of hepatospheres and active perfusion of the 3D tissue constructs 
The fluidic platform, glass vials, caps and polytetrafluoroethylene (PTFE) tubing (inner diam-
eter of 0.8 mm) (BOLA 1818-10, Bohlender GmbH, Germany) were sterilized by autoclaving 
before assembling in a laminar flow bench. 0.5 M NaOH was flushed throughout the system 
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to ensure a sterile fluidic path. The system was subsequently flushed with sterile water and 
then with culture medium. The fluidic molds were treated with oxygen plasma (125 W, 13.5 
MHz, 50 sccm, and 40 millitorr) to render their surface hydrophilic and sterilized by leaving 
them in ethanol overnight. 
Gelatin 5% (w/v) was partly cross-linked with 5 Units of TG per g-1 of gelatin was prepared 
and incubated for 45 minutes at 37°C. A total of 0.5% (v/v) of chloroform was added to steri-
lize the solution. Then, the 3D sacrificial structure was inserted inside the fluidic molds. Sub-
sequently, stem cell derived hepatospheres were mixed with 1.5 mL of the gelatin/TG hydro-
gel and then casted into the fluidic molds. After the casting, the samples were incubated at 
4°C for 30 minutes to convert the liquid gelatin into a solid state. The construct was subse-
quently incubated for 1h at ambient temperature to ensure the chemical cross-linking of the 
gelatin ensuring mechanical stability at higher temperatures. The final dimensions of the tis-
sue constructs were 14 mm (L) x 11.5 mm (W) x 10 mm (H) with a resultant volume of ≈ 1.5 
cm3. The fluidic molds were then placed in the fluidic platform and media was perfused 
through at 5µL·min-1 for 30 minutes to ensure the total removal of the sacrificial template 
from the 3D constructs. After the total removal of the sacrificial structures from all the sam-
ples, the flow rate was increased to 10 µL·min-1. The entire system was incubated at 37 °C 
under 95% air 5% CO2. The hepatospheres were cultured for 7 days. A fully assembled fluid-
ic platform along with the vascularized tissue constructs is shown in figure 1(C). As a control, 
hepatospheres encapsulated in the same gelatin/TG hydrogel were cast around the sacrificial 
template in the fluidic mold and after sacrificial template removal, the part was submerged in 
a petri dish with fresh medium. The controls were then incubated at 37 °C under 95% air /5% 
CO2 for one week exchanging the media every second day. 
Fluorescent staining 
The cell viability of the engineered 3D tissue constructs was assessed using a LIVE/DEAD 
assay (Thermo Fisher Scientific). The constructs were removed from the fluidic mold, and 
sectioned along the cross-sectional direction. The constructs were removed from the mold, 
and sectioned along the cross-sectional direction. Since the gel was soft, it was impossible to 
get a clear cut, thus the surface was not entirely flat making it difficult to perform the micros-
copy analysis. The samples were then washed with Hank’s balanced salt solution (HBSS) and 
incubated for 30 minutes with 1.5 mL of HBSS containing 5 µL of SYTO 10 and DEAD read. 
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Then, samples were washed again with HBSS and imaged on a Zeiss LSM confocal micro-
scope.  
Imaging and analysis  
Confocal acquisitions were performed using a Zeiss LSM 700 module in the Axio Imager M2 
upright microscope using an epiplan-neofluar 5X/0.13 HD, an epiplan-neofluar 10X/0.25 HD, 
an epiplan-neofluar 20X/0.5 HD. To eliminate any possible crosstalk between channels, im-
ages were collected with a sequential scan, using the following laser lines and mirror settings: 
488(30%) 495-560nm; 555(30%) 605-700nm. Photographs and videos of tissue fabrication 
were acquired using a DSLR camera (Canon EOS, 5D Mark II; Canon). Fluorescent dyes 
were used to improve visualization of gelatin construct (Fluorescein). ImageJ was used to 
visualize composite images by combining fluorescent channels. The diameter of the channels 
was measured by ImageJ software using at least 4 images from different areas of 2 constructs 
for each condition. 
Results and discussion  
Fluidic mold design 
The fluidic mold used for casting the hydrogel and subsequent perfusion was manufactured 
using a molding technique, where PDMS was cast in a 3D printed mold (figure 2(A)). The 3D 
printed mold consisted of three main parts responsible for defining the external surface of the 
fluidic chip and one part responsible for defining the internal chamber. The mold was de-
signed to simplify insertion of the 3D printed template within the internal chamber and to 
simplify insertion of fluidic connections (figure 2(A)). Attention was given to the internal 
chamber (figure 2(B)-(C)). The internal chamber was inverse fabricated from a PVA printed 
mold. The mold responsible for defining the internal chamber was designed to have a volume 
of 1.5 cm3 and to include protrusion in correspondence of the inlet and outlet respectively 
(figure 2(C)). The protrusions were responsible for defining the cavities within the PDMS 
mold (figure 2(A)). These cavities were required to avoid delamination in the internal channel 
between the hydrogel and the PDMS during the dissolution and removal of the PVA. Fur-
thermore, the cavities helped to avoid undesired leaking from the constructs during the perfu-
sion (data not shown). Due to the complexity of the inner chamber, the part defining the nega-
tive of the internal channel was 3D printed in PVA. The PVA material was needed since it 
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was not possible otherwise to de-mold the part defining the inner chamber from the fluidic 
mold without breaking the PDMS or to use multiple layers of PDMS. In this way, the PVA 
printed part enclosed in the fluidic mold was dissolved in water revealing the desired inner 
chamber in the fluidic mold (figure 2(D)).  
 
 
Figure 2. (A) Designed mold used to the fabrication of the fluidic mold. The mold consisted in three exter-
nal parts responsible for defining the external surface of the fluidic mold while the internal chamber was 
designed and 3D printed in PVA to include the final cavities. (B-C) Photograph of the PVA printed mold 
used to the define the inner chamber of the fluidic mold. (Scale bars: 4 mm) (D) Photograph of the fabri-
cated fluidic mold after the demold process and dissolution of the PVA printed part, which was responsi-
ble for defining the internal chamber.  
3D printing of planar and non-planar sacrificial structures 
One of the most employed method for the fabrication of micro- and milli-channels within 
hydrogels is the 3D sacrificial molding technique [29–44]. In this study, PVA was used as 
sacrificial material, and it was 3D printed in planar and non-planar structures to demonstrate 
the versatility of the method proposed. Figure 3(A)-(D) shows the designed CAD and the 3D 
printed template for a “ring” and “zig-zag” structure respectively. Both structures were planar 
and were designed to have width dimensions of 500 µm (W) x 500 µm (H). The final printed 
structures had width dimensions of 550 ± 50 µm (W) and x 500 µm layer thickness (H). To 
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demonstrate the simplicity of the method, planar and quasi 3D structures were printed with 
the same printing parameters of the previous one (figure S1(B)-(C)). Like the 3D printing of 
most materials, the resolution of the 3D printed structures was strictly dependent on machine 
settings that required optimization. In particular, PVA is a hygroscopic [52,53] material and 
has very close melting and degradation temperatures [54]. As consequence, it can be difficult 
to maintain stable PVA during the cycles of increase and decrease of temperature within the 
printing process [54,55]. This often leads to the failure of the printing process. When printing 
simple and regular geometries such as square lattices, cubic forms that doesn’t require the 
presence of support structure it is easier to control the PVA because the temperature is con-
stant during the fabrication process. However, when printing structures that can be freely de-
signed into the 3D space and needs support structure underneath, the failure of the printing 
process is more pronounced because the 3D printer will need to switch material every layer, 
and the risk of oozing and clogging increases dramatically.  
Since one of the key points of this study was to create freeform 3D structures, a 3D branch 
was designed and 3D printed (figure 3(E)-(F)). The 3D branch was printed using a dual print-
ing strategy, where the primary structure was printed using PVA, and the support material 
was printed using PLA. The support structure was selectively removed with chloroform. At-
tention was given to the generation of the support structure. At first, Kisslicer was used to 
generate multiple support structures by tuning different parameters, such as the support densi-
ty, support inflation, and distance between the support and the designed part (first two sam-
ples from the left, figure 3(G)). However, none of the support structures generated could 
achieve successful printing of the designed branch and to ensure the total removal of the PLA 
support material without disrupting the printed PVA structure (first sample from the left, fig-
ure S1(D)). Moreover, the very few 3D branch obtained after the successful dissolution of the 
PLA were characterized by poor quality (last sample from the left, figure S1(D)). Therefore, 
the support structure was designed directly on the 3D branch using the CAD tool (last two 
sample from the left, figure 3(G)). The support structure was designed with the aim of mini-
mizing the amount of support material to be dissolved, but at the same time, use enough sup-
port material to give a mechanically stable support during the printing process. The new sup-
port structures covered the entire 3D branch maintaining however a distance of 100 µm from 
it to avoid any cross contamination of materials during the printing phase. However, none of 
the printed structures were capable of being dissolved without disrupting the PVA printed part 
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in the branch point (figure S1(E). Finally, a new version was designed. The main difference 
from the previous one was the almost absence of support material within the four channels of 
the branch but at the same time enough material to ensure mechanical stability during the 
printing phase (figure 3(H)). The new part was sliced with Kisslicer, using the same machine 
parameters used for the PVA part and 3D printed (figure 3(I)). The design and the Gcode pa-
rameters for the 3D branch, and all the other designed sacrificial templates can be download-
ed from https://3dprint.nih.gov that can be printed on any two headed RepRap or MakerBot 
3D printer. The resulting dimension of the 3D branch was ≈ 700µm for line width and layer 
thickness respectively (for a CAD design of 600µm) after the dissolution of the PLA support. 
The final resolution and quality of the 3D printed branch was a clear indication of how crucial 
was the design of the support structure to ensure mechanical stability of the PVA sacrificial 
template during the printing and PLA dissolution phase. Although there have been other strat-
egies to design PVA sacrificial structures, going from simple square lattices [39,40], to quasi 
3D structures [26,32], they still lack the versatility to be geometrically free in the 3D space 
which is enabled using the PLA support as described here. In contrast to other who rely on 
modified FDM printers [32] or modified materials [31], we achieve total geometric freedom 
of sacrificial molds using standard FDM printers as well as bio filaments.  
 
Figure 3. (A-B) Designed model and photograph of the 3D Printed “zig-zag” structure using PVA as sacri-
ficial material. (Scale bars: 3 mm, 6 mm) (C-D) Designed model and photograph of the 3D Printed “ring” 
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structure using PVA as sacrificial material (Scale bars: 3 mm, 6 mm) (E-F) Designed model and photo-
graph of the 3D Printed “branch” structure using PVA as sacrificial material and PLA as support mate-
rial. (Scale bars: 3 mm, 6 mm) (G) Photograph of the 3D Printed branch with four curved arms using 
PVA as sacrificial template and different support structures generated. (Scale bar: 8 mm) (H) CAD model 
of the designed 3D Branch and the customized support structure. The quantity of support material in the 
center was the minimal quantity necessary to ensure the mechanical stability of the 3D Branch. (I) Photo-
graph of the 3D Printed branch with four curved arms using PVA as sacrificial template and PLA as sup-
port material used. (Scale bar: 8 mm) 
PVA dissolution in water and soft hydrogels 
To estimate the kinetics of the dissolution in water of the PVA, the radius and length of the 
PVA filament were followed over time, and data was analyzed by the Noyes-Whitney equa-
tion (SI methods) [56,57]. Figure 4(A) shows the linear variation over time of the PVA fila-
ment mass in respect of a function f(t), which is the integral of a polynomial function F(t). 
F(t) represents a polynomial function used to fit the variation over time of the radius and 
length of the PVA filament dissolved in water (figure S1(F)). The calculated slope on figure 
4(A) represents the rate constant of the dissolution, and it was found to be 1.9 µm·s-1. The rate 
of dissolution shows that in water the PVA filament would lose approximately 100 µm of 
PVA every minute. A fast rate of dissolution means that when in contact with water, a fabri-
cated PVA structure will rapidly lose material leading towards the loss of mechanical and 
structural stability. However, if the bulk is changed from water to a hydrogel material the 
model used to evaluate the rate of dissolution of PVA in water is not valid anymore because 
the sink condition is lost and this would likely result in slower degradation. It is important to 
realize that cross linking of the hydrogel and the dissolution of the PVA needs to be timed so 
the hydrogel is formed before the PVA is completely dissolved. Ideally the PVA will essen-
tially appear to be as defined after the dissolution as the initial 3D printed structures.  
The dissolution of the PVA and hydrogel formation was studied by varying the concentration 
of gelatin, the added cross linker TG and the temperature (figure 4(B)-(C)). The PVA struc-
ture was not at all defined after 25 minutes in PBS leaving the PBS as a milky dispersion. 
Considering the rapid dissolution of PVA (figure 4(A)), this was expected but also empha-
sized that the crosslinking of hydrogels need to happen fast. PVA structures in 7.5% (w/v) 
gelatin at ambient temperature resulted in a well-defined PVA essentially confined to the 
space of the initial PVA structure (Figure 4B). By contrast, a PVA structure in 5% (w/v) gela-
tin resulted no such confinement. The difference between was that PBS and 5% (w/v) gelatin 
at ambient temperature was not a gel while 7.5% (w/v) gelatin was (Supplementary figure 
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S1(G)). To chemically crosslink the gelatin, various additions of TG were investigated. The 
results showed that increasing the TG concentration and thus the cross linking of 5% (w/v) 
gelatin gave more confined PVA after 25 min incubation at ambient temperature (figure 
4(C)). Despite this, PVA was not as confined in 5% (w/v) gelatin with highest tested amount 
of TG as in 7.5% (w/v) gelatin indicating that the kinetics of chemical cross linking is still too 
slow for the lower percentage gels. Crosslinking of hydrogels was investigated by tilting the 
mold 90 degrees and observed if the gel was intact (S1(H)). All concentration of TG tested 
could crosslink 5% (w/v) gelatin in 25 min at ambient temperature. Since gelatin can be phys-
ically crosslinked via thermal cooling [58,59], 5% (w/v) gelatin hydrogel crosslinked with 
various concentration of TG were used to encapsulate a PVA structure at 4 °C for 25 minutes. 
The PVA structures were better confined but not compared to 7.5% (w/v) gelatin at ambient 
temperature (Figure 5(D)). To increase the rate of gelation, gelatin was partly crosslinked 
before casting. Partly crosslinking was evident by an increase in viscosity. The partly cross-
linked 5% (w/v) gelatin/TG solution was casted around PVA and cooled to 4 °C to rapidly 
induce thermal gelation by the reduced temperature. The TG could then create chemical 
crosslinks of the gelatin while still being in a gel state by the low temperature. This resulted in 
PVA being well contained in the gelatin during the dissolution phase (see for instance figure 
5(A)) resulting in well-defined channels (figure 5(B)) and this method was subsequently used 
throughout the study. It was possible to make well defined structures using 2.5 Units of TG·g-
1 of gelatin using this method. The partial cross linking was dependent on the concentration of 
TG for a given concentration of gelatin (data not shown). As varying the TG concentration 
resulted in hydrogels with varying stiffness (figure 4(E)), the time for partly crosslinking must 
be considered in each case. Here we use 2.5 or 5 Units of TG·g-1 gelatin and for that we incu-
bate 3.5h and 1h, respectively, at 37 °C before casting. Higher concentration such as 50 U 
TG·g-1 of gelatin requires only a 10-minute incubation before casting. To our knowledge, 
partly crosslinking of gelatin before casting to improved PVA sacrificial molding has not 
been reported in the literature. Partly chemical crosslinking and the physical gelation enabled 
us using 5% (w/v) gelatin. Such low gelatin concentration has not been possible to use in 
PVA sacrificial molding before.  
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Figure 4. (A) Linear variation over time of the PVA mass in respect of a function f(t), which is the integral 
of a polynomial function F(t). F(t) represents a polynomial function used to fit the variation over time of 
the radius and length of the PVA filament dissolved in water (SI methods). (B) PVA dissolution of a mold-
ed structure within a 7.5% (w/v) gelatin, 5% (w/v) gelatin and PBS at ambient temperature right after the 
casting and after 25 minutes. (C) PVA dissolution of a molded structure within a 5% (w/v) gelatin hydro-
gel chemically crosslinked with 50, 20, and 5 Units of TG per g of gelatin, and within a 7.5 % (w/v) gelatin 
(control) at ambient temperature immediately after the casting and after 25 minutes. (D) PVA dissolution 
of a molded structure within a 5% (w/v) gelatin at 4 °C temperature right after the casting and after 25 
minutes. (E) Stress and strain response of gelatin 5% (w/v) cross-linked with different degrees of TG un-
der compressive loading. 
Fabrication of vascular engineered constructs  
The method to structure soft gels was tested on planar and non-planar PVA structures inserted 
into the fluidic mold (figure 5(A)-(C)). The sacrificial template was dissolved and removed 
from all the construct leaving a well-defined and open channel networks (figure 5(D)-(F)). It 
was possible to create engineered constructs with planar channel networks (figure S1(J)-(K)), 
with 3D lattice channel networks (figure S1(L)-(M)), and with 3D channel networks. Moreo-
ver, the creation of different channel networks was obtained either for hydrogels with low and 
high compressive modulus (e.g. 2 kPa, 6.5 kPa). The final vascular construct had dimensions 
of 14 mm (L) x 11.5 mm (W) x 10 mm (H) with a resultant volume of ≈ 1.5 cm3, and alt-
hough the tissue construct was extremely soft, the channels didn’t collapse (figure 5(G)). The 
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final diameter of the channels within the construct was 1 mm for 2D constructs (figure 5(I)) 
while 3D structure had a final diameter of 1.3 mm (figure 5(I)). The structural stability of the 
fabricated constructs along with its different vascular networks was tested by perfusing them 
with 100 µL·min-1 for 24 hours at 37 °C. It was found that the construct along with its built-in 
channel network were mechanically stable without any structural deformation in response to 
the increased volumetric flow rate or increase in temperature. Crucial to the final morphology 
of the embedded channel networks within the construct was the structural stability of the PVA 
structures. It was found that the planar printed PVA structures with dimensions smaller than 
500 µm (W) x 500 µm (H) were unable to maintain their mechanical stability when in contact 
with the hydrogels used in this study. By contrast, for the non-planar, the limit was higher, 
and it was found to be 700 µm. This limitation is more important when dealing with non-
planar structures where their structural stability is crucial to the creation of complex perfusa-
ble networks. Moreover, when increasing the diameter of the printed PVA structures, the 
quantity of the material to be dissolved and removed increased significantly. This lead likely 
to an increase in the intra pressure within the hydrogel and the result was an increase of the 
final diameter of the vascular channel. To control the internal overpressure generated during 
the PVA dissolution inside the channels embedded within the construct the dissolved PVA 
was continuously extracted. The extraction of the dissolved PVA from the embedded chan-
nels was obtained by perfusing the fabricated constructs with a volumetric flow rate of 5 
µL·min-1 for 30 minutes (figure 5(H)). The flow rate was sufficient to slowly dissolve the 
PVA structures and to ensure a continuous extraction of the dissolved PVA from the channel 
networks without damaging extensively the surrounding ECM (Supplementary Movie S1). 
The interface between the fluidic mold fabricated in PDMS and the gelatin hydrogel is critical 
for the active perfusion of the constructs. At first, poly(methyl methacrylate) (PMMA) was 
used as the material for the fabrication of the fluidic mold. However, during the dissolution of 
the PVA and the perfusion of cell culture medium, the hydrogel was fully delaminated from 
the PMMA mold (Supplementary Movie S2). PLA was subsequently chosen as the main ma-
terial for the fabrication of the fluidic mold. Despite this, the delamination was still apparent 
during the dissolution of the PVA leading again to the leaking (Supplementary Movie S3). 
Considering that both PLA and PMMA are highly hydrophobic materials [60,61] and that 
gelatin is mainly water-based, the leaking was an indication that the surface of the molds 
needed to be functionalized. Therefore, both PMMA and PLA molds were plasma treated thus 
	
	
 107 
making their surface hydrophilic. The plasma treatment of the molds fabricated in PMMA 
resulted in gelatin gels adherent to PMMA during the dissolution of the PVA and perfusion of 
constructs without any visible leaking (Supplementary Movie S4). By contrast, the plasma 
treatment did not work for the fluidic mold fabricated in PLA (data not shown). Although 
PMMA material was a viable candidate for the fabrication of the fluidic molds, the manufac-
turing process required for manufacture the designed fluidic molds were complicated and la-
bor consuming. Instead, the fluidic mold was fabricated in PDMS using a molding technique 
where the inner chamber contained features that suppress leakage (as previously described in 
figure 2). Plasma treated PDMS was hydrophilic [62] resulted in a fluidic mold to which gela-
tin bound making the construct completely leak proof for long term perfusion experiments 
(Supplementary Movie S5). 
 
Figure 5. (A-C) Photograph of the planar and non-planar 3D printed sacrificial templates embedded in a 
gelatin hydrogel construct before the dissolution and removal of PVA. (Scale bars: 9 mm) (D-F) Photo-
graph of the resulting vascularized 3D construct with different networks. (Scale bars: 8 cm) (G) Photo-
graph of the cross section of the vascularized 3D construct showing the volumetric distribution and struc-
tural stability of the channels. (Scale bar: 6 mm) (H) Photograph of fluidic platform and the three engi-
neered constructs allocated for the smart dissolution/removal of the PVA under fluid flow. (Scale bar: 12 
mm) (I) Quantification of the diameter of the embedded channels for the engineered constructs actively 
perfused comparing planar and non-planar networks. 
Encapsulation of hepatospheres and active perfusion in soft constructs 
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To demonstrate the ability of our platform to induce active perfusion throughout the engi-
neered construct with embedded channel networks, hepatospheres were encapsulated in 1.5 
mL of a gelatin/TG solution, with a stiffness of 3.3 kPa (stiffness of a liver [63–65]). To that 
end, the hepatospheres were mixed with gelatin/TG solution that was previously incubated for 
1h, and cast in the fluidic mold (see material and methods for details), around the “zig-zag” 
sacrificial template. The PVA template was removed and the constructs were perfused with a 
volumetric flow rate of 10µL·min-1 for 7 days (figure 6(A)-(B)). Fluorescence micrographs of 
the constructs sagittal plane were taken on multiple time points (days 1, 7) (figure 6(C)-(D)) 
to investigate the cellular viability, the effect of dissolution and removal of PVA, and the ef-
fect of the perfusion over time. Confocal microscopy images of live/dead stained 
hepatospheres were taken at the inlet and at the center of the constructs (figure 6(D)-day 1, 
inlet-center). The hepatospheres had similar viability after 7 days perfusion as after one day 
perfusion. Furthermore, the hepatospheres maintained similar morphology during the seven 
days of perfusion (figure 6(E)-(H)) thus indicating that the system and processes used to en-
capsulate the hepatospheres and structure the gel is biocompatible. The hepatospheres were 
homogeneously distributed in the gel. It is likely that the partial cross linking, which resulted 
in a gel with high viscosity, suppressed sedimentation of the relatively heavy hepatospheres 
during the casting and crosslinking process. In principle, this method could be translated for 
the encapsulation of a single or a multiple cell population into the same hydrogel creating a 
more complex construct. This together with the ability of engineer several perfusable net-
works suggests the possibility for the engineering of complex and thick tissue constructs with 
controlled micro- and milli- environment. 
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Figure 6. (A-B) Photograph of vascularized 3D tissue construct with encapsulated hepatospheres after 7 
days of active perfusion using a flow rate of 10 µL min-1 (A) inside the fluidic mold (Scale bars: 2mm), and 
(B) removed from the fluidic mold. (Scale bar: 2mm) (C) Schematic of the cross section through the 
sagittal plane of the 3D tissue construct on depicting the distribution of hepatospheres in respect to the 
channel networks. The arrow indicates the inlet of the active perfusion. (D) Live/dead confocal 
microscopy through the cross section of the sagittal plane in the constructs with embedded channels in 
correspondece of the inlet of the perfusion and the center of the construct. The hepatospheres were encap-
sulated in a hydrogel with stiffness of 3 kPa and perfused for 7 days. The stripped lines represents the 
embedded channel networks within the constructs. (Scale bar: 500 µm) (E-H) Live/dead confocal 
microscopy of encapsulated hepatospheres after 7 days of active perfusion showing the morphology within 
the tissue constructs. (Scale bar: 50 µm) 
 
Conclusions 
Here we show a method to fabricate thick, soft, cell laden hydrogels perforated with fluidic 
channel. We also demonstrate a method to interface such constructs to a fluidic system for 
long term perfusion. The approach to achieve well defined channels in soft gelatin gels using 
PVA sacrificial layer depended on a partial crosslinking of gelatin by TG before casting and a 
physical gelation immediately after casting. Leak free perfusion of such hydrogels depended 
on the design of the case (“fluidic mold”), plasma treatment of the case and molding of gela-
tin directly in the case. The case material was PDMS which could be structured by sacrificial 
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molding which was necessary to introduce features suppressing leakage. The encapsulated 
hepatospheres were homogeneously distributed with gelatin/TG having stiffness of 3kPa. The 
fabricated construct with the encapsulated hepatospheres was perfused for 7 days indicating 
that all steps were biocompatible. The proposed method coupled with the presented fluidic 
platform would allow the fabrication of engineered constructs able to recapitulate the complex 
3D micro- and milli-environment and with perfusable vasculature, which could enable ad-
vances in designing tissue engineered constructs with translational potential and for the mod-
eling of tumors.  
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Supplementary information 
Methods 
Noyes-Whitney equation  
The dissolution phenomena of a solid particle in a excess of water follows the Noyes–
Whitney Equation: 
 −
dm
dt =
DS
hN
(cs − ct )  (S1)  
where m is the solid mass at time t , D is the solute diffusion in the water, S is the solid sur-
face, h is the width of the diffusion layer, cs is the solid concentration at saturation, and ct is 
the concentration of the solution at time t. The equation can be re-written as: 
 −
dm
dt = K(cs − ct )  (S2)  
where K represents the rate constant of dissolution. When the solute is highly soluble in water 
and the water in excess as well as stirring at a constant and rapid velocity (to ensure the 
Nernst model validity) cs >>ct and the equation S2 can be written as: 
 −
dm
dt = Kcs  (S3)  
For a cylindrical shape, the surface is described as: 
 S = 2πr2 + 2πrl  (S4)  
And	the	mass	is	described	by:	
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 m = ρπr2l  (S5)  
If the equation S4 and S5 are substituted in the equation S3, the equation S6 can be written as: 
 −
dm
dt =
2Dcs
hρ
1
r +
1
l
⎛
⎝
⎜
⎞
⎠
⎟m  (S6)  
It is difficult to evaluate how the mass m vary with the time since both r and l are time de-
pendent. Therefore, r and l where experimentally measured over time and the sum 
[(1/r)+(1/l)] was fitted to a polynomial function F(t) using the least-squares method. The inte-
gration of the equation S6 leads to: 
 ln mm0
⎛
⎝
⎜
⎞
⎠
⎟= −2 Dcshρ f (t)  (S7)  
where m0 and m are the masses at time 0 and t respectively, and f(t) is the integral of the poly-
nomial function F(t). We can therefore define a new constant k´ that can be written as: 
 k´= 2k cs
ρ
= 2 Dcshρ  (S8)  
From calculating the slope in the equation S7 it is possible to evaluate the rate costant k´ that 
describes the dissolution process of the PVA in water. 
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Figure S1. (A) Photograph of a cylindrical PVA filament, with radius r and height l, used to study the 
dissolution in water. (Scale bar: 5 mm) (B) photograph of a PVA Printed part with a planar structure. (C) 
photograph of a PVA Printed part with a square lattice structure. (D) Printed PVA branch obtained after 
the dissolution of PLA fabricated using the support structure generated from Kisslicer. (Scale bar: 5 mm) 
(E) Printed PVA branch obtained after the dissolution of PLA fabricated using the support structure 
custom designed. (Scale bar: 5 mm) (F) Variation in time of the inverse of the radius r, the inverse of the 
length l, the sum, and the fitted polynomial function F(t) for the PVA filament dissolved in water. (G) 
PVA dissolution of a molded structure within a 7.5% (w/v) gelatin, 5% (w/v) gelatin and PBS at ambient 
temperature after 25 minutes. (Scale bar: 10 mm). (H) PVA dissolution of a molded structure within 5% 
(w/v) gelatin chemically crosslinked with 50, 20, 5 Units of TG per g of gelatin in respect to gelatin 7.5 % 
(w/v) (control) at ambient temperature immediately after the casting and after 25 minutes. (Scale bars: 10 
mm) (J) Photograph of a planar 3D printed sacrificial templates embedded in a gelatin hydrogel construct 
before the dissolution and removal of PVA. (Scale bar: 9 mm) (K) Photograph of the resulting vascular-
ized 3D construct with an embedded planar channel network. (Scale bar: 8 mm) (L-M) Photograph of the 
resulting vascularized 3D construct with an embedded square lattice channel networks. (Scale bars: 5 
mm) 
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THREE-DIMENSIONAL FABRICATION OF THICK AND DENSELY POPULATED SOFT 
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Abstract 
One of the fundamental steps needed to design functional tissues and, ultimately organs is the 
ability to fabricate thick and densely populated tissue constructs with controlled vasculature 
and microenvironment. To date, bioprinting methods have been employed to manufacture 
tissue constructs with open vasculature in a square-lattice geometry that lacks the ability to be 
directly perfused. Moreover, it appears to be difficult to fabricate vascular tissue constructs 
targeting the stiffness soft tissues such as the liver. Here we present a method for the fabrica-
tion of thick (e.g. 1 cm) and densely populated (e.g. 10 million cells·mL-1) tissue constructs 
with a three-dimensional (3D) four arm branch network and stiffness in the range of soft tis-
sues (1-10 kPa), which can be directly perfused on a fluidic platform for long time periods (> 
14 days). Specifically, we co-print a 3D four-arm branch using water-soluble Poly(vinyl alco-
hol) (PVA) as main material and Poly(lactic acid) (PLA) as the support structure. The PLA 
support structure was selectively removed, and the water soluble PVA structure was used for 
creating a 3D vascular network within a customized extracellular matrix (ECM) targeting the 
stiffness of the liver and with encapsulated hepatocellular carcinoma (HepG2) cells. These 
constructs were directly perfused with medium inducing the proliferation of HepG2 cells and 
the formation of spheroids. The highest spheroid density was obtained with perfusion, but 
overall the tissue construct displayed two distinct zones, one of rapid proliferation and one 
with almost no cell division and high cell death. The created model, therefore, simulate gradi-
ents in tissues of necrotic regions in tumors. This versatile method could represent a funda-
mental step in the fabrication of large functional and complex tissues and finally organs. 
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Introduction 
In the last decade, significant effort has been made to fabricate functional three-dimensional 
(3D) Tissue Engineering constructs to simulate a portion of a human tissue [1–6]. Such con-
structs could open up for a new world of applications in drug delivery [7,8], 3D cell culture 
[9–11], disease model platforms [12] and tissue regeneration [13–16].  
The current challenge in fabricating functional 3D constructs relies on the difficulties in creat-
ing relevant perfusable vasculatures, necessary to overcome the regarded diffusion limit of 
oxygen and nutrients (i.e., 200 µm) [17], within an ECM simulating soft tissue stiffness (e.g. 
liver) [18,19]. This is mainly due to the fact that it is hard to maintain the physical integrity of 
the ECM and the channels within [20]. In addition, to keep densely populated tissue con-
structs alive (cell density in the range of 10 – 500 million cells·mL-1 [21]), an open vascula-
ture without active perfusion would probably not be sufficient [22]. Therefore, to guarantee 
the final success of the fabricated construct it is necessary to developed a strategy to actively 
perfuse these tissues constructs [23]. Direct 3D printing has gained an important role in the 
fabrication of thick, vascularized, and complex 3D constructs [14,15,18,22,24–32], since it 
allows layer-by-layer printing of a variety of complex shapes. The drawback is that it is not 
possible to print structures with 3D degree of freedom, without having a support structure 
underneath. This has mainly led to the fabrication of simple self-sustained square lattices 
which do not represent the complexity of real tissues [15,21,25,27,30,33]. Kolesky et al [33] 
reported a technique where they printed two different inks at the same time followed by ca-
sting an ECM into the printed structure. The first ink used was Pluronic F127, which was the 
sacrificial material responsible for defining the vascular channels. The second ink was a mix-
ture of cells and suitable ECM that was made by a blend of gelatin and fibrinogen, which was 
direct printed in the positions along the vascular channels. Then, another mixture of gelatin 
and fibrinogen cross-linked by a dual-enzymatic strategy by using thrombin and transglutam-
inase (TG) was cast around the direct printed structure. The thrombin was used to rapidly pol-
ymerize fibrinogen, and TG, which is a slow-acting Ca2+-dependent enzymatic cross-linker, 
acted on the gelatin to give mechanical stability on the final printed construct.  
Another strategy that has been employed to fabricate 3D constructs is the 3D sacrificial mold-
ing technique [21,28,33–45]. Bio-printers have been used to print gelatin [44,45], agarose 
[46], Pluronic F127 [43] as sacrificial material to create vascular networks. Miller et al. [21] 
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reported a method for fabricating 3D vascular constructs, in which a modified Fused Deposi-
tion Modelling (FDM) printer has been used to 3D print carbohydrate glass structures serving 
as sacrificial template. Then, a poly(ethylene glycol) (PEG) based hydrogel with cells encap-
sulated was cast around the sacrificial template. Subsequently, the sacrificial material was 
removed from the PEG hydrogel leaving behind a network of open microchannels. FDM has 
been also used to print sacrificial templates in PVA [39,40,42]. However, in some cases the 
3D printed structures were used to create porous elastomeric scaffolds [39,40] for 2D cell 
culture. In another case, although custom modified machines allowed the realization of more 
complex PVA structures, the ECM used was extremely stiff with no cells encapsulated in it 
[42]. Finally, molds have been used to create sacrificial templates using sodium alginate [37] 
and PVA [38]. Although direct printing and 3D molding strategies have shown advantages in 
fabricating tissue engineered constructs with perfusable vasculature there are some aspects 
that needs to be addressed. The majority of the proposed vascular networks were composed 
by single [44,46] or multiple microchannels in a single plane [21,28,37,38,42,43,47], or in a 
square lattices-like structure [15,26,27,30,33,48]. It appears to be difficult to manufacture 
thick tissue constructs able to integrates (1) soft tissues stiffness (2) relevant cell density (3) 
complex vascular networks and (4) perfusion. We believe these four points are critical for the 
final success of an engineered construct and this is what are addressing in this paper.  
Here, we describe a method for the fabrication of a thick and densely populate tissue construct 
with full 3D perfusable network and stiffness in the range of soft tissues. The obtained 3D 
tissue constructs are relatively thick (1 cm3) allowing a connection with a custom fluidic plat-
form and being perfused for extended time periods (> 14 days). Long term cell culture 
demonstrated strong dependence of nutrient and oxygen feed for cell growth.  
Materials and Methods 
Hydrogel preparation 
Gelatin cross-linked with transglutaminase (Activa-TI, Ajinomoto North America Inc., Illi-
nois, US, (TG)) was used in this study. Briefly, 7.5% (w/v) gelatin (48723 Fluka) was mixed 
with cell culture medium (Roswell Park Memorial Institute, RPMI 1640) supplemented with 
10% fetal bovine serum (FBS; Gibco Labs), and penicillin/streptomycin at 60 °C and stirred 
until fully solubilized. The degree of cross-linking of the resulting gelatin/TG hydrogel was 
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controlled by varying the amount of TG in respect to the mass of the gelatin. The appropriate 
mass of TG (Activa-TI, Ajinomoto, Inc., activity of approximately 100 U·g-1 of TG according 
to the manufacturer) was dissolved in 15 mL of PBS (Sigma Aldrich) to give concentrations 
of 2.5, 5, 10, and 20 units of TG per g of gelatin. The final concentrations of the gelatin/TG 
hydrogel used in this study were 5% (w/v) gelatin, with 2.5, 5, 10, and 20 units of TG per g of 
gelatin.  
Mechanical properties 
Mechanical tests were performed on cylindrical shaped samples (n= 6). Briefly, 1mL of the 
5% (w/v) gelatin/TG pre-polymer solutions (ratio of TG (2.5, 5, 10 and 20 units of TG per g 
of gelatin) was cast in a cylindrical PMMA mold (10 mm in diameter, 10 mm in thickness). 
Samples were incubated at 37°C for 24 hours allowing gelatin cross-linking. The cylindrical 
samples were tested at 37°C, and compressed to 10% of the initial length using 0.1% strain 
rate using the Solid Analyzer instrument (0.1 µN force resolution, 0.5 mN minimum force, 1 
nm displacement resolution) (RSA II, Rheometrics, Inc.). The compressive elastic modulus of 
each sample was calculated from the stress-strain curve (first linear zone, 2% strain).  
Design and 3D Printing of the 3D sacrificial structures 
The 3D sacrificial structures were designed and converted into STL files using Solid Works 
CAD software (computer aided design, Dassault Systemes SolidWorks Corporation, US). All 
STL files were processed by KISSlicer (www.kisslicer.com) software and sliced into 100-µm-
thick layers to generate G-code instructions for the 3D printer. G-code instruction sets were 
sent to the printer using Repetier-host (https://www.repetier.com), an open-source 3D printer 
host program. Then commercially available PVA and PLA filaments (Makerbot Industries, 
Brooklyn, NY, USA) were printed using the Felix 3 (Felix Printers, IJsselstein, Netherlands) 
printer with a nozzle of 250 µm.  
Dissolution of support material in the 3D sacrificial structures 
The 3D sacrificial structures were printed with PLA as support material. Then, the structures 
were immersed in 200 mL of chloroform (Sigma Aldrich) under continuous stirring until all 
the solid PLA support was dissolved. After the total dissolution of the PLA, the 3D sacrificial 
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structures were immersed in 10 mL of clean chloroform for an additional day to reduce the 
layer of PLA around the 3D printed PVA.  
HepG2 encapsulation and active perfusion of the 3D tissue constructs 
All reagents were purchased from Sigma Aldrich unless otherwise specified. The liver hepa-
tocellular carcinoma (HepG2) cells (American Type Culture Collection, Rockville, MD, 
USA) were cultured in RPMI 1640 supplemented with 10% (v/v) fetal bovine serum, and 1% 
(v/v) penicillin/streptomycin. 
The fluidic platform was sterilized using ethanol. Glass vials, caps and polytetrafluoroeth-
ylene (PTFE) tubing (inner diameter of 0.8 mm) (BOLA 1818-10, Bohlender GmbH, Germa-
ny) were sterilized by autoclaving before assembling in a laminar flow bench. A total of 0.5 
M NaOH was flushed throughout the system to ensure a sterile fluidic path. The system was 
subsequently flushed with 10 mL of sterile water and then with 10 mL of culture medium. 
The fluidic molds were fabricated using polydimethylsiloxane (fabrication not showed, 
PDMS) and were sterilized by washing the fluidic molds in ethanol. 
Gelatin 5% (w/v) cross-linked with 5 units of TG per g of gelatin was prepared and incubated 
for 45 minutes at 37°C. A total of 0.5% (v/v) of chloroform was added to sterilize the solu-
tion. Then, the sacrificial template (Fig. 1B) was placed inside the fluidic molds (Fig. 2A). 
Subsequently, HepG2 cells were mixed with 1.5 mL of the gelatin/TG hydrogel and then cast 
into the fluidic molds, to have a final density of 1 x 107 cells·mL-1 of gelatin/TG hydrogel. 
After the casting, the samples were incubated at 4°C for 30 minutes to convert the liquid gela-
tin into solid state. The construct was subsequently incubated for 1h at ambient temperature to 
allow chemical cross-linking of the gelatin, ensuring mechanical stability at higher tempera-
tures. The final dimensions of the tissue constructs were 14 mm (L) x 11.5 mm (W) x 10 mm 
(H) with a resultant volume of ≈ 1.5 cm3. The fluidic molds were placed in a fluidic platform 
able to hold 3 samples at a time, and media was perfused through at 5µL·min-1 for 30 minutes 
to ensure the total removal of the 3D sacrificial structure from the 3D constructs. After com-
plete removal of the 3D sacrificial structures from all the samples, the flow rate was increased 
to 100 µL·min-1. The entire system was incubated at 37 °C under 95%air/5% CO2, and the 
medium was exchanged every second day. Cells were cultured for up to 14 days. To investi-
gate the importance of direct perfusion within the 3D constructs, control experiments with the 
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same cellular densities were prepared and conducted under passive media exchange. A total 
of 1.5 mL of encapsulated HepG2 cells were cast in the fluidic mold, in one case without the 
3D sacrificial structure, and in another with the 3D sacrificial structure placed inside the fluid-
ic mold, following subsequent removal, as described above. The tissue constructs (with and 
without perfusion channels) were placed in a petri dish with fresh medium to provide a pas-
sive exchange of medium. The controls were then incubated at 37 °C under 95%air/5% CO2 
for one week, exchanging the media every second day. 
Fluorescence staining 
The cell viability of the engineered 3D tissue constructs was assessed using a LIVE/DEAD 
assay (Thermo Fisher Scientific). The constructs were removed from the mold, and sectioned 
along the cross-sectional direction. Due to the softness of the gel, it was impossible to get a 
clear cut, and therefore the surface was not entirely flat making it difficult to perform the mi-
croscopy analysis. The samples were then washed with Hank’s balanced salt solution (HBSS) 
and incubated for 30 minutes with 1.5 mL of HBSS containing 5 µL of SYTO 10 and DEAD 
read. After incubation, the samples were washed again with HBSS and then imaged with the 
Zeiss LSM confocal microscope. Engineered 3D tissue constructs were also stained for the 
nuclei, cellular membrane and F-actin. Briefly, samples were fixed in 4.5% (v/v) paraformal-
dehyde in phosphate buffered solution (PBS) for 20 minutes and permeabilized with 0.1% 
(v/v) Triton X-100 in PBS for 10 minutes followed by a PBS washing in between. Subse-
quently, they were stained for 1 hour with Höechst 33342 (Invitrogen) for labeling the cell 
nuclei, Phalloidin (F432, Invitrogen) for labeling the F-actins, and with Cell mask (C37068, 
Invitrogen) for labeling the cellular membrane according to manufacturer’s instruction.  
Imaging and analysis  
Confocal acquisitions were performed using a Zeiss LSM 700 module in the Axio Imager M2 
upright microscope using: an epiplan-neofluar 5X/0.13 HD, 10X/0.25 HD, 20X/0.5 HD, and a 
40x/1.20 W Korr C-Apo objective. To eliminate any possible crosstalk between channels, 
images were collected with a sequential scan, using the following laser lines and mirror set-
tings: 405 (30%) 420-480nm; 488(30%) 495-560nm; 555(30%) 605-700nm. Photographs and 
videos of tissue fabrication were acquired using a DSLR camera (Canon EOS, 5D Mark II; 
Canon). Fluorescein dye was used to improve visualization of gelatin construct. ImageJ was 
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used to visualize composite images by combining fluorescent channels. Three-dimensional 
rendering and visualization of confocal stacks were performed in Imaris 7.6.4, Bitplane Scien-
tific Software. The diameter of vascular channels and spheroids was measured using ImageJ 
software using at least 4 images from different areas of 2 constructs for each condition. 
 
Results and discussion  
3D printing of sacrificial structures and support dissolution 
One of the main challenges in engineering functional dense 3D tissue constructs or organs is 
the lack of a perfusable vasculature [1,15,17,23,49,50]. Considering that the vascular system 
within tissues and organs is not distributed in a single plane but is branched [23,51–53], we 
designed a 3D vascular branch with four curved arms distributed in the 3D space to ensure a 
volumetric distribution of flow throughout the tissue construct (Fig. 1A-D). When designing 
non-planar geometries, the main limitation on using any standard layer-by-layer 3D printer is 
the difficulties to deposit material in the 3D space without the presence of support material 
underneath. Therefore, the 3D bifurcated branch was printed using a dual printing strategy, 
where the primary structure was printed using PVA, and the support material was printed us-
ing PLA (Fig. 1A). The support structures were designed using the CAD tool (Fig. 1D) with 
the aim of minimizing the amount of support material to be dissolved, but at the same time 
using enough material to guarantee the mechanical stability of the part during the printing 
process. The support structure was then selectively removed with chloroform after completed 
printing (Fig. 1B). Like the 3D printing of most materials, the resolution and morphology of 
the 3D bifurcated branch was dependent on several machine settings and required optimiza-
tion for the two materials used. The design for the 3D bifurcated branch can be downloaded 
as an STL file together with the generated Gcode from https://3dprint.nih.gov and can be 
printed on any two-headed RepRap or MakerBot 3D printer. After the dissolution of the PLA 
support of the 3D bifurcated branch, the resulting line width and layer thickness of the PVA 
structure was approximately 700 µm (for a CAD design of 600 µm). The final resolution and 
quality of the 3D printed branch showed that the created support structure was fundamental to 
ensure mechanical stability of the PVA structure during the printing phase. Also, the created 
	
	
 131 
support structure was important because the amount of PLA used was minimized to induce 
the dissolution of the PLA without damaging or breaking the fragile 3D branch.  
There have been several strategies to design sacrificial PVA structures, going from simple 
square lattices [39,40] to quasi 3D structures [38,42]. However, these attempts still lack the 
ability to create a branched vasculature with curvatures and points of junction in the 3D space 
that are characteristic for the human vasculature. The key advantage of our fabrication method 
is that it is not relying on modified FDM printers [42] or modified materials [21]. Instead, we 
focused on the design of the desired structure, and we used the built-in ability of the FDM 
printer to print complex structures by printing two materials at the same time, and by using 
biomaterials that are commercially available (e.g. PVA, PLA). 
 
Fig. 1. (A) Photograph of the 3D printed branch with four curved arms using PVA as sacrificial template 
and PLA as support material. (B) Photograph of the 3D Printed branch with four curved arms after the 
dissolution of the PLA support material. (Scale bar: 3 mm) (C) CAD model of the designed 3D vascular 
branch. (D) Visualized motion program for 3D printing branch. Lines of green indicate the dispensing 
paths of PLA whereas lines of blue indicate the dispensing paths of PVA. (Scale bars: 6 mm)  
 
3D vascular branch formation 
The fabrication of the constructs with a built-in vasculature was achieved using the 3D mold-
ing technique (Fig. 2A). Since we wanted to create constructs in the range of soft tissues (i.e. 
1.5 – 12kPa [54–58]) with cells encapsulated in it, we used 5% (w/v) gelatin. To ensure ther-
mal stability, and to control the mechanical properties of the gelatin hydrogel, TG, a slow-
acting Ca2+-dependent enzymatic cross-linker, was used [59–61]. To demonstrate that the 
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amount of gelatin and TG, respectively, resulted in constructs with stiffness in the range of 
the soft tissues, we performed uniaxial compressive tests after 24h at 37°C. The resultant 
compressive modulus (Fig. 2B) was found to be 2kPa for the samples with 2.5 units of TG per 
g of gelatin while for the samples with 20 units of TG per g of gelatin was 6.5kPa. To demon-
strate the ability to create 3D vasculature within the gelatin/TG hydrogel, we cast 1.5 mL of 
5% gelatin with the lowest ratio of TG per g of gelatin around the 3D branch printed with 
PVA (Fig. 2C). The sacrificial template was then dissolved and removed by perfusion leaving 
a well-defined and open 3D vasculature (Fig. 2D-E). To ensure a continuous removal of the 
dissolved PVA from the vasculature the constructs were perfused with a volumetric flow rate 
of 5 µL·min-1 for 30 minutes. This was sufficient to slowly dissolve and remove the PVA 
without damaging the surrounding ECM extensively. The perfusion of the constructs was 
achieved using a custom-made fluidic platform. The fluidic platform was 3D printed using 
PLA and integrates a peristaltic pump able to perfuse three samples at the same time and all 
the electronics needed to control the pumps (Fig. 2F). After the total removal of the PVA it 
was possible to create a 3D branch network within a hydrogel with stiffness of 2 kPa having 
dimensions of 14 mm (L) x 11.5 mm (W) x 10 mm (H) (Fig. 2D). The branch point was sta-
ble and capable of supporting the four rounded arms within the gelatin/TG construct; although 
the construct was extremely soft the channel network did not collapse (Fig. 2E). We then 
evaluated the diameter of the newly formed vasculature. It was found that the final diameter 
of the vasculature was 1.3 mm. To verify the structural stability of the fabricated constructs 
along with its vascular branch, constructs were perfused for 24 hours at 37 °C. It was found 
that both the construct and vascular branch were mechanically stable without any structural 
deformation in response of the increased volumetric flow rate or increase in temperature (Fig. 
2G).  
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Fig. 2. (A) Schematic illustration of the fabrication of the 3D construct: (i) the PVA printed structure used 
as sacrificial template is inserted in the fluidic mold, (ii) ECM material is casted over the 3D printed tem-
plate, and (iii) the PVA sacrificial template is then dissolved, removed and perfused by a peristaltic pump. 
(B) Elastic modulus of gelatin 5% (w/v) cross-linked with different amounts of TG. (C) Photograph of the 
3D printed branch embedded in a gelatin hydrogel construct before the dissolution and removal of PVA. 
(D) Photograph of the resulting vascularized 3D construct (Scale bars: 1.4 cm). (E) Photograph of the 
cross section of the vascularized 3D construct, showing the volumetric distribution and structural stability 
of the channels (Scale bar: 5 mm). (F) Photograph of the custom made fluidic platform and the three tis-
sue constructs allocated on it used for the long-term studies (Scale bar: 5 cm). (G) Photograph of vascular-
ized 3D construct having stiffness of 2 kPa after 24h of direct perfusion using a flow rate of 100µL min-1 
(Scale bar: 4.5 mm). 
The sacrificial templates fabricated in this study were printed using PLA as support material 
and then the PLA support was dissolved in chloroform. The dissolution of the PLA was ob-
tained by immersing one 3D printed structure in 200 mL of clean chloroform with constant 
stirring of 400 rpm until the PLA fully dissolved and went in solution revealing the PVA 
structure. However, it was observed the formation of a coating of PLA surrounding the sacri-
ficial templates printed with PVA (black coating of PLA surrounding the otherwise white 
PVA, Fig. S1A). When these 3D printed structures were used as sacrificial template to fabri-
cate hydrogel constructs with open and well-defined vasculature it was observed that the coat-
ing of PLA remained adherent within the walls of the hydrogel vasculature (Fig. S1B). It has 
been demonstrated that a coating layer of biopolymer material surrounding the sacrificial 
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template could be beneficial for the fabrication of tissue constructs with embedded vascula-
ture [21,42]. However, if not carefully tuned, the coating of adherent PLA within the walls of 
the hydrogel vasculature could potentially inhibit the ability of the network to support convec-
tive and diffusive transport into the bulk gel. Therefore, the sacrificial templates were treated 
again in 10 mL of clean chloroform for one day without any stirring. The second treatment 
was sufficient to tune the formation of a layer of PLA thin enough to be removed from the 
hydrogel during the dissolution of PVA (Fig. S1C). This led to the formation of gelatin/TG 
constructs with open and well-defined 3D vasculature with no PLA residues within the vascu-
lature of the hydrogel construct (Fig. S1D).  
Another critical point concerned the use of the 3D molding technique is the final dissolusion 
of the fabricated vasculature within the hydrogel construct. It has been shown that the diame-
ter of the vasculature is not only dependent on the diameter of the sacrificial templates, but it 
also depends on the hydrogel cross-linking strategy [38,42]. In fact, when using gelatin 7.5% 
(w/v) with 20 units of TG per g of gelatin in combination with a sacrificial template having 
dimensions of 500 µm (i.e., line width and layer thickness) it was possible to fabricate gela-
tin/TG constructs with an open and well defined built-in vasculature having diameter of 500 
µm (Fig. S2A). By contrast, it was not possible to fabricate constructs with well-defined vas-
culature when using gelatin 5% (w/v) crosslinked with the same amount of TG and with a 
sacrificial template having dimensions of 500 µm. This was because the sacrificial templates 
printed with PVA lost their mechanical stability as consequence of the slow crosslinking reac-
tion of the gelatin/TG hydrogel (Fig. S2B). The same occurred for structures having dimen-
sions up to 700 µm. However, when increasing further the dimensions of the printed PVA 
structures, the quantity of material to be dissolved and removed increased significantly. For 
structures having 700 µm dimensions, the absence of an active removal of the dissolved PVA 
led to the formation of a vasculature with channel diameter of 2 mm (Fig. S2C). The increase 
in channel diameter was probably caused by an increase of the intra-pressure within the vas-
culature while dissolving the PVA during the slow cross-linking reaction. By contrast, when 
the PVA was dissolved and removed via perfusion, it was possible to control the intra pres-
sure since the final diameter of the channel networks was 1.3 mm. 
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Fig. 3. (A) Schematic illustration of the fabrication of the 3D tissue construct: (i) the PVA printed struc-
ture used as sacrificial template is inserted in the fluidic mold, (ii) ECM material, which contains gelatin, 
cells, and TG, is cast over the 3D printed template. After casting, TG slowly cross-links the gelatin, and 
(iii) the PVA sacrificial template is dissolved, removed and perfused by a peristaltic pump with a flow rate 
of 100µL min-1. (B) Viability of HepG2 cells encapsulated in 5% gelatin hydrogels with stiffness of 3 kPa, 
comparing constructs with embedded vasculature, with and without direct perfusion, versus control of 
blocks without vasculature for 15 days (Scale bar: 500 µm). (C) Quantification of the diameter of the em-
bedded vasculature comparing tissue constructs directly perfused versus tissue constructs not perfused 
for several days. 
HepG2 encapsulation and direct perfusion in soft constructs 
To demonstrate the importance of direct perfusion within a densely populated thick tissue 
construct, we casted 1.5·107 HepG2 cells in 1.5 mL of a gelatin/TG pre-polymer solution into 
the fluidic mold, with a resultant stiffness of 3.3 kPa (stiffness of a liver [57,58,62]). PVA 
was dissolved and removed by the start of the perfusion (Fig. 3A). The constructs were per-
fused with a volumetric flow rate of 100µL·min-1 for 15 days.  
To investigate the cellular viability, the effect of dissolution and removal of PVA, and the 
effect of the direct perfusion over time fluorescence micrographs of the constructs, in closed 
proximity of one of the channels, were taken on multiple time points (days 1, 3, 7, and 15) 
(Fig. 3B). At day 1 we observed a ring of dead cells surrounding the channels (Fig. 3B-day1). 
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This ring of dead cells was also observed for both perfused and unperfused constructs at day 
3, 7, and 15. The presence of the ring of dead cells in the unperfused constructs at day 1 indi-
cates that cell death happened during the process of dissolution and removal of the PVA. It is 
possible that the over pressure created within the vasculature during the dissolution and re-
moval of the PVA from the soft ECM could lead to a radial expansion of the vascular chan-
nels (see video S5). This could potentially disrupt all the cells in close proximity of the vascu-
lature [42,63]. In addition, there was no substantial difference in the diameter for both per-
fused and unperfused constructs within the 15 days (Fig 3C). Our results show that the layer 
of dead cells is induced by the over pressure created during the dissolution and removal of the 
PVA and not by the shear stress coming from the fluid flow. Our observations are in agree-
ment with previous studies that shows that for cells encapsulated on different ECMs the force 
due to a pressure drop across the encapsulated cell dominates the integrated shear force com-
ing from the fluid flow [64–67].  
To investigate the effect of perfusion on the cellular viability, we compared perfused and not 
perfused tissue constructs, versus a control with a confined block without vascular network 
(Fig. 3B). On day 1, all the encapsulated HepG2 were homogeneously distributed within the 
perfused and unperfused constructs and the control. At day 3, the cell viability dropped dra-
matically in the control, and at day 8, most the encapsulated HepG2 were dead. By contrast, 
the cellular viability was considerably higher for both the perfused and the unperfused con-
structs. At day 3, the cellular viability was considerably higher for the unperfused construct in 
respect to the control. However, at day 8, the cellular viability dropped significantly in the 
unperfused construct. Although the cellular viability was considerably higher in the unper-
fused construct in respect to the control, the directly perfused construct showed a better per-
formance in terms of cellular viability. These findings are in accordance with previous studies 
[21,46] that have shown the importance of the vasculature to maintain a higher cellular viabil-
ity for constructs with encapsulated cells.  At day 8, perfused construct had high viability and 
showed signs of cell proliferation as indicated by spheroid formations (Fig. 3B). The HepG2 
residing within the surrounding matrix exhibit cell spreading and proliferative phenotypes 
localized to regions in proximity of the vascular channels, allowing them to cluster into more 
organized structures. The HepG2 cells had high cell viability on day 15 (Fig 3B). The layer of 
spheroids increased in size from 300 µm to 600 µm between day 8 and day 15. The findings 
suggest that direct perfusion is crucial, which is in accordance with others [22]. 3D finite-
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element simulation also showed that the vasculature was not sufficient to avoid the cell death 
for densely populated constructs (Fig. S3A). The perfusion was critical to ensure the amount 
of oxygen and nutrients required for the cells to stay metabolically functional (Fig. S3B). 
 
 
Fig. 4. (A) Schematic of the cross section of the 3D tissue construct on day 15, depicting the formation and 
the distribution of spheroids in respect to the vasculature: (i) in the frontal plane, corresponding to a sin-
gle channel in the inlet, (ii) in the frontal plane, corresponding to the center, and (iii) in the sagittal plane. 
(B-C) Live/dead confocal microscopy of the frontal-cross section in the inlet of the perfusion (B) and the 
center with the four channels (C) of a 1cm thick vascularized tissue construct on day 15, showing spheroid 
viability and distribution (Scale bar: 2 mm). (D) Live/dead confocal microscopy through the sagittal-cross 
section of the branching point in the vascularized tissue construct on day 15 showing spheroid viability 
and distribution (Scale bar: 1 mm). 
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The formation of spheroids was only observed in some specific regions within the tissue con-
structs (Fig. 4A). The analysis of the fluorescence micrographs of the cross section through 
the frontal plane, in correspondence to the single inlet channel within the construct, revealed a 
layer of viable spheroids surrounding the vasculature as well as in proximity to the walls of 
the fluidic mold (Fig. 4B). This pattern is likely because the oxygen concentration is consid-
erably higher in the proximity of the channels, because of the media perfusion (Fig. S3B), and 
because the PDMS surrounding the construct in the fluidic mold is extremely permeable to 
oxygen [68] (Fig. S3). By contrast, the cells in the center of the construct, between the four 
vascular channels, showed signs of cell death and living cells showed no sign of cell prolifera-
tion (Fig. 4C). In addition, spheroids were found only in the outer proximity of the four chan-
nels (Fig. 4C). To further confirm the absence of the spheroids within the inner region of the 
tissue construct, fluorescence micrographs of the sagittal (longitudinal cross-section) plane 
were acquired (Fig. 4D). The fluorescence micrographs confirmed that the spheroids only 
populate regions in the vasculature towards the external surface of the constructs whereas 
only single cells populate the central core between the two vascular channels surfaces. This 
might be an indication of hypoxia in the core region, a hypothesis that was confirmed by a 3D 
finite-element model analyzing the transport of oxygen in the tissue construct (Fig. S3B). In 
agreement with previous studies [21,69], the direct perfusion allowed the HepG2 to prolifer-
ate in regions of the tissue construct where the concentration of oxygen was high. However, it 
is not clear why there were no spheroids surrounding the vasculature towards the core regions 
of the tissue construct. There has been reported some evidence that when cells are encapsulat-
ed in a 3D matrix, not only the biochemical cues are responsible for proliferation, but also 
several properties of the matrix and environment such as, composition [70], stiffness [71,72], 
compliance [24], and interstitial flow [65,67] play a decisive role [73]. Since the results 
showed the presence of spheroids only in some specific regions within the vascularized tissue 
construct, it might be possible that in some areas the matrix would react in a different way in 
response to e.g. the pressure caused by the flow. Therefore, a 3D finite-element model was 
developed to assess the displacement and stresses of the vascular walls embedded in the tissue 
construct that might occur while being directly perfused (Fig. S4). The model showed that the 
perfusion generated a pressure gradient within the walls of the vasculature that induced an 
expansion of the vasculature. The expansion of the vasculature caused by the pressure gradi-
ent generated by the flow created a pressure force that compressed the matrix in the outer sur-
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face of the vasculature within the construct. Interestingly, the volumes where the hydrogel is 
predicted to be compressed can be correlated with the volumes where poor cell proliferation 
was observed.  
 
Fig. 2. (A) Schematic of the cross section through the median plane of the 3D tissue construct on day 15, 
depicting the formation and the distribution of spheroids in respect to the vasculature. (B) Confocal mi-
croscopy images of nuclei (blu), cellular membrane (green) and F-actin (red) on day 15 of the 3D tissue 
construct cross-section, corresponding to the inlet of the perfusion, and the center, showing the spheroids 
morphology and distribution (Scale bar: 2 mm). (C) High resolution imaging of nuclei (blue), cellular 
membrane (green) and F-actin (red) on day 15, showing the morphology and the different dimensions of 
the spheroids in respect to the vasculature (Scale bar: 1 mm). (E-J) High resolution imaging of spheroids 
formed after 15 days by encapsulated HepG2 cells, showing different spheroid morphologies within the 
tissue construct. (K) 3D reconstruction of spheroids formed by HepG2 cells after 15 days within a vascu-
larized 3D tissue construct possessing a stiffness of 3 kPa (Scale bars: 30 µm).  
Spheroids Characterization 
 Since it has been demonstrated that the encapsulation of HepG2 in hydrogels with different 
stiffness could induce the formation of spheroids with various morphologies and liver specific 
functions [8,58,69,74], we evaluated the spheroid morphology within the directly perfused 
construct (Fig. 5). As expected, the fluorescence micrographs in the median plane of the tis-
sue constructs (Fig. 5A) after 15 days of direct perfusion further confirmed that spheroids are 
located only on one side of the vasculature (Fig. 5B). Moreover, the dimensions of the sphe-
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roids vary with the distance from the channnel, likely because of the oxygen and nutrients 
gradients (Fig. 5C). Spheroids with larger dimensions were in the regions close to the vascula-
ture whereas those with small dimensions were located at a larger distance. It is recognized 
that the proliferation time for cells encapsulated within an ECM matrix is slower than for 
those cultured on 2D surfaces [73,74]. Nevertheless, after one week of direct perfusion, the 
diameter of the spheroids within the tissue construct increased from 40µm to 70µm (Fig 5D), 
showing extensive proliferation and self-aggregation activity within the tissue construct as 
these spheres likely were derived from single cells. Two distinct spheroid morphologies were 
encountered: a rounded-shape structure [75,76] characterized by robust cell-cell adhesion and 
organized nuclei distribution and a mass-shape structure [75,76] characterized by robust cell-
cell adhesion and disorganized nuclei distribution (Fig. 5E-K). The rounded shape spheroids 
mostly resembled hepatoids, which are cluster of hepatocytes usually seen in in 3D matrices 
(Fig. 5E-K) [58]. Interestingly, our results are in agreement with a previous study [58], show-
ing that HepG2 encapsulated within a collagen matrix with stiffness in the range of the physi-
ological liver were able to induce the formation of spheroids with similar dimensions and 
morphologies as the ones presented in this study.  
Conclusions 
We introduce a novel strategy to fabricate and perfuse thick and densely populated engineered 
constructs with 3D vascular network and controlled mechanical properties, using the 3D 
molding approach. It was demonstrated that it is possible to fabricate 3D sacrificial templates 
with branches using commercially available FDM technology. The fabricated network, creat-
ed in very soft gels, maintained their integrity and survived perfusion for more than two 
weeks. The proposed method allows the fabrication of tissue constructs, with cellular densi-
ties of native tissues (approximately 10–500 million cells ml-1), able to sustain cellular surviv-
al, proliferation, and to promote more complex biological phenomena, as demonstrated by 
observations of in situ spheroid development. In addition, the engineered constructs could 
recapitulate the complex 3D microenvironment in terms of cellular adhesion, matrix elasticity 
and transport of molecules, which could enable advances in designing tissue engineered con-
structs for tumor modeling and for regenerative medicine.  
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Fig. S1. (A) Photograph of the 3D printed branch with four curved arms after the dissolution of the PLA 
material treated in 200 mL of chloroform and constant stirring (400 rpm). (B) Photograph of a 3D con-
struct with the unremoved layer of PLA (arrow) fabricated using a 3D printed sacrificial template after 
the dissolution of the PLA material treated in 200 mL of chloroform and constant stirring (400 rpm) 
(Scale bar: 3 mm). (C) Photograph of the 3D printed branch with four curved arms. The sacrificial tem-
plates were treated as in (A) with the addition that the sacrificial templates were treated with 10 mL chlo-
roform overnight (Scale bar: 5 mm). (D) Photograph of a 3D construct fabricated using a 3D printed sac-
rificial template with the extra treatment of PLA dissolution (Scale bar: 3 mm). 
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Fig. S2. (A) Photograph of a perfusable construct with 2D vasculature fabricated using gelatin 7.5% (w/v) 
cross-linked with 20 units of TG per g of gelatin, and a channel diameter smaller than 1mm. (B) Photo-
graph of a perfusable 2D construct fabricated using gelatin 5% (w/v) cross-linked with 20 units of TG per 
g of gelatin with the undefined channel vasculature (arrow) (C) Photograph of a perfusable construct with 
3D vasculature and channels diameter ~ 2mm fabricated using 3D sacrificial template, without actively 
removing the dissolved PVA. (Scale bars: 5mm). 
 
Fig. S3. Comsol model of nutrient uptake (e.g. oxygen) of the vascularized 3D engineered tissue constructs 
with no active perfusion. The model shows that without the active perfusion, is theoretically not possible 
to maintain alive a thick and densely populated tissue construct. (B) Comsol model of nutrient uptake (e.g. 
oxygen) of the vascularized 3D engineered tissue constructs. Comparison of the consumption of oxygen 
between a tissue construct with1.5·107 epG2 cells encapsulated into the interstitial space versus the second 
one with 3·107 HepG2 cells encapsulated cells encapsulated. In both cases the flow rate and the volume 
were the same (i.e., 100 µL·min-1 and 1.5 cm3), matching the experimental one. The model shows that even 
by using a flow rate of 100 µL·min-1theoretically is not possible to maintain alive all the cellular popula-
tion within a thick and densely populated tissue construct. 
Fig. S3 
COMSOL Multiphysics (COMSOL Inc.) was used to estimate the oxygen and flow fields. 
Standard transport equations were used in the simulations. Navier-Stokes equations with no 
slip boundary was used for modelling of the flow. The concentration profile of dissolved oxy-
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gen across the construct was simulated using a reaction-diffusion advection model. 1.5·107 
and 3·107 non-growing HepG2 cells were assumed to be encapsulated evenly throughout a 1.5 
cm3 of hydrogel (modelled as water), and the inner vasculature was perfused with medium at 
the flow rate of 100 µL·min-1, and the oxygen concentration at the inlet was considered to be 
constant and uniform. At steady state, the mass transfer through the vasculature through the 
hydrogel construct can be described by Eq. 1 and 2: 
∂Ci
∂t = D∇
2Ci − v∇Ci + R
     (1) 
∂CHyd
∂t = Deff∇
2CHyd + R
     (2) 
Here we assume that for the given cell concentration the rate of oxygen uptake can be de-
scribed by Michaelis-Menten kinetics [1]: 
R = −Vmax
CO2
gel
KM +CO2
gel ⋅δ(CO2gel >Ccrgel )     (3) 
 
where Vmax is the maximum oxygen uptake rate and KM is the oxygen concentration at which 
uptake rate is half-maximal.  @ABC = 	 DEFGHHIJ       (4) 
Although the cellular metabolic rate is recognized to be lower for the encapsulated cells with-
in ECMs in comparison to the cells seeded in a 2D environment, the values used in this study 
were the ones obtained for the HepG2 cultured in a 2D environment [2]. In particular, q repre-
sents the oxygen consumption per cell; its value is 6.62·10-17 mol·s-1 [3], Ncells is the number 
of cells, and V the volume of the hepatic construct in the bioreactor (1.5 mL). Moreover, a 
value of 6.3 µM [4] was considered for KMM,O2, which represents the Michalis-Menten con-
stant. A Heaviside function was implemented to account for the cellular necrosis and there-
fore to cut the oxygen consumption when the concentration falls below a critical value, CCr  = 
1·10-4 mol·m3 [5]. 
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Fig. S4. Comsol model of the radial dilation of the vasculature walls within the hydrogel constructs in 
response to the pressure generated during the active perfusion. The dilation of the vascular walls leads to 
a compression of the hydrogel within the areas surrounding the vasculature 
Fig. S4 
COMSOL Multiphysics (COMSOL Inc.) was used to estimate the displacement and stresses 
of the vascular walls embedded in the hydrogel construct when subjected to the pressure gen-
erated by the fluid flow caused by the active perfusion of the construct. Standard mechanical 
equations were used in the simulations. Navier-Stokes equations with no-slip boundary was 
used for modeling of the flow. The displacement and stresses were modeled as one-way fluid 
interaction. The active perfusion and the fluid pressure is computed in the first step after 24h 
transient analysis. The forces exerted by the fluid on the walls of the vasculature are used as 
loads for the structural analysis of the surrounding hydrogel construct. Considering that the 
pressure generated during the active perfusion was small, it was sufficient to model the hy-
drogel as a linear elastic material. The compressive Young's modulus was evaluated experi-
mentally from compressive mechanical tests. A compressive modulus of 3 kPa was used to 
simulate the construct. The structural analysis was calculated at 60-time points during 24 
hours of active perfusion (every 24 minutes). A supplementary video was also created to illus-
trate the effect of the 24 hours perfusion within the tissue construct. 
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Abstract 
Biological barriers are created in vitro on top of porous membranes which do not fully reca-
pitulate the in vivo microenvironment. Here we present a gelatin hydrogel device composed 
by two parallel 1.2 cm long microfluidic channels separated by a gelatin membrane of 370 
µm for simulation of physiological barriers such as intestine and blood-brain barriers. The 
hydrogel device has integrated electrodes suitable for measuring trans-epithelial electrical 
resistance (TEER), a common-used parameter to assess biological membranes integrity. The 
device is fabricated using polyvinyl alcohol sacrificial molding using guides to incorporate 
electrodes into channels having 1.7 mm diameter. The described device has electrodes to as-
sess TEER of the "intestine" channel and the "blood" channel respectively. The electrical 
characterization of the sensor was performed by using buffers proving that different conduc-
tivities could be measured. Electrical signals varied very little (max ± 3.5 Ω) during 48h per-
fusion with medium, indicating that the device could support long term experiments. The pre-
sented model could represent a step forward for the fabrication of fluidic devices that could 
mimic more closely the physiological barrier microenvironment. 
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Introduction 
In multicellular organisms, epithelial and endothelial cell layers form selectively permeable 
interfaces between several tissue compartments (blood-brain barrier (Obermeier et al., 2013), 
intestinal mucosal (Turner, 2009), lung alveolar-capillary interface (Whitsett and Alenghat, 
2015)). Tight junctions (intercellular connections) connect adjacent cells, regulate diffusion 
and facilitate active transport processes along the paracellular and intracellular pathways, re-
spectively, to maintain homeostasis (Zihni et al., 2016). An intact barrier is crucial for the 
physiological activities of the tissue. However, cellular barriers can be modulated to be open 
or close by exposure to specific external stimuli, thus allowing controlled passage of mole-
cules (Zihni et al., 2016).  
Several in vitro barrier models for drug permeability studies have been proposed (Moraes et 
al., 2012). Typically, these systems consist of cell culture monolayers grown on permeable 
porous membranes designed to define both apical and basolateral compartments (Bhatia and 
Ingber, 2014). However, such system lacks the presence of extracellular matrix representative 
of characteristic interstitial tissue confined within the two cellular layers (Thuenauer et al., 
2014) that is critical to recapitulate the tissue-tissue interfaces (Huh et al., 2011).  
Several techniques have been developed to assess barrier integrity in vitro. Among these 
quantitative measurements of the permeability of the barrier to paracellular hydrophilic com-
pounds of various molecular weights like radioactively labeled markers (i.e., sucrose, inulin, 
mannitol, albumin), nonradioactive fluorescence-labeled marker proteins (i.e., fluorescein 
isothiocyanate (FITC)- labeled dextrans), or enzymatic markers (i.e., as horseradish peroxi-
dase (HRP)) (Srinivasan et al., 2015). Aside from being labor intensive and resource consum-
ing, most of these conventional assays require the use of chemicals and labeling steps that can 
interfere with the transport process and/or disrupt cellular functions and thus the barrier integ-
rity. Moreover, many of these assays are based on single end-point measurements without 
providing real-time insight about the barrier quality during cell proliferation and growth. 
Trans-epithelial electrical resistance (TEER) assesses the electrical resistance across a cellular 
monolayer (Benson et al., 2013; Srinivasan et al., 2015). TEER measurements have become a 
well-established method to characterize epithelial and endothelial tissue barrier integrity, and 
represent a non-destructive, label-free method to quantitatively monitor the integrity and per-
meability of the barrier in real-time. TEER can be obtained according to Ohm’s Law by ap-
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plying either a DC or AC voltage (usually 12.5 Hz) across the barrier, and measuring the re-
sulting current (Benson et al., 2013; Srinivasan et al., 2015). However, more information 
about the barrier electrical properties (e.g. TEER, capacitance) can be obtained if the electri-
cal resistance is measured over a range of AC frequencies, which is known as impedance 
spectroscopy (Srinivasan et al., 2015; Stolwijk et al., 2015). Conventional devices consist 
either of two sets of chopstick-like electrodes (i.e., Ag/AgCl or Platinum) placed one on each 
side of the cell layer (Douville et al., 2010; Ferrell et al., 2010; Kim et al., 2012) or special 
chambers with patterned electrodes (Ag/AgCl, gold, or Platinum) that enable measurements 
in culture inserts (Booth and Kim, n.d.; Hediger et al., 2001; Sun et al., 2010). However, these 
technical approaches are strongly dependent on handling and positioning of the probing elec-
trodes and thus prone to errors, artefacts and large variance (Benson et al., 2013; Srinivasan et 
al., 2015). Existing systems such as transwell plates, which are characterized by a thin porous 
membrane, are limited to batch culture environments. Thus, these simple and widely used 
devices has limited possibilities to mimic the characteristic dynamical flow experienced by 
the cells lining across the barrier. To address these issues, attempts have been made with mi-
crofluidic systems (Thuenauer et al., 2014) mimicking i) the small distance between the blood 
vessel and the endothelium (Genes et al., 2007; Kim et al., 2012; Kim and Ingber, 2013), ii) 
blood flow by channels having diameters representative of the resistance vessels in vivo 
(Genes et al., 2007) and iii) integration of technology for in situ detection of the integrity of 
the barrier (TEER, cell capacitance) (Kim et al., 2012; Vogel et al., 2011). Several strategies 
to perform on-chip TEER measurements of endothelial monolayers grown on a porous mem-
brane separating two parallel fluidic channels. Most of the proposed systems are characterized 
by semi-permeable membranes fabricated in PDMS (Booth and Kim, n.d.; Douville et al., 
2010; Ferrell et al., 2010; Griep et al., 2013; Hediger et al., 2001; Huh et al., 2011; Kim et al., 
2012; Ramadan et al., 2013; Sun et al., 2010; Vogel et al., 2011). These PDMS membranes 
are unable of recapitulating the intricate in vivo environment of a native vascular barrier (i.e. 
cell-cell, cell-extracellular matrix (ECM) interactions) (Moraes et al., 2012). Moreover, these 
thin barriers do not allow the creation of the third comportment often presented within the 
barrier itself which consist on cells presented in the connective tissue (Moraes et al., 2012). 
In this work, we present an in vitro model capable of simulating physiological barriers. The 
system consists of two 1.2 cm long parallel fluidic channels separated by a hydrogel barrier of 
370 µm thickness. Such device has the capacity to for instance model an intestine barrier (the 
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first channel), tissue e.g., smooth muscles cells or immune cells embedded in the gel and 
blood vessels (the second channel). It was demonstrated that the fabricated system is capable 
of discriminate electrolytes with different conductivities and that the device was capable to 
perform under continuous perfusion over 48h. The proposed in vitro device could represent a 
step forward in the fabrication of a more biomimetic system capable of simulate more closely 
the barrier microenvironment that could be beneficial for drug permeability studies as well as 
disease models.  
Materials and Methods 
Hydrogel preparation 
The sacrificial templates and molds were designed and converted into STL files using CAD 
software (computer aided design, Dassault Systemes SolidWorks Corporation, US). All STL 
files were processed by KISSlicer (www.kisslicer.com/) software and sliced into 100-µm-
thick layers to generate G-code instructions for the 3D printer. G-code instruction sets were 
sent to the printer using Repetier-host (https://www.repetier.com), an open-source 3D printer 
host program. Commercially available poly(vinyl alcohol) (PVA) and poly(lactice acid) 
(PLA) filaments (Makerbot Industries, Brooklyn, NY, USA) were printed using the Felix 3 
(Felix Printers, IJsselstein, The Netherlands) printer with a nozzle diameter of 250 µm. All the 
sacrificial templates were printed using PVA as material. The printing settings were as fol-
lows: nozzle temperature 200 °C for the PVA, bed temperature 55 °C. 
Fluidic mold design and fabrication 
The fluidic mold used for casting the hydrogel and subsequent perfusion was a modified ver-
sion from the one presented in the Chapter 3. The new fluidic mold was manufactured using 
flexible clear polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning Corporation) poly-
mer within a 3D printed mold. The new mold consisted of three main parts responsible for 
defining the external surface of the fluidic mold and one part 3D printed in water soluble PVA 
was responsible for defining the internal chamber (18 mm (L) x 14 mm (W) x 9 mm (H)), 
four hub-free stainless steel blunt needles (18G; Kimble Chase, Vineland, NJ) were used to 
define the fluidic connections, and four solid stainless steel needle electrodes (active elec-
trode) (Neuroline Monopolar (74325-36/40), Ambu) were used to create the electrode guides 
(Figure 1A). Central to the fabrication of the fluidic mold, was the integration of four stainless 
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steel electrodes having an external diameter of 350 µm. To avoid undesired movements that 
could cause changes in the recorder electrical measurements, the electrodes needed to be posi-
tioned at the same location every time. Therefore, the bottom as well as the top part of the 
mold was designed to precisely allocate the four electrodes (Figure 1B). Moreover, the print-
ed PVA mold responsible for defining the internal chamber, presented two guiding holes on 
each side of the part allowing the electrodes to be inserted and located at the same position 
prior the casting of the PDMS (Figure 1C). 
As opposed to a fluidic mold used in Chapter 3, the mold must harbor two pair inlets and out-
lets corresponding protrusions were used to define these inlets and outlets (Figure 1C). The 
parts responsible for defining the external surface of the fluidic molds were fabricated using 
the Form 2 SLA 3D printer (Formlabs, Somerville, Massachusetts, USA). The photocurable 
resin employed in this study were: GPCL02 clear resin and GPWH02 white resin (Formlabs, 
Somerville, Massachusetts, USA). By contrast, the part responsible to define the internal 
chamber was fabricated by 3D printing the internal chamber in PVA with the following set-
tings: 195 °C for the PVA, bed temperature 55 °C. The 3D printed parts together with the 
stainless-steel needles and electrodes were assembled into a mold and secured together using 
screws (Figure 1D). PDMS prepolymer (10:1 w/w ratio of PDMS to curing agent) was casted 
in the assembled 3D printed mold. The mold was degassed in a vacuum chamber to ensure the 
removal of the bubbles entrapped. Then, the mold with the polymer was placed in an oven 
overnight at 60˚C to ensure the polymer to be completely cured. After curing, the mold was 
disassembled (Figure 2E) and the resultant PDMS fluidic mold was immersed into water. In 
this way, the PVA printed part enclosed in the fluidic mold was dissolved in water revealing 
the desired inner chamber and the insertion guides for the four electrodes in the fluidic mold 
(Figure 2F). The fluidic molds were treated with oxygen plasma (125 W, 13.5 MHz, 50 sccm, 
and 40 millitorr) to render their surface hydrophilic. The mold was subsequently sterilized by 
autoclaving. 
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Figure 1. (A) Designed mold used for the fabrication of the fluidic mold. The mold consisted in three ex-
ternal parts responsible for defining the external surface of the fluidic mold while the internal chamber 
was designed and 3D printed in PVA to include the final cavities and the guides for the electrodes inser-
tion. (B) Photograph of the mounted mold with screws and electrodes in place prior the casting of the 
PDMS used for the fabrication of the fluidic mold. (Scale bar: 3.5 cm) (C) Photograph of the de-molded 
mold revealing the fabricated fluidic mold before the dissolution of the 3D printed PVA structure respon-
sible for defining the internal chamber. (Scale bar: 4 cm) (D) Photograph of the top part of the mold 
mounted with the PVA structure responsible for defining the internal chamber with the four electrodes in 
position and four needles responsible for defining the fluidic connections. (Scale bar: 2.5 cm) (E) CAD 
Designed of the part responsible for defining the internal chamber depicting the guides used to control the 
insertion and final position of the electrodes. (F) Photograph of the fabricated fluidic mold after the 
demold process and dissolution of the PVA printed part (Scale bar: 2.2 cm). 
Fluidic Platform 
Figure 2A shows the schematic of the fluidic platform utilized in the present study. The sys-
tem has been described previously in chapter 3 of this thesis. Briefly, the fluidic platform was 
fabricated from PLA polymer by using a 3D printer. 3D printing settings were as follows: 
nozzle temperature 190 °C for PLA, bed temperature 55 °C. The device was modified to hold 
two fluidics devices with electrodes and cables by designing a new fluidic array. The fluidic 
array was fabricated using the Form 2 SLA 3D printer using the GPCL02 clear resin material. 
An arduino micro (Arduino, Italy) and an easydriver stepper motor driver (Brian Schmalz, 
Creative Commons Attribution 3.0 United States License) was mounted on the 3D printed 
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part to control and to power supply the stepper motor respectively. The 3D CAD assembly 
designed using SolidWorks, as well as Gcodes generated for every part can be downloaded at 
https://3dprint.nih.gov.  
	
Figure 2. (A) Designed fluidic platform. (B) Designed hydrogel-based fluidic system with the schematic of 
the four-terminal sensing configuration used for impedance measurements. W and C form the source 
connections used to apply a defined current, while S and R form the sensing connections, used to record 
the resultant voltage. (C) Photograph of the assembled fluidic platform with the 2 fabricated hydrogel-
based fluidic system. (Scale bars: 1.5 cm) (D) Photograph of the hydrogel-based fluidic system with inte-
grated sensors for electrochemical impedance spectroscopy (EIS) measurements. (Scale bars: 1 cm)  
Hydrogel based fluidic device fabrication and testing 
The fluidic platform, glass vials, caps and polytetrafluoroethylene (PTFE) tubing (inner diam-
eter of 0.8 mm) (BOLA 1818-10, Bohlender GmbH, Germany) were sterilized by autoclaving 
and then assembled in a laminar flow bench. 0.5 M NaOH was flushed throughout the system 
to ensure a sterile fluidic environment. The system was subsequently rinsed with sterile water 
and then perfused with culture medium. Sterile solid stainless steel needle electrodes were 
used. The needles were insulated except for the active electrode area determined by the ex-
posed beveled tip. The 3D sacrificial templates were placed inside the fluidic molds. Subse-
quently, the four electrodes were inserted in the electrode guides until the needles went in 
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contact with the sacrificial templates. The electrodes were positioned across the barrier within 
the two channels and the configuration was as follows: working electrode facing the counter 
electrode (source connections) and sensing electrode facing the reference electrode (sensing 
connections) (Figure 2B). Gelatin 5% (w/v) cross-linked with 50 Units of TG per g of gelatin 
was prepared and incubated for 45 minutes at 37°C to partly crosslink the gelatin (it was still 
a solution although with high viscosity). A total of 0.5% (v/v) of chloroform was added to 
sterilize the solution. Once the electrodes and sacrificial templates were in position, 2.3 mL of 
gelatin/TG hydrogel was cast around the sacrificial templates and electrodes. After the cast-
ing, the samples were incubated at 4°C for 30 minutes to convert the liquid gelatin into a solid 
gel and to chemically cross link the gelatin. The fluidic device was subsequently incubated for 
1h at ambient temperature to fully finalize the chemical cross-linking of the gelatin ensuring 
mechanical stability at higher temperatures. The fluidic molds were then placed in the fluidic 
platform and media was perfused through at 5µL·min-1 for 30 minutes to ensure the total re-
moval of the sacrificial template from the 3D constructs (Figure 2C-D). The final dimensions 
of the tissue constructs were 18 mm (L) x 14 mm (W) x 9 mm (H) with a resultant volume of 
≈ 2.3 cm3. Once the fluidic devices were ready, both channels were coated with 100 µg·mL-1 
laminin in PBS for 20 minutes. Then, EIS measurements were performed for the fluidic de-
vices in static and in perfusion conditions. A Four-terminal sensing method was used to per-
form the EIS measurements. In the perfusion conditions, the fluidic devices were placed in the 
fluidic platform, and both channels were continuously perfused with cell culture media at 65 
µL·min-1 (fluid shear stress, 0.02 dyne·cm-2) for 48h at 37 °C under 95% air 5% CO2. In static 
conditions, the fluidic devices have both channels filled with cell culture media. EIS meas-
urements were performed every 24h.  
Electrical characterization 
The electrical characterization was performed both on a gelatin hydrogel with and without the 
presence of fluidic channels. For the characterization of the hydrogel barrier, EIS measure-
ments were acquired after filling the channels with solutions characterized by different con-
ductivities. Air (ơ = ~3-8 10-15 S·m-1), 1:1, 1:2, 1:10 dilutions of phosphate buffered saline 
(PBS) in DI water (PBS ơ = ~1.5 S·m-1), and culture medium (DMEM Medium/1% Pen-
Strep/20% fetal bovine serum (FBS)) (ơ = ~0.25 S·m-1) were employed as electrolytes. The 
influence of the position of the needle electrodes on the measured impedance was evaluated 
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by comparing spectra acquired at different distances (2, 3.5, 5.5 mm). The EIS analysis were 
performed using the galvanostic mode. For the recording of the EIS, a sinusoidal perturbation 
of 30 µA (RMS) with respect to the open circuit potential was applied in the frequency range 
between 1 kHz and 100 kHz, sampling at 10 points/decade. The measurements were per-
formed using a PGSTAT128N potentiostat (Metronohm Autolab, The Netherlands), and 
MATLAB (Mathworks, Sweden) was used to analyze the acquired data. For every condition 
analyzed, three samples were used. 
Cell seeding  
Human intestinal epithelial Caco-2 cells (ATCC® HTB-37™) were grown in Dulbecco’s 
Modified Eagle Medium (DMEM; Gibco) supplemented with 20% fetal bovine serum (FBS; 
Gibco), 1% penicillin/streptomycin (P/S; Gibco). Cells were maintained at 37°C in a humidi-
fied incubator under 5% CO2 in air. Once the fluidic device was fabricated and both channels 
were coated with laminin for 15 minutes, Caco-2 cells were seeded into both channels at the 
cellular density of 1.5·105 cells·cm-2 and 8·105 cells·cm-2. To avoid any aggregation or super-
position of cells in the channels the device was flipped by 90° rotations every 30 minutes for 
2 hours. Once the rotations were finished, one of the channels were gently flushed with fresh 
culture media and the other channel was not. After 24 hours, the hydrogel was removed from 
the fluidic mold, and was sectioned along the cross-sectional direction to evaluate the seeding 
quality. 
Fluorescence staining 
The seeding quality cell was assessed by staining the cells for the nuclei and F-actin within 
both the channels. Briefly, the samples were washed twice with PBS, fixed in 4.5% (v/v) par-
aformaldehyde in phosphate buffered solution (PBS) for 20 minutes, and permeabilized with 
0.1% (v/v) Triton X-100 in PBS for 10 minutes followed by a PBS washing in between. Sub-
sequently, they were stained for 45 minutes with Höechst 33342 (Invitrogen) for labeling the 
cell nuclei, and Phalloidin (F432, Invitrogen) for labeling the F-actins for labeling the cellular 
membrane according to manufacturer’s instruction.  
Imaging and analysis  
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Confocal acquisitions were performed using a Zeiss LSM 700 module in the Axio Imager M2 
upright microscope using: an epiplan-neofluar 5X/0.13 HD, and 10X/0.25 HD. To eliminate 
any possible crosstalk between channels, images were collected with a sequential scan, using 
the following laser lines and mirror settings: 405 (30%) 420-480nm; 555(30%) 605-700nm. 
Photographs of the fabrication of the fluidic system were acquired using a DSLR camera 
(Canon EOS, 5D Mark II; Canon). ImageJ was used to visualize composite images by com-
bining fluorescent channels, to visualize the dark-field mode images. The diameter of the 
channels was measured by ImageJ software using at least 4 images from different areas of 3 
samples for each condition. 
Results and discussion  
3D printing and fabrication of the barrier fluidic device  
3D printed PVA structures were used as the sacrificial template for creating two engineered 
channels separated by a barrier with a controlled thickness within hydrogels (fabrication de-
scribed in chapter 3). Figure (3A-B) shows the designed CAD structure and the sacrificial 
templates 3D printed in PVA, respectively. The printed structure was planar and was designed 
to have dimensions of 1.2 mm (W) x 1.2 mm (H). The design of the printed PVA structure 
was chosen to give two independent channels separated by a hydrogel barrier with an intend-
ed thickness of 300 µm. The final printed structures had a width dimension of 1.33 ± 0.04 mm 
(W) and layer thickness of 1.21 ± 0.10 mm (H). The printed PVA templates and the four sens-
ing electrodes were inserted into the fluidic mold. The position of the electrodes is controlled 
by the use to the guides for the electrodes integrated into the fluidic molds. The electrodes are 
inserted until the tip of the needle is in strong contact with the sacrificial templates printed in 
PVA (Figure 3C). Partially crosslinked gelatin/TG was cast around the printed PVA templates 
as well as the four electrodes (Figure 3D). The sacrificial templates were dissolved and re-
moved from the gelatin/TG hydrogel leaving two well-defined and open channels separated 
by a thin barrier of hydrogel material (Figure 3E-F). The final gelatin/TG hydrogel fluidic 
device had dimensions of 18 mm (L) x 14 mm (W) x 9 mm (H) with a resultant volume of ≈ 
2.3 cm3. The width (W) and the height (H) of the two embedded channels within the hydrogel 
were then measured by microscopy. The final dimensions of the channels within the device 
were 1.78 ± 0.18 mm (W) and 1.76 ± 0.15 mm (H) (Figure 3G). The barrier thickness was 
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found to be 370 ± 75 µm (for a design of 300 µm). The structural stability of the fabricated 
device was tested by perfusing both channels with 65 µL·min-1 for 48 hours at 37 °C. It was 
found that the device along with its built-in barrier was mechanically stable without any struc-
tural deformation in response to the volumetric flow rate or increase in temperature. The ex-
posed area of the electrodes was in position inside the channels and stayed in place during 
perfusion (Figure 3H-G). Although it was possible to get barrier thickness smaller than 370 
µm by changing the dimensions of the PVA sacrificial template, in most cases this resulted in 
merged channels. It was fundamental that the active area of the electrodes was precisely 
placed within both channels as well as without contacting the fluidic channels. Figure 3J 
shows that the exposed active electrode area is located within the fluidic channels. The pres-
ence of the electrodes insertion in the fluidic mold coupled with the crosslinked gelatin/TG 
hydrogel was sufficient to keep accurate the positioning of the electrodes. The electrodes nei-
ther influenced the final quality of the fabricated devices as well as the integrity of the barrier 
(Figure 3K).  
As opposed to other proposed microfluidics devices (Bhatia and Ingber, 2014; Douville et al., 
2010; Griep et al., 2013; Huh et al., 2013, 2011, 2010; Kim et al., 2012; Vogel et al., 2011), ), 
the hydrogel-based fluidic system was fabricated using gelatin, a commonly used hydrogel 
material in tissue engineering applications (Drury and Mooney, 2003; Ito et al., 2003; Yung et 
al., 2007). This means that our system can present three distinct compartments (e.g., intestine, 
blood and connective/target tissue). This would allow the creation of different in vitro barrier 
models able to simulate different barrier environments (e.g., intestinal barrier, blood brain 
barrier) in more a physiological way by using the same device. The presence of the gelatin 
material would give the more characteristic cell-cell and cell-ECM interaction, which are so 
important for the cells correct functioning. The presence of two parallel channels of almost a 
cm in length would allow the formation of complex chemical gradients in both directions. The 
hydrogel barrier with thickness of 350 µm is at the same order of magnitude of the 200 µm 
distanced observed between capillaries (Thuenauer et al., 2014).  
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Figure 3. (A-B) Designed model and photograph of the two 3D printed structures using PVA as sacrificial 
material. (Scale bars: 6 mm) (C) Photograph of the inserted electrodes as well as the two PVA printed 
templates used for the creation of hydrogel-based fluidic device. (Scale bars: 2.5 cm) (D) Photograph of 
3D printed sacrificial templates along with the electrodes embedded in a gelatin hydrogel construct before 
the dissolution and removal of PVA. (Scale bars: 2.2 cm) (E-F) Photograph of the (E) dissolved and (F) 
removed PVA from the right channel revealing the fluidic channel divided by the hydrogel barrier. (Scale 
bars: 2.2 cm, 1.8 cm) (G) Quantification of the dimensions of the designed channels, 3D printed templates, 
and embedded channels fabricated within the gelatin/TG hydrogel. (H) Hydrogel-based fluidic system 
continuously perfused on both channels at 65 µL·min-1 after 48 h at 37°C. (Scale bar: 1.5 cm) (I) Magnifi-
cation of the right channel depicted in G showing the active area of the electrodes inside the fluidic chan-
nels (indicated by the black arrows). (Scale bar: 1.5 cm) (J) Dark-field image of the hydrogel-base fluidic 
system integrating the needle electrodes: the two fluidic channels are separated by a hydrogel barrier with 
controlled thickness and the four electrodes (indicating by the yellow arrows) are inserted within the flu-
idic channels. (Scale bar: 2 mm) (K) Fluorescence micrograph of the cross-section of the fluidic device 
showing the two channels separated by the gelatin barrier (Scale bar: 500 µm) 
Cell seeding optimization  
Since the TEER represents the electrical resistance of a confluent monolayer of cells lining 
within a channel, seeding tests were performed to form a confluent distribution of Caco2 cells 
	
	
 172 
within the surface of the channels. When the seeding was performed using 1.5·105 cells·cm-2, 
the Caco2 cells were lining on top of each other in one side of the channel after 24h incuba-
tion (Figure 4A). It is likely that the cells were aggregated on top of each as they had enough 
time to sediment. In contrast, we could observe a better cell distribution within the whole sur-
face of the channels when rotating the fluidic device for 90° degrees every 45 minutes for a 
total of 3 hours (Figure 4B). To increase the coverage of the surface, 8·105 cells·cm-2 were 
seeded and the fluidic device was rotated as described above. After 45 minutes from the last 
rotation, one of the channels was flushed with fresh culture media, removing the excess of not 
adherent cells, while the other was not. After 24 hours, the cells were homogeneously distrib-
uted as well as covered the whole surface of the channels in both flushed and not flushed con-
dition, respectively (Figure 4C-D). However, in the channel that was not flushed, a major ag-
gregation and superposition of caco2 cells were observed after the last rotation (Figure 4C-D, 
left channel). This was not observed in the channel where the excess of non-adherent cells has 
been removed (Figure 4C-D, right channel).  
Although in previous studies the caco2 density of 1.5·105 cells·cm-2 could create a confluent 
monolayer in a PDMS membrane (Kim et al., 2012; Kim and Ingber, 2013), the same did not 
happen for our gelatin fluidic device. One possible explanation is that since PDMS is a rela-
tively stiff material and the surface occupied by the adherent cells is dependent on the stiff-
ness of the substrate (Discher et al., 2009), it is possible to assume that the material could in-
fluence the number of cells needed for covering the whole surface. Considering that gelatin is 
softer compared to PDMS the overall morphology of the adherent caco2 cells most-likely 
would have been different. The results confirmed that it was necessary to increase five times 
the cell density necessary to form a confluent monolayer in a PDMS membrane to obtain the 
same confluent monolayer in our gelatin based fluidic device (Figure 4E). 
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Figure 4. (A-B) Confocal microscopy images of nuclei (blue) and F-actin (red) of the hydrogel-based fluid-
ic system cross-section at 24 hours after the seeding of 1.5·105 cells·cm-2 in both channels and without 
flushing; (A) when the fluidic device was not rotated the caco2 cells sediment on top of each other (as indi-
cated by the white arrows) while (B) by rotating the fluidic device of 90° every 45 minutes, for a total of 3 
hours, the cells started to be distributed within the surface of both channels. (Scale bars = 500 µm) (C) 
Confocal microscopy images of nuclei (blue) and F-actin (red) of the hydrogel-based fluidic system cross-
section at 24 hours after the seeding of 8·105 cells·cm-2 in both channels and with rotation as described in 
B; when the fluidic device was not flushed (channel on the left) the caco2 cells sediment on top of each 
other in the last rotation position (as indicated by the white arrows) while when flushed (right channel) 
the amount of aggregate cells were smaller (as indicated by the white arrow) compared to the channel not 
flushed (Scale bar: 500 µm). (D) Confocal microscopy images of nuclei (blue) and F-actin (red) of the hy-
drogel-based fluidic system cross-section, parallel to both channels, at 24 hours after the seeding of 8·105 
cells·cm-2 in both channels and with rotation as described in B confirming that when not flushed the cells 
will sediment on top of each other. (Scale bar: 1 mm) (E) Confocal microscopy images of nuclei (blue) and 
F-actin (red) of the hydrogel-based fluidic system cross-section, depicting the barrier and caco2 cells after 
24 hours of the seeding of 8·105 cells·cm-2. (Scale bar: 200 µm) 
System characterization 
A total of three different configurations were possible to use, allowing the sensing of three 
distinct areas in the barrier model (Figure 5A-C). When the couple S-R are inside of the 2 
channels and characterized by a small distance, the measured TEER is an indication of the 
resistance of the barrier (Figure 5A). In this configuration, for a barrier model characterized 
by three compartments (e.g., intestinal channel, blood channels), the measured TEER repre-
	
	
 174 
sents the contribution of the sum of both compartments. When the R electrode is moved from 
inside the channel towards the hydrogel, it is possible to measure the TEER over a single 
compartment (Figure 5B). When the S electrode is moved away from inside the channel to-
wards the hydrogel and the R electrode is moved back to the starting channel, it is possible to 
measure the TEER over the remaining compartment (Figure 5C). These three distinct config-
urations allow the independent measurement of each compartment at the time and, also, the 
contribution of both. The configuration with the couple S-R inside the channels was used 
throughout the rest of this study. To characterize the hydrogel barrier from an electrical point 
of view, impedance spectra were acquired in the configuration 1, both within a gelatin/TG 
hydrogel and across a gelatin/TG hydrogel barrier defined by two fluidic channels perfused 
with culture medium at 37 °C. Figure 5D shows that no significant differences could be ob-
served between the recorded spectra for the hydrogel with channels filled with cell culture 
media and the hydrogel without channels. In both cases, the measured impedance magnitude 
was raging from 4Ω to 6Ω. The measured phase angle was ~0° throughout the whole frequen-
cy range (1-100 kHz), thus indicating that the bulk resistance (hydrogel) was measured (Fig-
ure 5E). The phase angle of 0° is characteristic from the impedance spectra acquired using the 
4-point probe measurement setup as the electrode polarization does not occur in the sensing 
couple. On the contrary, the polarization of the system occurs at the source electrodes thus 
allowing the measuring system to be independent from the electrode polarization contribution 
(Grimnes and Martinsen, 2008). Since the gelatin/TG hydrogel was solubilized in the culture 
medium, and the channels were filled with the same medium, the conductivities of the two 
phases across the barrier (i.e., liquid and solid gel) were identical. This, together with the 
small width of the barrier (~370 µm) and the short distance between the needle electrodes 
(~1.2 mm) causes no relevant variations in the impedance magnitude. As the system needs to 
follow changes in conductivity, impedance measurements were conducted using air to model 
the insulating properties of a material having extremely lower conductivity. Figure 5D shows 
that when an insulating material, such as air, is present within the channels, the impedance 
magnitude increases from 6Ω to 10kΩ. To evaluate the system sensitivity, impedance spectra 
were acquired after injection of physiologically relevant solutions having different conductivi-
ty. As shown in Figure 5F, spectra were recorded using PBS (ơ = ~1.5 S·m-1), diluted PBS 
(1:2 and 1:10 in DI water) and culture medium (ơ = ~0.25 S·m-1). As expected, PBS had the 
lowest impedance magnitude value (~3 Ω) followed by medium (~4 Ω). By contrast, when 
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the conductivity of the solutions decreased (e.g., diluted PBS with DI water) the impedance 
magnitude increased (Figure 5F). However, due to the small volume of electrolyte within the 
fluidic channels (100 µl), the impedance magnitude variation did not scale up with overall 
conductivity changes. This was most-likely an indication of a fast diffusion of ions from the 
hydrogel bulk to the small volume of the measure electrolyte since the hydrogel was prepared 
by solubilizing gelatin material in cell culture media. Interesting to notice was that culture 
media in the channels resulted in a very stable impedance phase, with a resultant phase angle 
of 0 (Figure 5G). This proved that the system can discriminate between small variations in 
conductivity even though the volumes within the channels are small (~100 µL).  
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Figure 5. (A-C) Schematic of the four-terminal sensing with the 3 different configurations used for imped-
ance measurements. W and C form the source connections used to apply a defined current, while S and R 
form the sensing connections, used to record the resultant voltage. (D-E) Bode plot ((D) magnitude and 
(E) phase angle) of the impedance spectra recorded at 37°C within a gelatin/TG hydrogel and across a 
gelatin/TG barrier defined by two fluidic channels perfused either with air or with culture medium. (F-G) 
Bode plot ((F) magnitude and (G) phase angle) of the impedance spectra acquired after injection of solu-
tions having different conductivities: PBS (ơ = ~1.5 S·m-1), diluted PBS (1:2 and 1:10 in DI water) and 
culture medium (ơ = ~0.25 S·m-1). Data are presented as mean ± standard deviation (n = 3). 
As reported in the literature, one of the main reasons for the significant variance of the report-
ed TEER measurements is related to the electrode positioning across the barrier (Srinivasan et 
al., 2015). Therefore, we investigated the influence of the electrodes position on the recorded 
impedance. At first, we evaluated the effect of the needle electrodes being in contact with one 
of the walls inside the fluidic channel embedded in the hydrogel. To discriminate the contact 
effect of the needle, measurements were performed using air as an insulating material. Figure 
6A shows impedance spectra recorded for electrodes well positioned within the fluidic chan-
nels and electrodes misplaced and in contact with the channel wall. The recorded values 
showed that the impedance significantly decreased (2 orders of magnitude) when the elec-
trodes were not entirely insulated from the surrounding gelatin/TG hydrogel channels. This 
can be explained by the fact that the current flows throughout a path characterized by the 
higher conductance which in this case is the hydrogel rather than air. When the electrode is 
correctly inserted into the channels, the current is forced to flow throughout the air making the 
overall recorded impedance much higher. The needle contact effect has also an influence in 
the measured phase angle that widely deviates from the ideal behavior (phase angle = 0) with 
significant variations among the samples (Figure 6B). Next, the distance between the elec-
trodes was varied by maintaining a pair of electrodes within one channel and moving the oth-
er pair of electrodes away from within the second channel until ending up in the hydrogel 
(Figure 6C). Impedance measurements were conducted for each distance (2, 3.5, 5.5 mm) 
with culture medium within the channels. As expected, by increasing the distance between the 
electrodes, the overall impedance magnitude increased (Figure 6D), and at the same time, the 
phase angle was almost zero (Figure 6E). However, when the electrodes were extremely close 
to each other, we could observe an increased phase shift probably due to an electrical cou-
pling phenomenon.  
As proof of concept, two fluidic samples integrating the measuring system were fabricated 
and the whole platform assembled. Then, a fluid flow of 65 µl·min-1 was applied (0.02 
dyne·cm-2 shear stress) for 48h at 37 °C. In parallel, two other fluidic samples integrating the 
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measuring system were fabricated and were incubated at the same temperature for 48h as 
well. In all the cases cell culture media was used as the electrolyte. Figure 6F shows the im-
pedance magnitude acquired every 24h for samples in static and flow conditions. It appears 
that for lower frequencies (1 kHz range) the impedance magnitude of samples under fluid 
flow is slightly higher than those not. By contrast, there is no significant difference between 
the static and the flow conditions for the mid-high frequencies range. The same behavior is 
seen in the phase as well (figure 6G). Samples in static conditions presented a phase angle 
close to the ideal behavior (phase angle = 0) whereas for samples in flow conditions there is a 
shift from the typical behavior for the low and for the high frequencies (~ -20° low frequen-
cies, ~ +40° high frequencies). The analysis of the equivalent circuit model of the impedance 
spectra can be used to quantify the electrical parameters which are characteristics of the barri-
er properties (i.e., TEER, cell capacitance) (Benson et al., 2013; Douville et al., 2010; Griep 
et al., 2013; Odijk et al., 2015; Srinivasan et al., 2015).  
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Figure 6. (A-B) Bode plot ((A) magnitude and (B) phase angle) of the impedance spectra acquired across a 
gelatin/TG barrier defined by two channels perfused with air. The plot shows the comparison of spectra 
acquired when the needle electrodes are correctly placed within the channel with spectra acquired when 
the electrodes are misplaced and in direct contact with the inner wall of the fluidic channels. (C) Schemat-
ic cross section of the hydrogel based fluidic system showing the needle electrodes positioning within the 
channels at different distances dele across the barrier. A pair of electrodes (S and W) was maintained with-
in one channel while the other pair (R and C) was moved as depicted. (D-E) Representative 3D Bode plot 
((D) magnitude and (E) phase angle), correlating the electrodes distance with the recorded impedance 
spectra. (F-G) Bode plot ((F) magnitude and (G) phase angle) of impedance measurements recorded 
across the barrier under static and flow condition at 37°C. Culture medium was used as electrolyte. Data 
are presented as mean ± standard deviation (n = 3). 
Conclusions 
Here we presented the fabrication of a hydrogel-based fluidic system with integrated needle 
electrodes capable of simulating physiological barriers. The system consisted of two inde-
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pendent fluidic channels separated by a hydrogel membrane of 370 µm thickness. Four stain-
less steel electrodes with controlled position were integrated within the hydrogel construct. 
The system was fabricated using a gelatin/TG hydrogel and the electrodes were used for 
measuring impedance spectroscopy. It was shown that the sensor is capable to discriminate 
different materials with different conductivities maintaining a good sample to sample repro-
ducibility. Finally, the fabricated fluidic devices were tested under continuous perfusion for 
48h at 37 °C showing that the overall device is capable of perform real time and long term 
measurements. The proposed device could represent an ideal system to simulate different bar-
rier models and could be beneficial for the fabrication of a more biomimetic device for drug 
permeability studies. 
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CHAPTER 6 
SUMMARY, CONCLUSIONS AND FUTURE WORK CONSIDERATIONS 
6.1 Summary and Conclusions 
This thesis presented two different approaches for the fabrication of in vitro systems 
for tissue engineered applications. In the first approach, scaffold, cells and bioreactors were 
used as building blocks (TE paradigm) to fabricate tissue constructs with relevant sizes. In 
the second approach, a sacrificial template is molded in hydrogels with controlled 
properties (e.g., chemical, mechanical) mixed with cells for fabricating constructs with 
integrated channel networks. The proposed approach offered several advantages, including 
that is easy to encapsulate the cells, it is perfusable, scalable, versatile and doesn’t need 
any post fabrication procedures. Also, we showed an elegant solution to suppress leakage 
of these soft constructs while directly perfused for several days. The whole platform 
presented at this thesis would allow the design of modular TE constructs capable of 
simulating different compartments at the same time.  
In Chapter 2, a modular in vitro system is presented for the differentiation under 
perfusion of hiPSCs. Porous elastomeric scaffolds with 3D architectures were fabricated 
using an inverse fabrication technique [1]. Such porous scaffolds were fabricated aiming to 
enhance the mass transport of oxygen and nutrients and the removal of waste within the 
construct. HiPSCs were seeded in the scaffolds and cultured in a perfusion bioreactor for 
25 days. It was showed that controlling the flow rate, it was possible to control both the 
mass transport and the shear stress presented to the hiPSCs. It was demonstrated that the 
control of the culture parameters (e.g., induction factors and fluid flow) was critical for the 
maturation and differentiation of the hiPSCs towards hepatocytes. The differentiated 
hepatocytes under perfusion had several important overlapping markers with fresh human 
precision cut liver slices thus indicating a high degree of hepatic differentiation. These 
results indicate the importance of controlling the cellular microenvironment to guide the 
hiPSCs differentiation towards the desired phenotype. Such control is mediated by the 
synergies created between the scaffold, bioreactor and induction factors, as previously 
discussed in chapter one. Although the presented in vitro system was capable of 
differentiating hiPSCs into hepatocytes with a high degree of hepatic differentiation, there 
are some issues that need to be addressed. The proposed PDMS porous scaffold does not 
present mechanical properties comparable with the one presented by the liver, which is 
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critical in guiding differentiation, as previously described by Engler et al. [2]. In addition, the 
porous architecture of the scaffold does not allow cell-cell and cell-ECM interactions in the 
3D space. This is because the mean diameter of the pores is ~ 150 µm. Stevens et al. 
showed how the scaffold architecture affects the cell binding and spreading [3]. For 
scaffolds with microscale architecture, the cellular adhesion is comparable to the one found 
in flat surfaces (i.e., 2D cultures) (Figure 6.1(A-C)), which is comparable with the cell-ECM 
adhesion of the hiPSCs cultured in the porous scaffold after 21 days (Figure 6.1D).  
 
Figure 6.1. Scaffolds with microscale architecture: (A) Microporous scaffold and (B) 
microfiber scaffold. (C) Nanofiber scaffold with nanoscale architecture. The 
image is reprinted from [3]. (D) 3D reconstruction of differentiate hiPSCs cells 
after 25 days of dynamic culture within a porous elastomeric scaffold with pore 
diameter of 150 µm. (Scale bar: 30 µm). 
These considerations led to the design of tissue engineered constructs (1) with 
targeted mechanical properties, (2) capable of inducing 3D interactions, and (3) able to 
integrate an efficient media exchanger. Therefore, in Chapter 3 is presented a fabrication 
technique capable of creating thick (~ 1 cm) engineered hydrogel constructs with integrated 
channel networks. Gelatin hydrogel, was crosslinked with transglutaminase thus tuning the 
mechanical properties of the final construct in the range of soft tissues (i.e., 1 – 12 kPa). 
Using the 3D molding technique, it was created a network of perfusable microchannels in 
the construct allowin the transport of oxygen and nutrients needed to maintain viable the 
encapsulated cells in the hydrogel. A fluidic mold was then developed to allow the 
engineered construct to be directly perfused, which was connected to a home-made fluidic 
platform integrating a peristaltic pump. To show the functionality of the fabrication method 
and platform, hepatospheres were encapsulated within the gelatin/TG hydrogel having a 2D 
Summary, conclusions and future work considerations 
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channel network and were actively perfused for seven days. We showed that the system 
and processes used to encapsulate the hepatospheres and structure the gel was 
biocompatible. Also, the ability of fabricate several perfusable networks suggested the 
possibility for the engineering of complex and thick tissue constructs with controlled micro- 
environment. 
The concept is further developed in Chapter 4. It was possible to create thick and 
densely populated constructs by encapsulating 15 million HepG2 cells in a 1.5 mL of 
gelatin/TG hydrogel with a stiffness of 3 kPa. The fabricated construct integrated a 3D 
perfusable vasculature, and was actively perfused for 15 days. It was showed that the active 
perfusion was critical for maintaining viable and metabolically active the encapsulated 
HepG2 cells in the gelatin/TG hydrogel. In fact, the HepG2 cells were capable of 
proliferating by forming spheroids with different dimensions (diameter of 40-70 µm) and 
different conformations (round and mass structures) [4]. These results illustrated how 
important is the control of the in vitro culture conditions. Also, it showed how important is 
the role of the construct material in creating the relevant ECM matrix environment to guide 
and to maintain the cells in the correct homeostasis [5,6]. These fabricated constructs could 
represent a step forward for the fabrication of functional constructs capable of shifting the 
paradigm of tumor modeling [7] as well as in drug studies [8]. The presented fabrication 
method could allow the fabrication of constructs with more relevant dimensions and, 
hopefully, with cell densities able to resemble the minimum number required to simulate a 
functional organ [9,10].  
To further illustrate the versatility of the presented fabrication method, in Chapter 5 
is shown the fabrication of a gelatin/TG device composed by two parallel microfluidic 
channels (1.2 cm long) separated by a gelatin membrane of 370 µm. The system was 
designed for the simulation of physiological barriers such as intestine and blood-brain 
barriers. Guides were used to incorporate electrodes horizontally into channels having 1.7 
mm diameter. The integrated electrodes were used to carry on real time impedance 
measurements across the barrier. These measurements could be used to extrapolate the 
trans-epithelial electrical resistance (TEER), which is an indication of the status and quality 
of the formed barrier. The electrical characterization of the sensor was performed by using 
buffers proving that different conductivities could be measured. Electrical signals varied 
very little (max ± 3.5 Ω) during 48h perfusion with medium, indicating that the device could 
support long term experiments. The presented model could represent a step forward for the 
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fabrication of fluidic devices mimicking more closely the physiological barrier 
microenvironment. 
6.2 Future work considerations  
In this thesis, we showed the fabrication of densely populated tissue constructs with 
controlled mechanical properties and a perfusable vasculature. However, the vasculature 
does not include the presence of endothelial cells, which is characteristic of the human 
vascular system. The need of creating an epithelial layer is crucial since it modulates the 
transport of molecules and nutrients throughout the barrier [11,12]. A future work 
recommendation could be the use of two different population of cells: one encapsulated 
into the hydrogel, and the second one lining into the conducts to generate a functional 
epithelium. This thesis demonstrated that an active perfusable 3D vasculature should be 
sufficient to maintain viable and metabolically active a high density of cells for several days. 
However, to further increase the dimensions of the construct along with the number of cells, 
the construct would need to be fully vascularized. At this moment, there are no fabrication 
techniques capable of creating engineered constructs with a vascular network comparable 
to the typical one found in the human body. However, It has been shown that endothelial 
cells encapsulated in the ECM should spontaneously induce the formation of a network in 
the construct that can naturally anastomose together with the pre-existent vascular network 
[13,14]. This is known as pre-vascularization and represents one of the possible strategies 
to create a vascular network guided by the maturation of the cells [15]. The pre-
vascularization has been investigated showing promising results [16,17]. Therefore, a future 
possibility could be (1) the encapsulation of endothelial cells together with another cell line 
in the gelatin/TG hydrogel to form a vascular network in the construct, and (2) the use of 
endothelial cells to form a monolayer within the engineered channel network as presented at 
this thesis. These two considerations are critical for creating fully vascularized tissue 
constructs [18].  
The fabrication method presented in this work allowed the creation of hydrogel-
based fluidic devices, with an integrated sensor, capable of simulating barriers. However, a 
barrier should include different cell lines lining in both sides of the barrier and parenchymal 
cells in between. Therefore, a future work should include multiple cells lines cultured within 
the device.  
Finally, around the fabrication method presented and with the fluidic platform, we 
envision the possibility of fabricating tissue engineered constructs capable of simulating 
Summary, conclusions and future work considerations 
 
 
 188 
different compartments that are connected in series or in parallel. This could represent a 
breakthrough and should allow the possibility to study the crosstalk between tissues, 
understanding as an example how a molecule absorbed through the intestine compartment 
could influence the liver cells in the liver compartment.  
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